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Surgical site infections (SSI) are common and can cause substantial patient 
morbidity and burden to health services. SSI outcome assessment is important 
for routine follow-up, research and audit but accurate assessment is 
challenging, particularly after hospital discharge. Existing tools for SSI 
assessment are limited. They are designed for healthcare professional 
completion in hospital, are complex to apply and do not identify SSI 
consistently. Patient-centred tools are lacking. This PhD set out to address the 
limitations of current methods for SSI assessment with two studies. 
Study 1 developed and validated a new SSI outcome measure, suitable for 
patient and/or healthcare professional completion after the patient has left 
hospital. An analysis of existing SSI tools and stakeholder interviews were 
undertaken to ensure content validity. Cognitive interviews were conducted to 
pre-test the measure. Finally, a large field-testing study was undertaken. 
Findings demonstrated that the measure was acceptable, reliable and valid for 
SSI assessment post-discharge.  
Study 2 developed and evaluated a method for remote wound assessment 
using patient-generated digital images. A review of wound-photography 
literature informed the development of photography instructions for patients. 
A process for patients to transmit images using their own mobile device was 
developed by adapting existing software. Pre-testing was undertaken with 
cognitive interviews and observations to study acceptability to patients. 
Evaluation of the method was performed with a further group of patients 
testing the method remotely. Findings demonstrated that the method was 
feasible, usable and acceptable, producing high quality images to supplement 
data from the SSI measure to identify SSI. 
The complementary methods developed in this work provide novel 
contributions to SSI outcome assessment, particularly for use when patients 
have left hospital. Future work is directed towards implementation and 
evaluation of these methods in routine follow-up, research and audit to 
enhance SSI outcome assessment, thereby improving surgical practice and 
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Study 1: Development and validation of a new outcome measure for SSI 
(Chapters 2 and 3). This study was embedded within the wider Bluebelle 
feasibility study: a two-year National Institute for Health Research (NIHR)-
funded feasibility study to explore whether it was possible to conduct a large 
multicentre randomised trial to compare the effectiveness and cost-
effectiveness of different types of wound dressings after elective surgery [1]. 
The author of this thesis co-led the development and validation of the SSI 
outcome measure sub-study, under supervision from Professor Jane Blazeby 
(Chief Investigator for the Bluebelle study and co-supervisor of this PhD) and 
Kerry Avery (co-supervisor of this PhD). Staff at the Bristol Clinical Trials and 
Evaluation Unit (CTEU) were responsible for the ethics application and 
management of the wider study, in which the SSI measure work was 
embedded. The author of this thesis contributed to the development of study 
documentation relevant to the SSI measure sub-study including the 
participant information leaflet (PIL) and case report forms.  
The author of this thesis undertook all steps in the content analysis of existing 
SSI tools, which involved identifying potentially important content domains 
to include in the new outcome measure (Phase 1). Identification of potential 
patient participants to take part in interviews to identify content domains 
(Phase 1) was conducted by research nurses and surgical trainees at 
participating centres involved in the wider Bluebelle study. A qualitative 
researcher from the Bristol Medical School, Alexandra Nicholson (A.N.) 
conducted and analysed the interviews. The involvement of another 
researcher to conduct the interview component of this study (rather than the 
author of this thesis) was necessary to adhere to timelines for the wider 





Transcription of interviews was supported by a research secretary at the 
Bristol Medical School. The author of this thesis conducted the synthesis of 
findings from the content analysis of existing literature and interviews (Phase 
1) and item formulation and design of the preliminary of the SSI measure 
(Phase 2), under supervision and with contributions from other members of 
the Bluebelle study team (Jane Blazeby; J.M.B., Barnaby Reeves; B.R.; Melanie 
Calvert; M.C. and Thomas Pinkney; T.P.). Identification of potential patient 
participants to pre-test the measure (Phase 3) was conducted by research 
nurses and surgical trainees at participating centres involved in the wider 
Bluebelle study. The author of this thesis conducted and analysed the 
cognitive interviews to pre-test the outcome measure (Phase 3), assisted by an 
academic foundation doctor (Thomas Milne; T.M.) as part of his academic 
training placement at the Bristol Medical School (for which the author of this 
thesis was co-supervisor). The author of this thesis led and managed the 
cohort field-testing study to validate the SSI measure (Phase 4). Identification 
of potential patient participants, recruitment and clinical data collection was 
conducted by research nurses and surgical trainees at participating centres 
involved in the wider Bluebelle study. A research associate (Katy Chalmers, 
K.C.) at the Bristol Medical School assisted with the final two months of the 
cohort study administration whilst the author of this thesis was on a second 
maternity leave. The Bluebelle pilot RCT, which contributed data to the 
validation of the SSI measure (Phase 4), was conducted by members of the 
wider Bluebelle study team and managed by the CTEU. The author of this 
thesis conducted all analyses for the validation of the SSI measure (Phase 4), 
with statistical guidance from Sara Brookes (S.B.) at the Bristol Medical 
School. The author of this thesis presented findings at Bluebelle study full 
team meetings throughout all phases of the study and comments and 





Study 2: Development and evaluation of a method for remote wound 
assessment using patient-generated digital images (Chapters 4 and 5). The 
author of this thesis led and conducted all phases of this study with 
discussion and review with her supervisors throughout. She was responsible 
for developing the protocol, the ethics application, the development and 
design of all study documents including participant information leaflets and 
interview topic guides, set-up and initiation of participating centres and staff 
training, survey administration, data collection and analysis and the patient 
and public involvement (PPI). Design of the study database and process for 
participants to transmit wound images was supported by a data manger 
(Alison Horne, A.H.). Research nurses and surgeons from participating 
centres identified and approached potential patient participants for both 
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CHAPTER 1.  SURGICAL SITE 
INFECTION AND METHODS 
OF ASSESSMENT 
 
“Decomposition or putrefaction has long been known 
to be a source of great mischief in surgery” 
Joseph Lister, 1867 
 
1.1. Introduction 
Infection of the wound after surgery, clinically known as surgical site 
infection (SSI), has been a problem throughout the history of surgery. In the 
early nineteenth century, wound infection was common and uncontrollable, 
literally causing decomposition, decay and rotting in the body. Mercifully, 
surgical practice has changed dramatically since the Victorian era when 
surgeon Joseph Lister pioneered wound infection control [2]. The significance 
of SSI and the importance of adopting measures to reduce it are now widely 
recognised. Accurate and reliable methods to assess and monitor SSI for 
routine surgical follow-up, research and audit, however, is an issue that 






This introductory chapter serves three main purposes. First, it describes 
surgical site infections: their history, prevalence and why they are a problem 
for patients and the health service. Second, the chapter describes how SSI is 
defined and the existing tools available for SSI assessment and diagnosis. 
Limitations of these tools are explained. Next, the concept of measurement 
theory is introduced, and the use of questionnaires and grading scales for 
measuring SSI. Finally, the chapter introduces the concept of using digital 
images as a method for remote wound assessment. It describes how advances 
in mobile technology provide a cutting-edge method for obtaining images 
directly from patients. The chapter concludes with a summary of these topics, 
bringing them together to outline the aims and objectives of this thesis. 
 
1.2. Surgical site infection: an overview 
1.2.1. What is a surgical site infection? 
A surgical site infection (SSI) is an infection that occurs in the part of the body 
where surgery took place [3]. It can be an infection in the layers of skin, or it 
can involve the underlying tissues or organs. An SSI occurs when bacteria 
multiply within a wound and produce toxins, triggering the body’s immune 
response. Consequences can range from minor symptoms of inflammation, 
such as swelling and pain, to systemic problems that affect the whole body, 
such as overwhelming sepsis. Sepsis occurs when the immune system 
overreacts and starts to damage the body’s own tissues and organ. It is life-
threatening and may result in death. Most SSIs are caused by contamination 
of micro-organisms from the person’s own body during surgery. Less 






1.2.2. The history of SSI  
Surgical site infections and the dangers and risks they pose have been 
notorious throughout surgical history. Until the 1840s before the era of 
antiseptics, the threat of contracting an infection in the wound after surgery 
was regarded as more dangerous than the primary surgery itself. The risks of 
surgery itself were already well recognised, and greatly limited the type of 
procedures that were attempted, with many surgeons restricting their scope 
to treatment of external problems such as minor skin conditions and 
superficial wounds, or only the most essential amputations [5]. In conditions 
where hospitals were notoriously known as ‘death houses’, many patients 
who survived surgery, however, succumbed to infections and many died as a 
result [5]. In London in the mid-1850s, approximately 50% people undergoing 
surgery for an amputation died, with most of those deaths attributed to SSI 
[6].   
 
Several revolutionary medical advances took place in the Victorian era that 
led to the understanding of how infections are contracted, and that 
contamination is caused by germs. In the 1860s, Lister’s discovery of the 
benefits of using antiseptics for sterilising surgical practice was game-
changing, substantially reducing rates of SSI [2,5]. Clean operating theatres, 
sterile instruments and basic procedures like hand washing, for example, are 
now standard practice. Evidence from randomised controlled trials (RCTs) 
has further extended this knowledge, and many more effective interventions 
to reduce SSI are known. Many SSIs are avoidable, and guidance is available 
for their prevention and treatment in the UK and worldwide [4,7].  Current 
UK National Institute for Health and Care Excellence (NICE) guidance, for 





intraoperative and postoperative surgical phases [8]. Examples include 
advising patients to bath or shower before surgery, using antiseptic skin 
preparations during surgery and using sterile saline to clean wounds after 
surgery. Ongoing research seeks to find further interventions to prevent SSI. 
The use of antimicrobial-impregnated drapes, sutures and specialist wound 
dressings, for example, are some of the interventions currently being 
evaluated [9]. Despite preventative advances, SSIs still occur in surgical 
practice. They continue to pose a significant threat and represent a global 
healthcare problem in surgery today, affecting millions of people worldwide 
[7]. 
 
1.2.3. The effect of SSI on the patient and the health 
service  
The severity of SSI can range from minor, non-problematic infections to more 
major, serious infections. In today’s surgical practice, most SSIs are 
superficial. They may involve minor symptoms such as redness or swelling 
around the wound, or some leaking of fluid. These symptoms can mostly be 
resolved with simple treatment of oral antibiotic therapy. The control of SSIs 
has undoubtedly been transformed since the discovery of antibiotics. There is 
a tendency, however, to over-treat, meaning that SSIs may contribute to the 
spread of antibiotic resistance [7]. Other SSIs can, however, have more serious 
effects. Patients may require admission to hospital for intravenous antibiotics. 
Serious infections can cause abscesses which may require treatment in theatre, 
for example, re-opening the wound to drain fluid or pus. Significant costs to 
the health services may be endured, requiring hospital readmissions and 
extended hospital stays [10]. When a serious SSI has occurred, there is often 





patients’ quality of life and ability to return to work. The most severe SSIs can 
still be life-threatening today.  
 
1.2.4. The prevalence of SSI 
SSIs are one of most common adverse events to occur after surgery [11]. 
Surgery plays a major role in treating patients in today’s society, with 
approximately eight million surgical procedures estimated to be performed in 
the UK each year [12]. It is estimated that at least one in every 20 (5%) patients 
undergoing a surgical procedure will develop an SSI [4]. The number of 
people at risk of SSI is therefore high [13].  After pneumonia and urinary tract 
infection, SSIs are the third most common healthcare-associated infection 
(HCAI) in Europe, compromising 18.4% of all HCAI infections in 2016-2017 
[14,15]. Around 800,000 cases of SSI per year have been estimated in the 
European Union and European Economic Area (EU/EEA), with an estimated 
16,049 resulting in death [16]. 
Incidence of SSI varies depending on many factors, such as the part of the 
body in which the surgery is performed, whether surgery is elective or 
unplanned and patient risk factors. The risk of contracting an SSI are greater, 
for example, if the surgery is an emergency procedure or in an area 
susceptible to contamination, such as the bowel [17]. Longer or more complex 
surgeries also carry an increased risk. Patients who suffer from co-morbidities 
are more likely to experience an SSI. Other patient risk factors include 





1.2.5. Timing of SSI appearance   
In today’s healthcare systems in developed countries there is a drive for 
shorter hospital stays. The changing nature of care, including advances in 
minimally invasive surgical technologies and enhanced recovery 
programmes, means that the proportion of day case surgeries has increased. 
Consequently, signs and symptoms of SSI often become apparent after the 
patient has left hospital; a situation that is becoming increasingly more 
common as hospitals stays become shorter. A systematic review of studies 
published over the last 20 years found that, of 140,000 infections diagnosed, 
most (60.1%, range 13.5% to 94.8%) occurred after hospital discharge [18]. The 
appearance of SSI after patients have left hospital presents several challenges 
for SSI assessment and the accurate measurement of SSI rates. This issue is 
fundamental to the aims of this thesis and will be described in more detail 
later in this chapter. First, it is important to describe why it is essential to 
accurately assess SSI as an outcome and measure and monitor SSI rates.  
 
1.2.6. The importance of SSI outcome assessment  
Assessment of SSI is crucial for routine surgical follow-up, research and audit. 
After surgery, monitoring of the wound for SSI is important so that early 
detection of problems can be treated and prevent further consequences [8]. In 
research and clinical trials, accurate SSI outcome assessment is essential in 
order to effectively evaluate interventions for their prevention or treatment 
[19,20]. Surveillance of SSI in-hospital statistics is necessary for benchmarking, 
that is, the sharing and comparing of practice across different hospitals, with 
the aim to identify best practice and to develop plans to remedy poor practice 





setting in the healthcare service; that is, deciding which interventions to carry 
out with the aim to reduce SSI.  
 
In the UK, there are several current initiatives in place to capture information 
on SSI rates. Public Health England (PHE) has a surgical site infection 
surveillance service (SSISS) which aims to help hospitals in England record 
incidents of SSIs and use the results to review or change practice as necessary 
[22]. The programme started in 2004 under the former UK government-
funded Health Protection Agency (HPA). Surveillance of SSI is mandatory in 
four types of orthopaedic surgery (hip replacements, knee replacements, 
repair of neck of femur and reduction of long bone fracture) under the PHE 
scheme. Surveillance is voluntary in 13 other surgical categories (for example, 
breast and cardiac surgery). Since 2016, the UK also has the Getting it Right 
First Time (GIRFT) programme; an initiative funded by the Department of 
Health that aims to improve the quality of care within the National Health 
Service (NHS) by reducing variations in the way that services are delivered 
and encourage the sharing of best practice [23]. A major project and cross-
cutting theme in the programme is an SSI audit; set up to measure and review 
SSI rates and review current practice in SSI prevention [24]. The UK also has 
the National Wound Care Strategy Programme (NWCSP), commissioned by 
NHS England and NHS Improvement in 2018 [25]. The aim of the programme 
is to improve the quality of wound care across England. Surgical wounds are 
one of three types of wound under focus of the programme (others being 
pressure wounds and lower limb wounds) with improved monitoring and 
measurement of SSI high on the agenda. These initiatives are, however, faced 
with challenging and problematic accurate SSI assessment. These issues will 





1.2.7. Problems with SSI assessment 
Accurate SSI assessment is challenging, hindered in part by the fact that 
patients are increasingly discharged soon after their surgery. This means that 
methods for detecting SSI post-discharge are required to obtain accurate data 
of SSI incidence. Robust methods for post-discharge follow-up, for example, 
telephone calls and face-to-face assessments are, however, resource-intensive 
and costly [26]. As a result of different methods for collecting SSI data, wide 
discrepancies in reported rates of SSI exist. For example, data from SSI 
surveillance in NHS hospitals in England report an incidence of inpatient and 
readmission SSI in large bowel surgery of 8.7% [27]. This does not, however, 
include cases of SSI that occur post-discharge that are treated in the 
community. It is likely, therefore, that it considerably underestimates the true 
incidence of SSI. In contrast, estimates of SSI rates after elective colorectal 
surgery in Spain, when surveillance included post-discharge SSI, have been 
reported to be as high as 20.7% [28]. Data from trials have reported higher 
rates still, with SSI incidence in patients undergoing laparotomy (incisions 
into the abdomen) reaching 25.4% [29]. This variation in reported SSI rates 
can, in part, be attributed to the methods used to detect SSI and collect 
information for surveillance programmes compared to research studies. The 
availability of resources such as staff, for example, will impact on the 
robustness of data collection and the procedures and methodology used for 
follow-up. It has been argued the most reliable SSI rates are provided by 
control arms of RCTs, where a more motivated and dedicated approach to 
patient follow-up enables more accurate detection of SSI after hospital 
discharge. Problems resulting from limitations of existing methods used for 






In summary, challenges are faced with accurately determining whether 
patients have experienced an SSI. A major challenge is that many SSIs occur 
after the patient had left hospital and robust methods for post-discharge 
surveillance are resource intensive and costly. A further and related challenge 
is that the existing tools that are used to diagnosis and measure SSI have 
limitations. The following paragraphs introduces this issue, describing the 
currently available tools and their shortcomings. 
 
1.3. Diagnosing and measuring SSI 
Accurate and reliable methods for detecting and diagnosing SSI are crucial in 
tackling the big problem that SSIs continue to be in global health today. As 
described at the start of this chapter, SSI is caused by bacteria multiplying 
within a wound and causing a reaction [3]. Diagnosing SSI, however, is 
complex, which causes problems for accurate assessment of SSI rates 
important for research, benchmarking and priority setting, as described. 
Defining or diagnosing SSI is complex because it is not a single entity that can 
be measured directly, like height or weight [30]. Instead, it is diagnosed or 
defined from multiple characteristics, including clinical signs and symptoms. 
Some of these signs and symptoms are directly observable (such as swelling, 
for example), while others are not (such as pain). Diagnosis of SSI may also 
include microbiological evidence of bacterial infection. The combination of 
signs and symptoms that are commonly used to define an SSI are described 
below, followed by a summary of existing tools that are currently available 






1.3.1. Defining SSI  
What defines surgical site infection?  
There is no single agreed definition of SSI. Various definitions are available 
and used in practice. A methodologically robust systematic review of SSI 
measurement and monitoring conducted by Bruce et al. in 2001 [31] identified 
the most commonly used definition by far was that published by the U.S. 
Centres for Disease Control and Prevention (CDC) [32,33]. This remains to be 
the most used definition, demonstrated, for example, in a Cochrane overview 
of systematic reviews of interventions for preventing SSI during surgery [19]. 
The CDC categorises three types of SSI: superficial, deep and organ/space. 
The different types are determined by on a combination of criteria that must 
be met, including signs, symptoms and microbiology. Criteria include, for 
example, localised pain, swelling, purulent exudate (pus), presence of an 
abscess, wound dehiscence or organisms identified from microbiological tests. 
The combination of criteria required to meet the different types of SSI are 
displayed in Box 1.  
 
The CDC definition was first published in 1992 and was updated in 2008 to 
distinguish between deep incisional primary (DIP) and deep incisional 
secondary (DIS) SSIs [32]. Despite being widely used in surveillance 
programmes and research [34,35], the CDC definition has been criticised as 
being complex to use and difficult to apply in practice [36,37]. For example, a 
study demonstrating poor reliability between surgeons’ diagnosing SSI using 
the CDC criteria questioned whether differences were due to subjectivity and 
interpretation of the CDC criteria or true differences in clinical interpretation 
[37,38]. With this in mind, the UK Nosocomial Infection National Surveillance 





version of the CDC diagnostic criteria for SSI, with the aim to improve its 
objectivity and practicality for use in a hospital setting [39]. For example, the 
criterion of “diagnosis of a superficial incisional SSI by the surgeon, attending 
physician or other designee” was excluded due to its vagueness and 
subjectivity as a criterion for diagnosis. Despite this, the combination of 
criteria that make up the definition remains complex to use. There is still 
considerable subjectivity because assessment allows for only dichotomous 
yes/no judgement of whether criterion for signs and symptoms have been 






Box 1. Centres for Disease Control and Prevention (CDC) definitions and 
criteria for SSI (2014) [40]
  
Superficial Incisional Infection 
SSI involving only the skin or subcutaneous tissue of the incision AND occurs within 30 days of 
surgery AND meets at least one of the following criteria: 
1. Purulent drainage from superficial incision 
2. Organisms isolated from an aseptically-obtained culture from the superficial incision or 
subcutaneous tissue 
3. Incision deliberately opened to manage infection and is culture positive or not cultured and at 
least 1 symptom of: pain/tenderness, localised swelling, redness or heat 
4. Clinicians’ diagnosis of superficial SSI 
Note: Stitch abscesses (minimal inflammation/discharge at suture point) do not classify as SSI 
Deep Incisional Infection 
SSI involving the deep tissues (i.e. fascial & muscle layers) AND occurs within 30 days of surgery 
AND meets at least one of the following criteria: 
1. Purulent drainage from deep incision (not organ space) 
2. Deep incision dehisces or is deliberately opened and is culture positive or not cultured and 
patient has at least 1 symptom of: fever (<38oC) or localised pain/tenderness 
3. Abscess or other evidence of infection involving the deep incision that is detected on re-
operation / histopathology / radiology 
Note: An infection involving both superficial and deep incisional = deep incisional 
Organ/space Infection 
SSI involving any part of the body deeper that the fascial/muscle layers that is opened or 
manipulated during the surgical procedure AND occurs within 30 days of surgery AND meets at 
least one of the following criteria: 
1. Purulent drainage from a drain that is placed into the into organ/space (e.g. closed suction 
drainage system, open drain, T-tube drain, CT guided drainage) 
2. Organisms isolated from an aseptically-obtained culture of fluid or tissue in the organ/space  
3. Abscess or other evidence of infection involving the organ/space that is detected on re-
operation / histopathology / radiology 





The Bruce et al. 2001 systematic review identified other standard definitions 
for SSI [31]. These, however, are less detailed and comprehensive than the 
CDC definition and are not widely used in current practice. One example is 
the definition developed by Glenister and colleagues [41]. The definition 
specifies that a wound infection must have purulent discharge, with major 
infection present when the wound is also broken down, gaping or completely 
dehisced, or there is evidence of septicaemia, spreading cellulitis or 
lymphangitis. Another example is the definition published by the UK Surgical 
Infection Study Group (SISG) in the early 1990s [42]. The proposed definition, 
intended to be suitable for bedside diagnosis, includes purulent discharge in, 
or exuding from, the wound, or a painful, spreading erythema indicative of 
cellulitis. It states that infection should be considered to be present when 
there is fever, tenderness, oedema and an extending margin of the erythema 
[42]. Also in the early 1990s, the second UK National Prevalence Survey (NPS) 
published a definition almost identical to that from the SISG with the 
exception not defining SSI by the timeframe in which it presents [43]. 
Although these definitions for SSI vary in the number and combination of 
indicators used to define SSI, there are many similarities and substantial 
overlap in the indicators that they describe. Purulent discharge, redness and 
swelling, for example, are shared features of all definitions [11,31]. A criticism 
of all these definitions used to diagnose SSI, however, is that they are based 
on a simple, dichotomous clinician’s judgement of whether a sign or 
symptom is present or absent. This judgement can be highly subjective and 
can vary depending on the person assessing the wound. In addition, none of 
these definitions provide an opportunity to take the severity of the individual 







1.3.2. Existing tools for diagnosing and measuring 
SSI  
Several tools have been developed to facilitate SSI diagnosis and assessment. 
The review by Bruce et al. (2001) and a subsequent 2006 systematic review of 
methods for identifying SSI after hospital discharge [31,44], for example, 
identified SSI criteria checklists, grading scales and questionnaires for 
patients. These tools will now be described, and their strengths and 
limitations compared. A scoping search conducted for the purpose of this 
thesis verified that no new validated tools had been developed since the 
Bruce et al. 2001 review was undertaken.  
 
Checklists of SSI criteria  
The most commonly used tools in SSI surveillance and research are based on 
the CDC criteria and definition for SSI [31]. In practice, these are typically 
‘checklists’ of criteria, that is, written lists of the individual diagnostic criteria 
that contribute to the definition of SSI. For example, the UK PHE SSISS 
surveillance programme uses a checklist of SSI criteria based on the CDC 
definition in their surveillance data collection sheets. A list of the diagnostic 
criteria from the CDC definition, for example “localised swelling” and 
“purulent drainage”, are listed in alphabetical order in the data collection 
forms, with an accompanying ‘tick box’ next to each criterion. If the wound 
displays a sign or symptom that is included in the list, the person assessing 
the wound can mark on the checklist that the sign or symptom is present by 
ticking the adjacent box. Responses can then be used to determine whether 
the combination of criteria that determines SSI in the CDC definition has been 





Simple checklists of criteria based on SSI definitions may be helpful in 
practice to record information to aid diagnosis and categorise SSI, but they 
have their limitations. As mentioned in the previous section, judgements are 
limited to a binary “yes” or “no” opinion. This judgement is subjective, 
meaning responses can vary between individuals who are assessing the 
wounds and consequently can lead to inconsistent diagnoses between 
assessors. There may be variation in the interpretation of, for example, what 
purulent discharge is. There may also be variation in the judgement of what 
amount of discharge would qualify as meeting that criterion because only a 
‘yes’ or ‘no’ response is allowed. This subjectivity in judgement can mean that 
diagnoses may be inconsistent when different people assess the wound, and it 
can also mean diagnoses may vary when the same individual assesses the 
wound. This has problems for SSI measurement and monitoring as it may 
lead to variability in SSI rates, by calling into question the accuracy and 
reliability of the data.  
 
Fundamentally, checklists of SSI criteria don’t ‘measure’ SSI because they do 
not quantify the frequency or severity of a contributing sign or symptom; 
instead, they simply record whether a sign or symptom is present or absent. 
These observations are then combined to inform a decision as to whether an 
SSI is present or not (that is, a binary outcome). The following paragraphs 
introduce the idea that SSIs can, instead, be more quantitatively measured 
using a numerical scale. First, the theory of how health, and health conditions, 
may be assessed (measured) is introduced before describing how the theory 







Since the mid-1900s, medicine has benefitted from the development and 
application of what is commonly referred to as measurement theory, and 
accompanying statistical models, to assess unobservable health conditions 
[30]. Popularised from the fields of psychology and education, a measurement 
theory approach is based on the philosophy that underlying, unobservable 
traits and characteristics, for example, intelligence, can be assessed indirectly 
from observable ‘measurable’ indictors, such as reading and language ability 
[45]. Translating this to medicine, measurement theory implies that many 
unobservable health conditions are reflected by observable characteristics that 
are related to and represent that underlying health condition. To apply this in 
practice, it is first necessary to define the health condition. The question 
“What is the ‘concept’ of the health condition?” needs to be considered. Next, 
the application of measurement theory requires the selection of indicators 
(observable characteristics) that represent that concept. Finally, numerical 
scores are assigned to these indicators so that the health condition can be 
‘measured’ [30,46]. 
 
Health measurement instruments 
In comparison to checklists of SSI criteria, health measurement instruments 
are tools that help us to measure, rather than simply record, the observable 
characteristics or indicators of health or a health condition. They vary in terms 
of where they lie on the subjective-objective spectrum. Instruments that 
measure biological and physiological indicators, such as blood pressure 
monitors and laboratory tests, for example lie at the more objective end of the 
measurement spectrum. They allow measurement with minimal or no need 





measurement [46]. Although these appear objective, they are subject to 
measurement error as for any tool [47]. At the other end of the spectrum lie 
subjective measurement instruments, which are influenced by the person 
performing the measurement, or the actual person being measured 
themselves. Examples include measurement of patients’ symptoms; feelings 
that are directly experienced by the patient. Other examples include 
measurement of clinical signs; characteristics that can be observed by the 
clinician examining that patient [46]. For the context of this thesis, only tools 
that can be completed by a patient or clinician will be examined. It will not 
include tools such as laboratory tests. 
 
Historically, assessment of subjective health indicators was limited to 
conversations between the patient and the clinician in face-to-face 
assessments. Since the 1930s the assessment of subjective health indicators has 
advanced. Much has been accomplished in methodology for developing tools 
to assess subjective states through the use of questionnaires and rating scales 
[30]. Accurate measurement, however, requires carefully developed and 
validated tools to ensure that data are reliable and valid. The properties 
required for a measurement tool to be considered high quality will be detailed 
in the following chapter. Questionnaires and rating scales typically comprise 
a list of ‘items’, often written as questions, with response options that can be 
answered by the person completing the tool [46]. Items are developed to 
collect information on a specific ‘indicator’ of the health issue of interest, with 
responses that can be scored in a meaningful way. If several items are scored 






Questionnaires and rating scales offer several advantages for measuring 
health. They can be developed for healthcare professionals to complete. They 
can also be developed to collect data directly from patients themselves. 
Patient-completed tools are important for measuring patients’ experiences 
and symptoms. They are referred to as patient-reported outcome measures 
(PROMs) [49]. Patient-completed tools also have advantages for remote data 
collection when the patient can complete and return data by post or using 
electronic data collection systems. There is also a new form of tool that has 
been developed although not yet validated called a universal-reporter 
outcome measure (UROM). This is a single tool that can be completed by a 
patient and/or a professional, when applicable [50].  
 
Following this brief description of measurement theory and health 
measurement instruments, it will now be explained how this relates to 
measuring SSI.  
 
SSI grading scales   
A grading scale is a name that has been given to a type of measurement 
instrument that can be used to describe the severity of a condition. While 
there are no SSI grading scales for patient completion, clinician-completed SSI 
grading scales exist. Unlike the tools based on the CDC criteria and definition 
for SSI which allow for a binary (yes/no) outcome, a grading scale allows for 
a measurement of SSI along a spectrum of severity. The most commonly used 
grading scale is the ASEPSIS grading scale [51]. The ASEPSIS grading scale 
was developed in the early 1980s as a ‘wound scoring method’ for use in a 
randomised controlled trial of antibiotic prophylaxis in cardiac surgery. It 





assessed by the clinician for each wound. Observable characteristics listed in 
the tool include serous exudate, purulent exudate, erythema and separation of 
deep tissue. Responders are asked to indicate the proportion of the wound 
affected. Further non-subjective criteria include, for example, treatment with 
antibiotics and wound debridement. Responses are assigned numerical scores 
(termed in the tool as ‘points’) with additional points for the objective criteria 






Box 2. ASEPSIS grading scale (Additional treatment, the presence of Serous 
discharge, Erythema, Purulent exudate, and Separation of the deep tissues, 
the Isolation of bacteria, and the duration of inpatient Stay) 
 
Points scale for daily wound inspection  
  
Wound characteristic  
Proportion of the wound affected (%) 
0 <20 20-39 40-59 60-79 >80 
Serous exudate 0 1 2 3 4 5 
Erythema 0 1 2 3 4 5 
Purulent exudate 0 2 4 6 8 10 
Separation of deep 
tissues 0 2 4 6 8 10 
The wound score  
Criterion Points 
Additional treatment   
Antibiotics 10 
Drainage of pus under local anaesthesia 5 
Debridement of wound (general anaesthesia) 10 
Serous discharge* daily 0-5 
Erythema* daily 0-5 
Purulent exudate* daily 0-10 
Separation of deep tissues* daily 0-10 
Isolation of bacteria 10 
Stay as inpatient prolonged over 14 days. 5 
* Given score only on 5 of first 7 postoperative days  
Category of infection: total score 0-10=satisfactory healing; 11-20=disturbance 
of healing; 21-30=minor wound infection; 31-40=moderate wound infection; 
>40=severe wound infection 
 
The ASEPSIS grading scale has been recognised as less subjective than other 
methods for assessing wounds for infection such as the CDC criteria 
described above [52]. This is because attempts to quantify the proportion of 
the wound affected can be considered rather than a binary yes/no judgement 





grading of the severity of the problem. The ASEPSIS scale has shown good 
reliability between assessors and is comparable and reproducible [11,36,53]. 
Despite being recognised as an important development in SSI measurement at 
the time of its conception, the ASEPSIS grading scale has limitations for SSI 
measurement and is less widely used than the CDC definition [52]. It was 
developed for use in-hospital by healthcare professionals and requires a daily 
assessment of the wound. This can be timely and resource intensive. 
Applying an estimate of the proportion of the wound can also be difficult in 
practice. Studies have reported that the score is cumbersome to collect and 
may need to be simplified to be clinically viable [37]. In addition, head-to-
head comparisons of SSI diagnoses when both the CDC and ASEPSIS tools 
have been used have found inconsistencies in numbers of SSIs diagnosed 
[36,37,54,55]. These limitations of the ASEPSIS grading scale are summarised 
in Box 3. 
Other grading scales for SSI exist [31]. They have not, however, been widely 
adopted, with little evidence of their use outside of the studies in which they 
were developed [31]. These grading scales were primarily developed for use 
within individual studies, were not developed with robust methodology and 
have not been validated. The exception is the Southampton Wound 
Assessment scale, which was the only other grading scale identified in the 
review that had been assigned a specific name [56]. The Southampton scale 
was developed in 1992 for detecting wound complications after hernia 
surgery. The scale comprises five grades determined from assessments of 
bruising or haematoma, erythema and other signs of inflammation, clear or 
haemoserous discharge, pus and ‘deep or severe wound infection’. The scale 
has been validated and used in subsequent studies outside of hernia surgery 
but, like ASEPSIS, has been criticised as labour-intensive and time-consuming 





Box 3. Weaknesses and limitations of the CDC definition and ASEPSIS 
grading scale - the most commonly used SSI definition and grading scale 
identified in the Bruce et al. 2001 review 
 
Definition / grading scale Weakness/ limitation 
CDC • Subjective interpretation of criteria 
 • Binary yes / no judgements; no 
grading of severity 
 • Complex combination of criteria to 
define SSI; difficult to use in 
practice  
 • Poor reliability between assessors 
ASEPSIS grading scale • Developed for use in-hospital 
 • Time consuming to complete 
 • Resource intensive; requires daily 
assessment of the wound 
 • Requires estimation of the 
proportion of the wound affected 
which can be difficult in practice 








Health measurement instruments can be designed as questionnaires for 
patient and/or clinician completion, as previously described. There are, 
however, no existing questionnaires that have been developed and validated 
specifically as a measurement instrument for SSI. This was evident from the 
systematic reviews conducted by Bruce et al. in 2001 and Petherick et al. in 
2006 [31,44]. The reviews identified some questionnaires designed to 
supplement other data collected from hospital records or data reported by 
clinicians. Examples include the PHE SSISS Post-Discharge Questionnaire 
(PDQ) (Appendix 4). The questionnaire was designed for patients to complete 
30 days following surgery. It includes items to collect information on possible 
SSI signs and symptoms (such as wound redness and pain), antibiotic 
prescription and hospital admissions for SSI, and is used to supplement 
surveillance data as part of the SSISS programme. An ASEPSIS-associated 
patient questionnaire also exists and has been used in trials to collect 
information on SSI signs and symptoms from patients after leaving hospital 
[57,58] (Appendix 5). Although designed for patient completion, neither the 
PHE nor the ASEPSIS-associated patient questionnaires involved patients in 
their development, which is now recognised as a key quality indicator of 
questionnaire development and validation [45]. They have also not been 
formally validated or tested to ensure the language is appropriate and 
understood by patients. Importantly, they were not developed for use as a 
standalone tool for SSI measurement or diagnosis. Instead they were designed 







In summary, problems with SSI assessment remain. The current, most 
commonly used tools for diagnosing and measuring SSI are sub-optimal, as 
detailed in Box 3. Importantly, the CDC definition and the ASEPSIS grading 
scale were designed for completion by a healthcare professional in a face-to-
face assessment with the patient. They are suitable for use if the patient is still 
in hospital. After the patient has been discharged, however, assessment of the 
wound using these tools becomes more complicated. Bringing the patient 
back to hospital for a face-to-face assessment may be logistically or practically 
challenging for patients. Being seen in the community for a face-to-face 
assessment, for example, by a healthcare professional visiting the patient at 
home, is resource intensive and expensive. Use of these tools do not allow for 
remote assessment and have implications, therefore, for trials and routine 
surveillance. An SSI outcome measure suitable for patient completion could 
allow for remote assessment, however, no such tool exists.  
 
Evidence suggests there is a need for better measures and methods for SSI 
assessment after hospital discharge, the time when SSI signs and symptoms 
most often become apparent. A new tool – a measurement instrument that is 
reliable, valid and suitable for use both in-hospital and after the patient has 
left hospital - is needed. A tool that can be completed by healthcare 
professionals and by patients is desired so that it can be used in either or both 
of these settings. The following paragraphs will now turn to another method 
with potential to address the challenge of assessing wounds after the patient 
has left hospital. The use of technology and digital wound images will be 
described and how this may benefit SSI outcome assessment after the patient 






1.4. The use of digital photography for 
assessing wounds  
There is a growing body of evidence that a photographic image of the wound 
is a valuable tool for monitoring and aiding the diagnosis of various wound 
complications [59-61]. This has obvious advantages for remote wound 
assessment, when the specialist is unable to see the patient face-to-face or 
when there is a need for regular monitoring of how the wound is healing. 
Being able to review an image of the wound has advantages when clinic visits 
are difficult for logistical or financial reasons. Whilst other information is also 
required for identifying and diagnosing SSI, such as patient reports of 
symptoms, for example, images may be used together with such data 
providing a valuable method for remote post-discharge follow-up and SSI 
outcome assessment [62].  
 
1.4.1. Existing use of wound images in research and 
routine practice  
The use of digital images in healthcare is well established. Reviewing images 
is an integral part of telemedicine, defined as “the use of electronic 
information and communications technologies to provide and support health 
care when distance separates participants”[63]. In dermatology, for example, 
remote monitoring of patients’ skincare conditions using photographic 
images has been used for decades [64,65]. Specifically in the field of wound 
care, telemedicine and digital images have been used as a method for 
monitoring of chronic wounds, such as leg ulcers [66]. In the context of 





outcome assessment to take place. This can avoid any systematic difference 
between groups in how the outcomes are assessed (that is, detection bias) 
because knowledge of the intervention group is unknown [67]. An example is 
the WOLLF trial; a randomised controlled trial that used images for assessing 
wound healing in open fractures of the lower limb [68]. Images were 
reviewed by independent clinicians who were blinded to the treatment 
allocation. In these examples, images have been taken by nurses during 
follow-up home visits and transmitted to specialists in the hospital or the 
research team. 
 
1.4.2. The use of digital images for diagnosing and 
monitoring SSI  
The use of digital images for assessing surgical wounds is less common than 
other areas of wound care. A 2016 systematic review, for example, examined 
how telemedicine was used to facilitate recovery after a patient left hospital 
following surgery in the US [69]. From 21 included studies, the use of digital 
images for postoperative wound monitoring was reported in only two case 
series.  
 
The use of digital images for diagnosing SSI is, however, an area of growing 
interest. A small number of studies have examined the use of digital images 
for assessing wounds for SSI. A study in the US explored the impact of a 
digital image of the wound on diagnostic accuracy of SSI [70]. Surgeons’ SSI 
diagnosis based on a scenario of surgical history, physical exam and wound 
appearance was compared first without, and then with, accompanying 





surgeons’ confidence significantly improved with the addition of the images. 
This study, however, had some limitations. It used a scenario-based design 
rather than actual clinical cases. In addition, the wound images had been 
taken by a healthcare professional while the patient was still in-hospital, 
meaning its relevance to post-discharge wound assessment is unknown. A 
study undertaken in the US and Netherlands found that the use of wound 
images alongside clinical vignettes increased specificity but worsened 
accuracy and sensitivity for SSI diagnoses [71]. As with the previous study, 
this was based on scenarios using data collected from patients’ hospital 
records. The study, did, however, use patient-generated wound images. For 
images to be used as a method for remote assessment of wounds post-
discharge, patient provision of wound images would offer significant 
advantages. The following paragraph will now turn to the idea of the patient 
as the photographer and the provider of their own wound images after 
leaving hospital. 
 
1.4.3. Patient provision of wound images  
Advances in technology, including mobile devices such as smart phones, now 
provide an opportunity for patients to take and transmit images of their 
wound using their own devices. A high proportion of adults in the UK own 
or have access to a smartphone. The annual statistical survey published by 
Ofcom, the government-approved regulatory and competition authority for 
the UK communications sector, estimated that 78% of adults in the UK use a 
smartphone and 90% of people have access to the internet in the home [72]. 
Mobile phones are recognised as an ideal platform in telemedicine, with 
advantages of internet access, text messages, cameras, applications (apps) and 





pressure monitors [73]. Indeed, the emergence of ‘medical selfies’ and the 
concept of ‘selfie telemedicine’ have been reported in recent literature and 
media headlines [74]. 
 
The advantages of patient-taken images for remote wound assessment are 
clear. From the patient’s perspective, the need to travel and take time off work 
for face-to-face visits is reduced. For healthcare providers, fewer clinic visits 
mean the burden on resources can be reduced, saving costs. The same 
advantages also apply to follow-up assessment in RCTs. Real-time monitoring 
of wound healing using images may also facilitate the earlier detection of 
problems [62].  
 
1.4.4. Wound images as part of mobile phone ‘apps’ 
Recent work in the US has specifically explored patient-provided images of 
wounds for SSI diagnosis using mobile technologies. Funded by the U.S. 
Health Technology Assessment (HTA) in 2017, work was undertaken to 
evaluate and define the roles of patient-generated health data (PGHD) and 
mobile devices in post-operative surgical care and SSI surveillance [75,76]. 
The programme of work included a review of the literature including a 
technical and market review of available post-operative mobile apps. The 
review identified 11 apps specifically developed for patients to report 
information about wound healing after surgery; with eight including a 
wound image as part of the app. Findings demonstrated that patient-
submitted images were beneficial for identification of post-op complications 
and reducing readmissions. The use of apps for SSI surveillance and in 





and resource use burden. As well as costs for the healthcare providers 
associated with initial purchasing and ongoing technical management the 
app, training for patients in how to use it may be required. Furthermore, 
patients may not always have the appropriate mobile devices to support the 
app [66].  
 
1.4.5. Feasibility of obtaining patient-provided 
images 
Several challenges exist surrounding the use of patient-provided wound 
images for the assessment of wounds for SSI remotely. Firstly, it may not be 
possible for all patients to take and transmit images. The process relies on 
patients having the appropriate device to take and transmit the image and the 
ability to use the device and technology. The capacity of the research team or 
healthcare service to receive and process the images is also critical. Secondly, 
there may be challenges surrounding the suitability of the image for assessing 
wounds for SSI. It is important that the image is standardised so that it is of 
adequate quality and clarity for clinical use and that relevant features of the 
wound can be examined [77-79]. Standardisation is important if there is a 
need to compare images over a period of time, often important for monitoring 
would healing [77]. Challenges in extracting clinically-useful wound features 
from non-standardised images taken by patients or their carers at home have 
been highlighted [78]. Different lighting conditions compared to clinical 
environments, for example, and patient positioning, obstructions and framing 
of the wound in the image are all issues that may affect the quality of the 
image. The authors report how these issues have not been addressed in 
existing literature. Image quality was one of the issues experienced in a pilot 





[80]. In this study, however, healthcare professionals were responsible for 
photographing the wound and authors reported the problems with quality 
related mainly to staff skills rather than camera quality. Evidence suggests, 
therefore, that high-quality instructions for patients are needed to ensure a 
clear, standardised wound image that it is clinically useful and fit for purpose 
is provided.  
 
Some studies have explored patient views on the acceptability and feasibility 
of providing their own wound images remotely. A qualitative study with 
patients who had experienced post-discharge wound infection following 
abdominal surgery in the US explored patients’ views on the acceptability of 
using a mobile application for identifying and managing wound 
complications after surgery [81]. The app included questions on symptoms 
and a function to take and submit a wound image. Interviews found that a 
wound monitoring application was highly acceptable to most participants. 
Some concerns were raised, however, including the lack of an appropriate 
device or problems with usability, such as difficulty using the application 
itself. The study findings are, however, limited by a hypothetical scenario and 
the use of paper mock-ups of the app, rather than participants being able to 
test a working version. The study had a relatively small sample size of 
thirteen participants. Other pilot work with patients undergoing general 
surgery has demonstrated that patients are willing to take and submit images 
of their wound for post-operative assessment [82].  
 
Another example of a wound care application (a product called “Wound 
Check”) for use after surgery, including the facility for patients to transmit a 





general surgery inpatients, direct observation and user-feedback were used to 
examine patient usability of the app for post-operative wound monitoring. 
Findings demonstrated that patients were able to learn how to use the app 
and found it acceptable. Some difficultly was observed, however, in taking 
the image of the wound. Problems included confusion with changing the 
direction of the camera and achieving the optimal angle when taking the 
picture without assistance. This study examined the quality of the patient-
provided images. Images were independently reviewed by three physicians 
to assess their suitability for diagnostic and treatment purposes. Although the 
number of images generated in the testing sessions were few (n=11), most 
images (n=9, 81.8%) were found to be sufficient by the majority of rating 
physicians. This study is, however, limited by its small sample size of nine 
participants and 11 wound images. 
 
Lacking from the studies described above, however, is information on how 
patients were instructed to take the wound images. It is unknown whether 
they had considered the information patients might require to ensure the 
images of the wound were suitable and of sufficient quality to be clinically 
usable to assess the wound for SSI. The studies do not report whether 
instructions for patients, if any, were developed or provided. Only one study 
has provided detail on how patients were instructed to take images of their 
wounds and include the patient instruction sheet in a supplementary file to 
the publication [71]. Information on how these instructions were informed 







Although emerging evidence for using patient-taken images for wound 
assessment is encouraging, the small number of studies and their limitations 
demonstrate there is more work to be done to explore the feasibility of 
obtaining and using patient-provided images as a method for assessing 
wounds for SSI. Feasibility work to explore whether it is possible for patients 
to: 1) take a clear and standardised image of the wound that is clinically 
usable and; 2) use their own device to take and transmit an image, is required 
to assess the potential of this method for assessment of wounds for SSI after 
the patient has left hospital. 
 
1.5. Aims and objectives of thesis 
Evident throughout this chapter is that reliable and valid methods for SSI 
assessment, specifically designed for patient-report after leaving hospital, are 
needed. A patient-completed measurement instrument for SSI that has been 
developed and validated specifically for use after hospital discharge is not 
currently available. The use of supplementary digital images for assessing 
wounds for SSI is an emerging area with many potential benefits for use post-
discharge. Studies to date, however, have paid little attention to instructions 
for patients on how to photograph the wound and the important features that 
need to be considered when taking the photograph to ensure the images are 
standardised and provide images that are fit for purpose. Creating a reliable 
and valid SSI outcome measure will be valuable, particularly one that could 
be used both in hospital and post-discharge. It could be supplemented with 
patient-generated digital images for assessment of SSI remotely. This has the 
potential to provide a valuable contribution to SSI assessment for use in 






The aim of this thesis is to address the gaps and limitations of the current 
methods for SSI outcome assessment. Specifically, aims are to: 
1) develop and validate an SSI outcome measure for patient or healthcare 
professional completion, suitable for use after the patient has left 
hospital; 
2) develop and evaluate a method for patients to take and transmit a 
standardised image of their wound after leaving hospital, for remote 
wound assessment.  
 
Objectives  
Specific objectives of this thesis are: 
1) to use mixed methods to inform the content and design of a new 
outcome measure for SSI suitable for completion by patients or 
healthcare professionals;  
2) to pre-test the outcome measure with patients and healthcare 
professionals to explore acceptability, understanding and 
comprehensiveness;  
3) to examine the measurement properties of the outcome measure in a 
large sample of participants after having surgery;  
4) to develop a method for patients to take and transmit wound images:  
i) develop photography instructions for patients to take a 





ii) adapt existing IT software for patients to transmit wound 
images to a research/healthcare team using their own mobile 
device; 
5) to pre-test and refine the method for taking and transmitting images 
with patients; 
6) to examine the feasibility, usability and acceptability of the method for 
taking and transmitting images with a large sample of patients after 
having surgery, including an examination of image quality.  
 
These aims and objectives will be addressed in two studies. Study one will 
address the first aim to develop and validate a new outcome measure. Study 
two will address the second aim to develop and evaluate a method for 
patients to take and transmit wound images for potential use for SSI outcome 
assessment after hospital discharge. 
 
1.6. Scope of the proposed work 
Use of the outcome measure and method for obtaining patient-generated 
digital images are intended for SSI outcome assessment. The idea for this 
work was initially conceived within the context of a research study. It was 
considered that the methods could be applied in RCTs of interventions where 
SSI is a primary or secondary outcome. Study 1 was embedded in a wider 
study: the Bluebelle feasibility study [1]. This was a two-year National 
Institute for Health Research (NIHR)-funded feasibility study to explore 
whether it was possible to conduct a large multicentre randomised trial to 





dressings after elective surgery. The intended primary outcome was SSI 
occurrence within 30 days (The Bluebelle study, grant number 12/200/04, PI: 
Professor Jane Blazeby, supervisor of this PhD work). Patients with 
abdominal wounds were selected due to the higher associated risk of SSI in 
this population. Development and validation of an efficient and accurate SSI 
tool to use in hospital and post-discharge was one aim of the feasibility study. 
Appendix 6 includes a schematic overview of the wider Bluebelle study, 
showing how the development and validation of the SSI measure was one of 
its component parts. The Bluebelle study also considered the use of patient-
provided images of wounds for potential use for blinded outcome assessment 
in a future RCT. A full investigation of the feasibility of this idea and develop 
a method for obtaining images from patients was not, however, possible 
within the remit of the two-year study. It was, therefore, considered a 
valuable study to explore in detail as part of this PhD research. Although the 
concept of the SSI outcome measure and use of patient-generated digital 
images originated within the context of a research study, it is anticipated, 
however, that these methods (with possible necessary modifications) for SSI 
outcome assessment may also apply to routine surgical practice, SSI 
surveillance and audit.  
 
1.7. Summary 
Without robust methods and measures to collect accurate, reliable and 
comprehensive information, data on SSI is at risk of being poor quality, 
unreliable and inaccurate, posing problems for SSI surveillance and research. 
This introductory chapter has described the extent of SSI as a clinical problem 





patients have left hospital. The rationale for the research and aims and 
objectives of the current thesis are explained. Chapters 2 and 3 will now 
describe the methods and results of Study 1, relating to the development and 
validation of a new SSI outcome measure. Chapters 4 and 5 will then describe 
the methods and results of Study 2: the development and evaluation of a 
method to obtain digital wound images from patients. The sixth and final 
chapter of this thesis will bring these studies together, discussing the work in 
the context of recent literature, it’s strengths and weaknesses, it’s applications 
both in and outside of surgery and finally, recommendations for future 






CHAPTER 2.  METHODS: 
STUDY 1 
D E V E L O P M EN T  AN D  V A LI D AT I O N  OF  A  N E W  
O U T C O M E  ME A S UR E  F O R  S S I  
 
2.1. Introduction  
An optimal approach to the development and validation of a new outcome 
measure involves both quantitative and qualitative research methods 
[46,84,85]. Emphasis is placed on ensuring that the measure has appropriate 
measurement properties, including content, construct and criterion validity, 
reliability and responsiveness, if relevant [46,86,87]. A more detailed 
description of these properties will be provided below. In the initial stages of 
development, specific methods may include an evaluation of existing tools 
and published literature to inform the content of a new measure. Qualitative 
interviews with key stakeholders can also identify valuable and unique 
information. Quantitative and statistical techniques are also generally 
considered important for testing the reliability and validity of a new measure 
and ensuring that is appropriate, fit for purpose and performs as intended.  
 
This chapter gives a full account of the development and validation of a new 
SSI outcome measure. It describes established methods, applied to address 





study is the design of a single ‘universal-reporter’ outcome measure, intended 
for completion by a patient or a healthcare professional.  
 
2.2. Aim and objectives of the current study 
The aim of the study was to develop and validate a new outcome measure for 
surgical site infection, for patient or healthcare professional completion. The 
intention was that it could be used either in-hospital, or, after the patient had 
been discharged. Specific objectives, as outlined in Chapter 1, relevant to the 
current study were: 
1) to use mixed methods to inform the content and design of a new 
outcome measure for SSI suitable for completion by patients or 
healthcare professionals;  
2) to pre-test the outcome measure with patients and healthcare 
professionals to explore acceptability, understanding and 
comprehensiveness;  
3) to examine the measurement properties of the outcome measure in a 
large sample of participants after having surgery. 
 
2.3. Essential properties of an outcome 
measure: a synopsis 
Understanding of the essential properties of a high-quality outcome measure 
(measurement instrument) is well established [45,46,48,85]. A detailed 





brief definition of each property and an explanation of its value is provided as 
follows: 
i) Content validity 
Content validity (including face validity) is defined as “the degree to which 
the content of a measurement instrument is an adequate reflection of the 
construct to be measured” [88]. Specifically, the outcome measure must be 
relevant, comprehensive (with no key aspects missing), and understood as 
intended [46].  
ii) Construct validity  
Construct validity is defined as “the degree to which the scores of a 
measurement instrument are consistent with a hypothesis, for example with 
regard to internal relationships, relationships with scores on other 
instruments or differences between groups” [88]. Construct validity can be 
described as three aspects: structural validity, hypothesis-testing and cross-
cultural validity.  
iii) Criterion validity 
Criterion validity is defined as “the degree to which the scores of a 
measurement instrument are an adequate reflection of a gold standard” [88]. 
This is especially important for new outcome measures that are intended to 
have diagnostic accuracy.  
iv) Reliability 
Measures must be shown to be reliable, yielding reproducible and consistent 
data [86]. Reliability can be further categorised into test-retest reliability (that 
is, consistency across timepoints when no changes would be expected) and 
inter- and intra-rater reliability (that is, consistency across different and the 





v) Responsiveness  
Responsiveness can be described as ‘the ability of an instrument to detect 
change over time in the construct to be measured’ [46]. This has relevance for 
outcome measures that intend to measure a construct that is expected to 
change, for example, after treatment. 
vi) Acceptability  
In addition to the established properties described above, another important 
property of an outcome measure is that it is acceptable to those intended to 
use it. It is essential that respondents are both willing and able to complete the 
new outcome measure. Acceptability is crucial to ensure there is a high level 
of data completeness and few missing data, essential for interpretation and 
generalisability of the findings [45,46]. 
 
Consideration of the measurement properties listed above in the development 
and validation of a new outcome measure is crucial to ensure that the 
measure is suitable, fit for purpose and ultimately can generate reliable and 
accurate data. 
 
2.4. Methodological framework and use of 
applied methods 
 
An existing, well-established framework for developing new outcome 
measures, with a particular focus on outcome measures intended for patient 
completion (PROMs) was applied [85,89]. The study was designed to ensure 





addressed. Table 2-1 presents an overview of the methods that were applied 
to address each property. For the current study, responsiveness was not 
considered relevant to address. This was because the outcome measure was 
not intended to be used to detect changes over time in the context of its use as 
an SSI outcome measure in an RCT. A detailed description of the study 






Table 2-1. Essential properties of an outcome measure including how and 
when these were addressed in the current study 
Essential property Applied methods to address 
property 
Phase of study 
Content validity Analysis of existing SSI tools Phase 1 




 Item formulation and design 
of preliminary measure 
Phase 2 
 Pre-testing using cognitive 
interviews with patients and 
healthcare professionals 
Phase 3 
Construct validity Analysis of underlying scale 
structure (multi-trait scaling, 
factor analysis) 
Phase 4 
 Assessment of internal 
consistency (Cronbach’s alpha 
coefficient) 
Phase 4 
Criterion validity Comparison with ‘gold 
standard’ measure (sensitivity 
and specificity) 
Phase 4 
Reliability Agreement between test-retest 
responses (Kappa statistic) 
Phase 4 
 Agreement between patient 
and healthcare professional 






Essential property Applied methods to address 
property 
Phase of study 
Responsiveness Not applicable to the SSI 
outcome measure within the 
intended context of use  
n/a 
Acceptability  Pre-testing using cognitive 
interviews with patients and 
healthcare professionals 
Phase 1 
 Examination of response rates Phase 4 
 Examination of missing data Phase 4 







2.5. Study design  
The overall design of the study was divided into four phases. A graphical 
representation of the study and each of the four chronological study phases 
are illustrated in Figure 2-1.  
As described above, a novel characteristic of the new outcome was the 
intention that it could be completed by either a patient or a healthcare 
professional (observer). The study design and methodology, therefore, 
purposively involved all key stakeholders during each phase, an important 
and crucial consideration for ensuring that the new measure was fit for 
purpose. 
• In Phase 1, potentially important domains (that is, aspects relevant to 
assessing wounds for SSI) were identified to inform the content of the 
new measure. Mixed methods were used, including:  
i) an analysis of existing clinical and patient-completed tools 
commonly used to capture information for the assessment 
and diagnosis of SSI and; 
ii) semi-structured interviews with patients and healthcare 
professionals with experience of SSI.  
• In Phase 2, relevant domains derived from Phase 1 were 
operationalised into items for a provisional measure for completion by 
patients or healthcare professionals. Items were formulated in a novel 
way using lay language alongside medical terminology. A preliminary 






• In Phase 3, the preliminary measure was pre-tested and refined in an 
iterative and cyclical process through cognitive interviews with 
patients and healthcare professionals.  
• Finally, in Phase 4, the measure was field-tested (that is, administered 
to patients and healthcare professionals to examine its performance) in 
a large sample of patients undergoing abdominal surgery. Descriptive 
data summaries and statistical analyses were performed to validate the 
new outcome measure. Acceptability, reliability and construct and 







Figure 2-1. Phases of study for the development and validation of the SSI 
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2.6. Phase 1 - Identification of important 
domains: content validity 
2.6.1. Objectives for Phase 1 
The objective for this phase of the study was: 
• to use mixed methods to inform the content and design of a new 
outcome measure for SSI suitable for completion by patients or 
healthcare professionals.  
 
This phase of the study involved a mixed methods approach. Two different 
data sources (existing tools and qualitative interviews with patients and 
healthcare professionals) were used to identify the domains relevant for the 
assessment of wounds for SSI (for example, signs, symptoms and wound care 
interventions). The aim of using this comprehensive approach was to 
maximise content validity and ensure that an exhaustive list of all potential 
domains, important to patients and healthcare professionals, could be 
considered for inclusion in the new measure [45,46].  
 
2.6.2. Content analysis of existing tools 
Existing tools, such as existing health measurement instruments and 
questionnaires, serve as vital sources of information to help generate ideas 
and identify relevant issues to inform the content of a new measure [46,85]. A 
review of the content of the existing tools is therefore typically considered 
necessary in the first stages of developing a new measure, to identify 





also ensures that an appropriate measure doesn’t already exist, and duplicate 
work unnecessarily. 
 
Identification of existing tools  
An existing comprehensive systematic review of SSI definitions, grading 
scales and scoring systems, published by Bruce et al. in 2001 was used to 
identify the most commonly used existing tools for assessing SSI [31]. The 
review used robust methodology and detailed search strategies. Although 
several years since the review was conducted, expert knowledge within the 
wider study team and colleagues in the field (at universities and hospital 
trusts in Bristol and Birmingham) knew of no new definitions or tools that 
had been widely adopted. A scoping search of SSI literature was conducted 
before the current study to confirm that the findings from the Bruce et al. 2001 
review were still demonstrated in current practice. This confirmed that the 
tools identified in the 2001 review continued to be the most commonly used 
tools, including those use by UK government agencies PHE and NICE [22,90]. 
Conducting a new systematic review was, therefore, considered not relevant 
for adding further value to the study. 
 
Obtaining the source documents 
At the time of this study, current versions of the tools were obtained 
electronically from the original published papers and via links on the 
associated websites giving accessibility to the documents online. Further 








To perform the content analysis of existing tools, verbatim text of the specific 
clinical criteria or questionnaire items used for the assessment of SSI were first 
extracted from the source documents. All corresponding response categories 
were extracted. Data were transcribed verbatim into a Microsoft Excel 
spreadsheet. Data extraction was performed by the author of this thesis. 
 
Data analysis: categorisation into SSI domains 
Inductive, open coding of extracted textual data was conducted, a commonly 
used method to identify content for outcome measure development [85,91]. 
This means that data were labelled using content-characteristic words and 
subsequently organised into groups or categories (domains) defined as broad 
aspects of the effects of SSI on a patient [92]. Methods followed a framework 
for grouping data into domains that is often used to develop core outcome 
sets [93-95]. This involves scrutinising text within items or criteria on an 
individual basis (rather than considering any pre-defined grouping into 
domains by the developers of the original questionnaire or tool) [96]. This 
technique aims to ensure that the actual issue being addressed by each item or 
criteria is considered independently and at face value. An inductive approach 
meant that grouping and categorisation into domains was driven by the data 
and not pre-defined prior to the analysis [91]. This approach was taken so as 
not to influence the emergence of any important domains which may have 
not originally been conceived by the author of this thesis. Grouping data into 
domains was done initially by the author of this thesis and verified by the 






2.6.3. Interviews with patients and healthcare 
professionals   
Qualitative interviews with key stakeholders are commonly used as a 
valuable method and source of information to identify relevant and important 
content domains to include in the development of a new outcome measure 
[46]. Used alongside other data sources, such as a content analysis of existing 
tools, data from interviews can be included to maximise content validity of 
the new measure. Interviews can provide a rich source of data, gathering 
expert opinion, knowledge and unique experiences directly from key 
stakeholders including, for example, patients and healthcare professionals. 
Interviews provide an opportunity to explore reasons that stakeholders 
consider certain domains to be important, i.e. why they should be included. 
As described in Chapter 1, existing SSI questionnaires for patients had not 
included patients in their development. A particular objective of the patient 
interviews was, therefore, to identify important aspects for assessing SSI from 
the perspective of the patient. The intention was that interview data would 
supplement the data extracted from the existing tools and identify any 
potential additional content domains not included in the existing tools. This 
was to ensure the list of content domains to consider for inclusion in the new 
outcome measure was as comprehensive as possible, and included issues 
considered to be important to patients as well as healthcare professionals [46]. 
The key aim of the interviews in the current study were for content generation 
for the new outcome measure and to identify a list of themes relevant to 
assessing wounds for SSI for consideration alongside the data obtained from 
the content analysis of existing tools. The interviews were not intended to 
develop theory or gain a full understanding of patients’ and healthcare 






As detailed above, a key objective and novel characteristic of the new 
measure was that it was intended to be a single ‘universal’ measure, 
appropriate for completion by a patient and/or healthcare professionals. It 
was considered essential that important content domains were, therefore, 
explored from the perspective of all key stakeholders. Key stakeholders 
included both patients and healthcare professionals with experience of SSI 
and post-surgical wound care. Patients were included as they served as 
experts with direct personal experience of symptoms and severity of SSI and 
the impact of SSI on quality of life and function. The perspectives of patients 
were considered to be especially important in this study as existing tools have 
lacked patient input in their development, as described in the first chapter of 
this thesis. Healthcare professionals were included to ensure that the expert 
opinion and views of those managing and treating patients with surgical 
wounds and SSI were sought, to ensure all relevant domains could be 
identified and considered for inclusion in the new measure.  
 
Sampling and identification of potential participants  
Patients 
Patients who had undergone abdominal surgery and had developed or had 
recent experience of a wound infection were sampled to take part in 
interviews. Abdominal surgery was selected due to the high rate of SSI in this 
speciality. This covers a broad range of surgical procedures and patient 
characteristics, offering a wide range of perspectives to explore. Types of 
surgeries include open and laparoscopic procedures, including 





experiencing SSI, as indicated in hospital records, were identified and 
approached for study participation by surgical trainees or research nurses 
involved in the wider Bluebelle study (in which this study was embedded, as 
described in Chapter 1; Section 1.6). Patients were approached on wards and 
in clinics at University Hospitals Bristol NHS Foundation Trust. Participant 
information leaflets describing the study were provided (Appendix 7). 
 
Healthcare professionals  
An opportunistic and snowballing approach to identify healthcare 
professionals was taken, in which potential participants were identified 
through personal knowledge (that is, healthcare professionals known to the 
study team as well as further recommendations of potential participants from 
those taking part in interviews). From those identified, a purposive sample of 
healthcare professionals was selected to ensure maximum variation in their 
characteristics and experience, including their roles working in primary or 
secondary care and within different clinical specialties (for example, 
gastrointestinal surgery and obstetrics).  
 
Recruitment and consent 
Details of individuals who had expressed an interest in participating in the 
study were recorded on a study database, purpose-built as part of the wider 
Bluebelle study by the person who had approached the individual (the trainee 
or research nurse in the case of patient participants). Participants were 
contacted by a qualitative researcher (A.N.) to further discuss the study and 





interview was arranged to suit the participant, either at the participant’s home 
or on hospital premises.  
 
The involvement of a qualitative researcher to arrange and conduct the 
interview component of this study (rather than the author of this thesis) was 
necessary due to the timing of the work and the fact that it was embedded 
within the wider Bluebelle study. There was a need to adhere to timelines and 
the author of this thesis was unavailable at this time due to maternity leave. 
The qualitative researcher (A.N.) was a member of the Bristol Medical School 
and was experienced in health services research and conducting interviews 
for developing new outcome measures.  
 
Participants were invited to provide written informed consent by the 
qualitative researcher at the time of the interview, allowing for further 
discussion and following time for asking questions, before the interview was 
conducted.  
Research ethics approval was granted from the NHS Health Research 




Interviews took a semi-structured form using topic guides (separate for 
patients and healthcare professionals), pre-written specifically for the study 
by a qualitative interviewer (A.N.) and informed by the content of existing SSI 
tools and literature (Appendix 8 and Appendix 9). Topic guides were used to 





flexibility to allow new emerging topics or issues of relevance to the 
individual interviewees to be discussed. This approach allowed for topic 
guides to be updated as the study developed to include new topics that arose 
in previous interviews. The topic guide used for the patient included an 
overview of the interviewee’s background and surgery details, their 
experience of wound infection, experience of common SSI signs, symptoms, 
severity of wound infection and problems, exploration of health care use, 
interventions and investigations (Appendix 8). The topic guide for interviews 
with healthcare professionals included an overview of the interviewee’s 
background and surgical expertise, the typical signs, symptoms considered 
indicative of infection and the interventions and care pathways used to treat 
infections (Appendix 9).  
 
During interviews, participants were shown existing tools commonly used in 
current practice for assessing SSI. These tools were identified by the methods 
described above and will be described in more detail in the following chapter. 
Patients were shown the PHE SSISS post-discharge questionnaire for patients 
[22] (Appendix 4) and items from an ASEPSIS-associated patient 
questionnaire [57] (Appendix 5). Healthcare professional participants were 
also shown the PHE SSISS list of SSI criteria [22] (Appendix 15) and the 
ASEPSIS grading scale [51] (Appendix 16).  The interview topic guides 
included prompts to elicit feedback on the relevance, ease of completion and 
understanding of criteria and items in the commonly used existing SSI tools. 
Views on the item wording used in the tools were sought in order to identify 
any potential issues with comprehension and acceptability of the language 






Interviews were audio-recorded using an encrypted Olympus DS-3400 digital 
voice recorder. Recordings were transferred for storage on secure password-
protected computers and networks at the University of Bristol, accessible only 
by relevant study personnel.  
 
Data analysis: identifying themes relevant to the content for 
the new outcome measure 
Audio-recordings were transcribed in full by a research secretary with 
experience in transcribing qualitative interviews at the Bristol Medical School, 
University of Bristol. Transcripts were anonymised (removing any mention of 
names or hospitals) so that participants could not be identified, using a 
unique numerical identifier. Transcripts were analysed by the qualitative 
researcher (A.N.) conducting this part of the study.  A thematic approach was 
taken to the qualitative data analyses, a method for organising and grouping 
the data often used for interview data [91]. First, transcripts were read and 
scrutinised. Data were coded or ‘labelled’ with context-specific labels using an 
inductive approach (as described earlier), a common approach to analysing 
qualitative data for the development of outcome measures [85]. Next, 
codes/labels were further grouped into themes (that is, data that shared 
similarities relevant to SSI diagnosis), for example, data relating to SSI signs, 
symptoms or wound care interventions. Lastly, a list of themes relevant to the 
assessment and management of wounds for SSI was produced. Participants’ 
views on the existing tools and any relevant issues or information raised in 
the interviews considered by the researcher to be important to consider for 
the development of the new outcome measure were summarised in a 
descriptive account. The descriptive account was updated as more interviews 





content domains for the new measure. A detailed narrative was, therefore, not 
intended, in line with the use of these methods for the development of other 
outcome measures [85,89] 
 
To maximise robustness of the qualitative research and reflexivity of the 
interviewer when conducting and analysing data, findings were routinely 
shared and discussed with the study supervisors during the iterative cycle of 
data collection and analysis. This was to minimise any undue impact or 
influence of the researcher on the collection and analysis of the data, a 
common consideration for qualitative research [97]. 
 
Interviews and analyses were performed in an iterative cycle drawing on the 
constant comparative method of qualitative analysis [98]. Small numbers of 
interviews were conducted and analysed before conducting the next set of 
interviews.  This approach allowed new data to inform topics for discussion 
in subsequent interviews. Information gathered from previous participants 
could then be used to explore whether the topic was a shared experience and 
to discuss its importance for SSI assessment. This is a well-established method 
and technique and is an approach commonly used for outcome measure 
development and generation of content domains [46]. 
 
2.6.4. Synthesis of findings 
Findings from the content analysis of existing tools and interviews with key 
stakeholders were combined by the author of this thesis to ensure identified 
domains were considered from both of the data sources, maximising content 





data sources, methods to identify data, and how data were synthesised is 
shown in Figure 2-2. Findings were initially combined by the author of this 
thesis and verified by discussion with the study team to ensure 
methodological rigour in the following way: 
i) First, the list of themes derived from the interview data were 
mapped onto SSI domains identified from the content analysis of 
existing tools. Mapping was performed when the theme reflected 
with, corresponded to, or added complimentary information to, any 
of the SSI domains.  
ii) Next, any themes that could not be mapped to an existing domain 
were added as a new domain. The descriptive terms used to define 
domains were broadened or narrowed to be more specific when 













Content analysis of existing tools 
Data extracted and categorised by SSI 
domains sign, symptom, intervention 
 
List of SSI domains 
Interviews with patients and healthcare 
professionals 
Data coded and grouped into themes 
Synthesis of findings 
List of SSI domains compared with interview themes.  
Similar domains and themes combined. 
Additional themes added as new domains 
Final list of SSI content domains 






2.7. Phase 2 – Designing the preliminary 
measure: content and face validity 
2.7.1. Objectives for Phase 2 
The objective for this phase of the study was: 
• to design the preliminary outcome measure, ready for pre-testing in 
Phase 3. 
 
2.7.2. Conceptual framework  
The conceptual framework for the new SSI measure was based on a reflective 
model. This means that the underlying relationship between the items and the 
construct of interest (SSI) was considered to be reflective; that is, the construct 
is expressed or reflected by the items, rather than ‘causing’ the items as in the 
case of a formative model [46]. Figure 2-3 describes these two types of models 
in a graphical form. Consideration of the conceptual framework is important 
when generating items for a new measure and how they will be phrased. The 
conceptual framework also plays an important part in determining the 
measurement theory and suitable analysis plan for evaluating a new measure 







Figure 2-3. Conceptual frameworks for relationships between constructs and 
items  
Reference: de Vet et al. 2011 [46] 
Key considerations for designing the measure 
After completion of Phase 1 of the study and a comprehensive list of domains 
considered important for inclusion in the new measure had been established, 
Phase 2 focused on formulating the items and designing the preliminary 
version of the measure. This phase was important for considering face 
validity and future acceptability of the measure as it involved the wording 
and formatting of its content. Specific steps included: 
i) the conversion (operationalisation) of domains into items 
(questions);  
ii) defining suitable response categories; 
iii) drafting instructions for how to complete the measure, and; 






2.7.3. Operationalisation of domains into items: a 
novel approach combining plain language 
and medical terminology 
As described previously, a key objective and novel aspect of the new measure 
was that it was intended to be a single ‘universal’ measure, appropriate for 
completion by a patient and/or a healthcare professional. The rationale for 
this approach was to reduce the potential risk that separate tools, with items 
written using different terminology and language for patients and 
professionals, may be interpreted differently and therefore measure a 
different or slightly different underlying construct than intended. To address 
this, domains identified in Phase 1 were initially ‘operationalised’ into items 
(questions) that could be easily read and understood by patients. This is a 
standard approach for designing a PROM that is intended to be completed by 
patients and not healthcare professionals. Items were phrased using plain 
language with the intention of being clear and unambiguous. Phrasing of 
items in existing SSI tools (identified in Phase 1) was considered, in 
conjunction with findings from the Phase 1 interviews (where views and 
suggestions on the wording of items in existing tools had been sought). In 
addition, and of specific relevance to the development of a single outcome 
measure that was intended for patient or healthcare professional completion, 
a novel approach was taken to include the medical terminology for the sign, 
symptom or intervention intended to be measured (when one existed) at the 
end of item in parentheses. Medical terminology was informed by existing 
clinical tools, literature and expert knowledge within the study team. This 
novel approach to questionnaire design has been pioneered in previous 
research conducted within the Bristol Medical School (in which the author of 





same subject is needed, for example in the development of stakeholder 
surveys to prioritise health outcomes for inclusion in core outcome sets 
[93,95,99].  
 
Phrasing of items was performed by the author of this thesis and members of 
the study team with expertise in developing and using patient-reported 
outcome measures and expertise in the assessment of SSI. 
 
2.7.4. Response categories  
For items addressing signs and symptoms, an initial five-point ordinal 
response category (‘not at all’, ‘a little’ ‘moderately’, ‘quite a bit’ ‘very much’) 
was used. These categories were chosen based on existing Likert scales 
commonly used in patient-completed questionnaires to assess health-related 
quality of life and symptoms. However, the methods sought to explore the 
appropriateness and relevance of using this type of response category 
compared to dichotomous yes/no options in the pre-testing stage of the study 
(described below, Section 2.8). For items addressing wound healing 
interventions, conditional yes/no response options were used, with the 
addition of a ‘don’t know’ option to examine whether individuals were 
unaware of any interventions that may have occurred or did not understand 
the item description; an important consideration when testing item 






2.7.5. Instructions for completion  
Appropriate written instructions on how to complete items are just as 
important to consider and test as the items in the outcome measure 
themselves. This is to ensure that the individual providing the data completes 
the outcome measure as intended and provides appropriate and relevant 
information [45,46]. Several issues needed addressing clearly in the 
instructions for the purpose of this study. Firstly, instructions asked the 
respondent to complete the items in relation to their main surgical wound. In 
cases where the participant has more than one wound and healing of a 
wound other that the main wound had been problematic, respondents were 
instructed to complete the items in relation to the problematic wound. This 
was to ensure that the measure captured the information that would be 
required for assessing whether SSI had occurred on an individual level (that 
is, per participant) rather than a wound-based level (that is, per wound). 
Accounting for SSI on an individual level is how the measure would be 
intended to be used in research studies and clinical practice, where it is 
typically the number of patients that experience SSI that is reported [20,22,27]. 
Secondly, in the preliminary version of the measure to be tested, instructions 
requested the respondent to consider what had happened to the wound since 
leaving hospital after having surgery. This was in order to have a fixed time 
period for participants to recall what had occurred, an important 
consideration for collecting data in questionnaires and surveys and an 






2.7.6. Draft of the preliminary measure 
A preliminary version (1.0) of the measure (expected to change during 
subsequent pre-testing in Phase 3 of the study as described below) was 
drafted by the author of this thesis and presented to the study management 
group of the wider Bluebelle study team for comment and suggestions for 
improvements. Feedback on the items, wording, response categories, design 
and layout was obtained, and minor modifications were made to the measure 
until it was considered ready to pre-test with a sample of potential 
respondents. 
 
The measure for participant and healthcare professional completion was 
identical, with the exception of the use of first- or third-person narrative in 
items (for example, “Has your wound…” or “Has the wound…”). This was 







2.8. Phase 3 - Pre-testing the measure: content 
and face validity 
2.8.1. Objectives for Phase 3 
The objective for this phase of the study was: 
• to pre-test the outcome measure with patients and healthcare 
professionals to explore acceptability, understanding and 
comprehensiveness. 
To ensure that items in the preliminary version of the measure were 
understood, acceptable, relevant and comprehensive, Phase 3 of the study 
pre-tested the measure with a sample of potential respondents. This served as 
a test of content validity, including face validity [45,46]. Pre-testing was 
performed in one-to-one cognitive interviews, an established technique for 
testing new questionnaires and measurement instruments and recognised as 
an ideal method to identify and correct any problems [45,101]. A novel 
characteristic of the measure and, therefore, essential to explore in this phase, 
was the combined use of plain language and medical terminology in items. 
 
Specifics objectives of the pre-testing phase were to: 
• Check interpretation and understanding of items as intended for the 
underlying issue being assessed; 
• Identify potentially confusing items or items that were difficult to 
complete; 
• Ensure that the plain language descriptions were an accurate reflection 





• Ensure acceptability of the length, format and response categories for 
effective completion of the measure;  
• Obtain general feedback and suggestions for improvement; 
• Explore views and acceptability on the novel approach to developing a 
single ‘universal’ tool for patient and healthcare professional-
completion, and the combined use of plain language and medical 





2.8.2. Participants and recruitment 
Sampling 
Patients and healthcare professionals were sampled to pre-test the 
preliminary version of the measure. Potential participants were sampled to be 
representative of the target population intended to use the measure. This 
included patients who had recently (within 30 days) undergone general 
abdominal surgery or had given birth by caesarean section and healthcare 
professionals involved in post-operative wound care and assessment. This 
timepoint was selected as it is the widely accepted timeframe for expecting 
SSI to have occurred [32]. It was appropriate, therefore, to pre-test the 
measure with patients within this timeframe as it reflected when the outcome 
measure would be intended to be used in research and routine practice. 
 
Patient participants were sampled using an opportunistic approach from 
post-surgical general and obstetric recovery wards at University Hospitals 
Bristol and North Bristol Hospital NHS Trusts. A variety of patients 
undergoing different surgical procedures and professionals from different 
specialties were sought to maximise variation in demographics and types of 
wounds in the sample. A purposive sample of healthcare participants were 
selected to ensure maximum variation in participants’ professional roles and 
clinical specialties. These sampling techniques ensured that pre-testing could 
be conducted in a sample representative of the wider population intended to 





Identification of potential participants  
Identification of potential patient participants and distribution of study 
information leaflets (Appendix 7) was performed by surgical trainees and 
research nurses involved in the wider Bluebelle study. Contact details of 
interested participants were passed on to the author of this thesis or a surgical 
trainee involved in this phase of the study (T.M.) as part of an academic 
placement with the Bristol Medical School. Potential healthcare professional 
participants were identified through suggestions from members of the 
Bluebelle study team and management group or through suggestions from 
the author’s professional colleagues at the Bristol Medical School.  
 
Recruitment and consent 
Study researchers (the author of this thesis and T.M.) contacted potential 
patient participants by telephone after they were discharged from hospital. 
Interested healthcare professionals were contacted primarily by email. 
Further explanation of the study was provided and a suitable date, time and 
location for an interview (offered to be either at patients’ own homes or on 
hospital or university premises, as convenient to the participant) was 
arranged with those agreeing to take part. Written informed consent was 
taken by the researcher at the time of the actual interview. 
 
2.8.3. Data collection 
Cognitive interviews were primarily conducted by the author of this thesis, 
with a minority conducted by a surgical trainee involved in this phase of the 





homes or on hospital or university premises (at the preference of the 
participant).  
 
During interviews, participants were asked to complete the preliminary 
outcome measure using a ‘think-aloud’ approach [101]. This required 
participants to verbalise their thought process as they read and responded to 
each item. Participants were, for example, asked to explain their 
interpretation and level of understanding (comprehension) of the item and 
the justification for their response. This approach allows for observation of 
any problems with specific items or issues raised, and is a common technique 
used for pre-testing questionnaires and surveys as it allows for the 
identification and understanding of any potential confusion, 
misinterpretation or problematic items [45,101].  On completion of the 
measure, the interviewer returned to any relevant items and asked probing 
questions to further explore understanding, accuracy and interpretation of the 
items, for example, asking “what does…[a word]… mean to you?”. Opinions 
on the combined use of plain language and medical terminology in items 
were specifically sought to explore this novel aspect of the new measure. 
General comments about the measure were also asked for, including the 
relevance of items to participant’s experiences (to explore whether all items 
were considered to be important), comprehensiveness of the items (to 
investigate whether any aspects relevant to SSI were missing), ease of 
completion, and suggestions for changes or improvements. A structured topic 
guide was developed and used flexibly to guide interviews to provide some 
consistency and ensure that the objectives of the interview were met, whilst 
allowing for modifications and adaptability across participants [101] 





of the interviews to allow flexibility and responsiveness to any emerging 
findings from previous interviews [101]. 
Interviews were audio-recorded using a digital voice recorder (Olympus DS-
3400). Recordings were stored as encrypted files on the device until they were 
transferred on to password protected computers and secure network space at 
the University of Bristol. Hand-written notes documenting any observed 
issues were made by the researcher while observing the participant complete 
the measure, so that problems or areas of interest could be explored further 
with the participant within the same interview [101]. Further written notes 
were made by the researcher within a short period after conducting the 
interview to record any relevant observations or personal notes about the 
process to supplement interview data and record any reflective information 
that might aid later analysis.  
2.8.4. Data analyses 
Each cognitive interview was listened to and summarised by the author of 
this thesis in a descriptive a memo, including; 
• the time and setting of the interview;  
• a brief summary of the surgery and wounds; 
• any details or direct issues considered relevant to how the measure 
might be completed or responses given; 
• key points for how the measure might be improved 
• selected verbatim quotations relevant to the combined use of plain 
language and medical terminology in items to allow a more in-depth 
analysis and apply a thematic approach to analyse this novel aspect of 





Interviews and analyses were conducted simultaneously in a cyclical, iterative 
manner [102]. Descriptive memoranda were scrutinized after approximately 
every three interviews for any issues or repeated key points for improvements 
that emerged.  Modifications to the measure (if required) were made to reflect 
the emerging findings and a new preliminary version (version 1.1, 1.2, 1.3 etc) 
of the measure was then provided to new participants participating in 
subsequent interviews (rather than modified versions of the measure being 
tested by the same participants). Interviews were conducted until no further 
substantial issues were identified or changes to the measure were required 
[101]. 
 
During Phases 1- 3 of the measure development, members of the immediate 
study team (experts in the development and/or use of PROMs in clinical 
trials, trial methodologists and experts in SSI) met routinely to discuss 
progress and findings. The preliminary version (1.0) and subsequent modified 
versions during pre-testing were circulated to the team and comments and 
suggestions for improvements were invited. Findings were also presented at 
coinciding full team meetings for the wider Bluebelle feasibility study, and 
comments and suggestions for improvements were invited from the wider 
study team (including nurses, surgeons, qualitative researchers, health service 
researchers and study management staff). Comments and suggestions were 
collated and considered by the immediate study team and adopted into the 






2.9. Phase 4 - Field-testing the measure: 
acceptability, reliability, construct and 
criterion validity 
2.9.1. Objectives for Phase 4 
The objective for this phase of the study was: 
• to examine the measurement properties of the outcome measure in a 
large sample of participants after having surgery. 
 
In line with the established methodological framework followed for this study 
[85,89], after pre-testing and making any required modifications to the new 
measurement instrument, the final stage of its development was to distribute 
the instrument to a larger sample of the target population. This process is 
known as ‘field-testing’. It serves to further assess the performance of the 
outcome measure, including acceptability, reliability and further types of 
validity such as construct and criterion validity in a more ‘real-world’ setting 
with a sample representative of the target population [46]. Using the measure 
to collect data on a large number of patients after undergoing surgery 
provides a better insight of the measurement properties of the outcome 
measure than can be gained from pre-testing with a small sample using 
qualitative methods, and allows for a quantitative analysis of the performance 






2.9.2. Study design 
Field-testing of the provisional SSI measure (version 2.0) was undertaken by 
administering the measure in two prospective, multicentre studies in order to 
maximise data available for evaluation. These were; 
i) a cohort field-testing study, and; 
ii) a pilot randomised controlled trial (RCT) 
Both studies were embedded within the Bluebelle feasibility study. As 
detailed previously in the introductory chapter of this thesis (Chapter 1), the 
Bluebelle study was exploring the feasibility of conducting a large RCT of 
different wound dressing strategies after abdominal surgery. The cohort field-
test study was specifically designed to evaluate the new SSI measure, and 
assess whether it was possible to collect reliable and valid SSI outcome data 
post-discharge. The pilot RCT was designed to assess whether it was possible 
to conduct a large RCT of different types of dressing strategies (the main aim 
of the Bluebelle study), with administration of the new SSI measure included 
to maximise data for its evaluation. Participant eligibility criteria, described 
below, were similar in both studies making the datasets acceptable to 
combine. The same provisional version of the SSI measure (version 2.0) was 
administered to participants in both studies. Figure 2-4 demonstrates how the 







Figure 2-4. Measurement properties addressed using data from the cohort 
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2.9.3. Participants and recruitment  
Sampling 
i) Cohort field-testing study 
Eligible participants were patients who had recently undergone surgery and 
met the following inclusion criteria:  
1. Aged 18 or over; 
2. Had undergone elective or unplanned abdominal surgery (including, 
but not limited to gastrectomy for benign or malignant disease, 
cholecystectomy, small or large bowel resection for benign or 
malignant conditions, abdominal wall hernia surgery (inguinal, 
femoral, incisional, epigastric and paraumbilical) or elective or 
unplanned obstetric surgery (caesarean section); 
3. Had undergone surgery by standard open, laparoscopic or 
laparoscopically-assisted surgical method; 
4. Willingness to have a home visit and/or attend follow-up at 15 and 30-
days. 
Patients could not enter the study if any of the following applied (exclusion 
criteria): 
1. Prisoners; 
2. Adults lacking capacity to consent; 
3. Lack of ability to read/understand English that would preclude 





ii) Bluebelle pilot RCT  
Eligible participants were patients about to undergo surgery and met the 
following inclusion criteria (to comply with the aims of pilot the RCT): 
1. Aged 16 or over; 
2. Undergoing primary elective or unplanned abdominal general surgery 
(including, but not limited to gastrectomy for benign or malignant 
disease, cholecystectomy, anti-reflux procedures, hepatic resection, 
small or large bowel resection for benign or malignant conditions, 
abdominal wall hernia surgery (inguinal, femoral, incisional, epigastric 
and paraumbilical)) or elective or unplanned obstetric surgery 
(caesarean section); 
3. Willingness to attend follow-up for 4-8 weeks. 
Any of the following criteria made the patient ineligible (exclusion criteria), 
the majority being relevant to the purpose of the pilot RCT for the wider 
Bluebelle study: 
1. Had undergone abdominal or other major surgery less than three 
months before the index operation; 
2. Intention to ‘close’ the wound with tissue adhesive (glue); 
3. Had an allergy to dressings or another contraindication to dressing 
allocation; 
4. Undergoing surgery where no skin incision occurs; 
5. Prisoners; 
6. Adults lacking capacity to consent; 
7. Lack of ability to read/understand English that would preclude 





Identification of potential participants  
Potential participants were identified and approached by research nurses or 
surgical trainees (from the regional surgical trainee collaboratives) involved in 
the wider Bluebelle study. Participants were identified from hospital wards or 
in clinics within a few days before or after surgery. In the cohort study, 
participants were identified from three UK hospital trusts, over a period of six 
months between August 2015 and January 2016. In the pilot RCT, participants 
were identified from four UK hospital trusts over a period of nine months 
between March and November 2016. Participant information leaflets 
(Appendix 11) describing the study were provided and enough time to read, 
discuss the study and the opportunity to ask questions was given.  
 
Recruitment and consent 
Potential participants were re-approached by research nurses or surgical 
trainees. Those expressing an interest in participating were recruited. All 
participants were asked to provide written informed consent at the time of 
recruitment (Appendix 12). Ethics approval was granted by the South West – 
Frenchay Research Ethics Committee (reference 15/SW/0008).  
 
Data collection  
A schematic overview of the data collection for the cohort and pilot RCT 
studies is shown in Figure 2-5. The new measure was administered to 
participants as a postal questionnaire to provide a self-completed assessment 
of their wound. The measure was also completed by healthcare professionals 
during follow-up telephone calls or in follow-up face-to-face appointments 





participants’ wound. A more detailed description of data collection and how 
data were analysed follows shortly under different subheadings pertaining to 
the different measurement properties being evaluated. 
 
Participant demographics 
Details of participants’ sex, age, marital status, employment status, smoking 
history, diabetes and physical status (American Society of Anaesthesiologists; 
ASA classification [103]) were collected from hospital records or directly from 
the participant by research nurses or trainee surgeons involved in the wider 
Bluebelle study. Basic operative details were recorded including elective or 
unplanned procedure, operation type, operation classification (clean, clean-
contaminated, dirty), open or laparoscopic, duration of operation and peri-
operative analgesia use. These data were collected in order to describe the 
basic characteristics of the study sample and to make comparisons between 






Figure 2-5. Data collection in the cohort and pilot RCT studies contributing to 
validation of the SSI measure 
 
  
Patients undergoing abdominal surgery  
demographic data / operation details  
Pilot RCT  
(March 2016 to November 2016) 
Cohort field-testing study  
(August 2015 – January 2016)  
 
Participant-completed SSI measure (self-assessment) 
30 days after surgery 
 
Debriefing questionnaire  
Participant test-retest self-assessment  
Within 1 week of 1st assessment  
 
Reference SSI assessment (CDC criteria)  





Observer-completed SSI measure  
4-5 weeks after surgery  
(by telephone) 
Observer-completed SSI measure  







Datasets and data preparation  
Data from the cohort field-testing study and the pilot RCT were combined 
into a single dataset to evaluate the specific properties of the new measure 
(described in each subheading below), where applicable. Assessment of some 
measurement properties, however, such as test-retest reliability, were limited 
to data from the cohort study alone because data to examine these properties 
were not collected as part of the pilot RCT design (Figure 2-5).  
 
Responses to items in the new measure were assigned values or ‘scores’ in 
order to perform quantitative data analyses. For items with an ordinal 
response category (items assessing symptoms), assigned values to the 
categories were on 4-point scale: ‘not at all’=0, ‘a little’=1, ‘quite a bit’=2, ‘a 
lot’=3. For items with conditional responses (items assessing wound care 
interventions), assigned values were ‘no’=0 and ‘yes’=1. These values were 
selected with the rationale that any participant who did not experience any 
symptoms or did not require any wound care interventions would have an 
overall summative score of zero. Interpretation of the overall score would, 
therefore, have a baseline score of zero making clinical and logical sense.  
Incremental unit values of one were assigned to the response categories in an 
order of increasing ‘severity’. The degree of severity between each category of 
‘not at all’, ‘a little’, ‘quite a bit’ and ‘a lot’ was assumed to be equal for 
purpose of analysis, in line with scoring of other similar health-related quality 
of life questionnaires using similar response categories [104,105]. Responses of 
“don’t know” were re-coded as missing data for parts of the analyses where 
their inclusion would affect item correlations (factor analyses). Statistical 






2.9.4. Acceptability   
Acceptability of the new measure, and a further assessment of content 
validity, was examined by exploring its use as both a patient- and observer -
completed tool. 
Acceptability was explored in three ways, by examining: 
• response rates  
• answers to debriefing questions 
• missing data 
 
Response rates for completing the SSI measure 
Patient-completed assessments (self-assessments) 
Participants were asked to complete the measure to provide a self-assessment 
of their wound after they had left hospital. Participants were posted a paper-
copy of the measure (named as the Wound Healing Questionnaire; WHQ) 
(Appendix 13) in time for completion around 30 days after their surgery, a 
widely accepted timeframe for expecting SSI to have occurred [32]. 
Instructions asked participants to complete the questionnaire in relation to 
what had happened since leaving hospital after having surgery, in order to 
collect all relevant information about wound healing since hospital discharge.  
 
Healthcare professional (observer)-completed assessments  
Healthcare professionals were asked to complete the measure when 
performing a participant wound assessment. Data collection for observer-





RCT. In the cohort study, a research nurse or trainee surgeon (involved in the 
wider Bluebelle study) trained in performing wound assessments attempted 
to telephone the participant approximately 30-35 days after surgery to discuss 
how their wound had been healing and any wound care interventions that 
may have occurred. The nurse or trainee completed the SSI measure (observer 
assessment) by telephone. Telephone follow-ups were selected for the study 
design rather than face-to-face follow-up appointments for the entire cohort 
due to limited financial and staff resources. Any participants who were still in 
hospital or had returned to hospital at this time-point were, however, seen in 
person and the SSI measure was completed face-to-face. 
 
In the pilot RCT, all observer assessments were completed by research nurse 
or surgical trainee as part of a face-to-face appointment with participants 
between four and eight weeks after surgery. These appointments were part of 
the trial follow-up for the pilot RCT; telephone follow-ups were not part of 
the pilot RCT design.  
 
Response rates for completing the SSI outcome measure were examined. 
Specifically, these included: 
i) the number of participant-completed self-assessments; 
ii) the number of observer-completed assessments; 
iii) the number of participants with either a participant-completed self-
assessment or an observer-completed assessment  
Demographics and operative details of participants who completed a self-
assessment were compared with those who did not have any assessments 





observer-completed assessment; complete non-responders). This comparison 
was performed to examine whether there was any observable difference 
between the groups that might provide an indication of acceptability of the 
measure for different types of patients.  
 
Debriefing questionnaire  
Acceptability was further evaluated by examining answers to debriefing 
questions. Asking participants to complete an accompanying debriefing 
questionnaire when field-testing a new outcome measure can provide 
valuable feedback, collecting information on the feasibility, suitability and 
content validity (how items are interpreted) so that problems with any of the 
items can be identified and modified if necessary [46].  
 
In the cohort study only, participants were posted a short debriefing 
questionnaire along with the new outcome measure to collect data about the 
feasibility of completing the measure. The debriefing questionnaire included 
questions on how long it took to complete the outcome measure and whether 
there were any problems with completing any of the items (Appendix 14). 
Debriefing questionnaires were administered only to participants (and not to 
healthcare professionals completing the measure as an observer assessment). 
This was due to the specific interest in using the measure primarily as a post-
discharge patient-reported tool for assessing SSI in future applications of its 
use. Debriefing questionnaires were only administered to participants in the 
cohort study (and not the pilot RCT). The cohort study was specifically 
designed to evaluate the new SSI measure and participants were not being 
randomised to any wound dressing interventions. There was scope within the 





inclusion of a debriefing questionnaire without the risk of over burdening the 
participants [88]. The pilot RCT was designed to assess the feasibility of 
conducting a large RCT of different wound dressing strategies and it was 
considered that asking participants to complete a debriefing questionnaire 
alongside the collection of other data necessary for the wider Bluebelle study 
may over burden participants unnecessarily.  
Descriptive statistics were used to summarise the time taken to complete the 
measure, whether help was needed to answer any items and if participants 
had difficulty answering any items as reported in the debriefing 
questionnaire. Additional free text responses from the box provided were 
examined and summarised to explore problems with feasibility and 
practicality on answering any of the items or completing the self-assessment.  
Missing data 
Examination of missing data is a useful method to explore acceptability, 
suggesting difficulty or problems with items that many not be easy to 
understand or answer and is a common technique used in the development of 
outcome measures [46,48]. Patterns in missing responses (that are not 
occurring at random) can indicate: 1) not understanding the item; 2) that the 
item was not applicable; 3) that the answers do not fit the response categories; 
4) that the responder does not know the answer or does not want to say; or 5) 
loss of concentration or motivation [46]. Proportion of missing data for each 
item was examined, in otherwise completed questionnaires. Less than 3% of 
missing data for each item is considered acceptable, and more than 15% is 
considered not acceptable [46]. Reasons for missing data were explored by 
examining any available free text and explanation provided by participants in 







It is important to test whether a new outcome measure demonstrates 
consistency, stability and reproducibility in the data that it provides [107]. 
This is to ensure that data are reliable and that a participant would give the 
same response if they were to complete the measure twice over a period when 
the condition being measured would not be expected to change. This is called 
test-retest reliability [46]. To examine this measurement property for the SSI 
measure, a subset of participants (n=50) in the cohort study were posted a 
second copy of the measure within one week of completing and returning the 
first self-assessment. An interval of one week was considered a reasonable 
timeframe for participants to not recall their previous responses (that is, 
minimise memory bias) so that a more confident assessment of consistency of 
responses could be examined [45]. It is a recommended period for test-retest 
reliability assessments for health measurement instruments [85,108]. 
Sampling for the test-retest subset of participants was conducted by 
convenience. During one month of the study, participants who had returned 
their first self-assessment within the expected timeframe were selected.  
It was necessary to determine an ‘anchor’ question to ensure that participant’s 
health had not changed during the test-retest time period. Item 11 (“Have you 
been back into hospital for treatment of a problem with your wound?”) was 
used as this anchor question. Responses to the item and any free text 
comments were examined as an indication of stable health between these 
assessments.  
Agreement in responses is a commonly used and established method to 
examine reliability [46]. Agreement between test-retest assessments were 





calculated using weighted Kappa statistics, typically used for ordinal data 
[46]. Equal weights between response categories for categorical items (items 1-
8) were assumed (because categories were chosen with intended similar 
increments of severity between each category), with assigned weightings of 0, 
0.333, 0.667 and 1 between categories. Kappa values <0.4 were considered 
poor agreement. Values between 0.4 and 0.75 were considered as fair to good 
agreement [46]. The stability of participants’ responses between test and retest 
assessment for items with a four-category response option (that is, those 
assessing signs and symptoms) was also examined using a graphical 
interpretation. Proportions of participants with an identical response, or those 
moving between categories, were examined using graphs of the differences in 
scores between assessments.  
 
Comparison of responses between self- and observer assessments 
It was important to examine the reliability of the new outcome measure as a 
patient-reported tool (PROM). This was in order to assess its suitability for 
use in research and clinical practice, where effective and efficient patient-
reported tools for use post-discharge are lacking. To study this, a comparison 
of responses in participants self- and observer assessments was examined for 
participants with available data from both assessments. A comparison of 
responses for each item was examined using graphical representations. Cross-
tabulations of responses from self- and observer assessments for each item 
and percentages of agreement and discordance between respondents were 
explored. Level of agreement was calculated using weighted Kappa statistics 
as described above, with equal weights between response categories for items 
1-8. The same cut off values described above for poor, fair and good 






2.9.6. Construct validity 
Evaluation of a new measure should include an examination of construct 
validity; ‘the degree to which the scores of a measurement instrument are 
consistent with a hypotheses (for instance with regard to internal 
relationships, relationships to scores of other instruments, or differences 
between relevant groups) based on the assumption that the instrument 
validly measures the construct to be measured’ [88]. One way this can be 
explored is by using a quantitative approach that looks at the underlying 
structure of the data and how the items correlate or cluster together [46]. This 
can provide an idea of the dimensionality of the data (that is, its scale 
structure), and whether the measure may be assessing a single, 
unidimensional construct or multiple constructs [46]. 
 
Determining the scale structure of the measure  
The conceptual framework for the SSI measure was based on a reflective 
model as described earlier (section 2.7). It is appropriate to analyse a reflective 
model using the principles of classical test theory (CTT). This is a 
measurement theory based on the principal of measuring an unobservable 
construct indirectly through the measurement of observable characteristics 
that are manifestations of that construct [46]. Classical test theory has been 
widely applied to assess outcome measures based on a reflective model 
conceptual framework, with multi-trait scaling and factor analysis being 
suitable analytic methods [46].  
 
In this study, analyses explored whether items in the new measure were 





reflected a more complex multi-dimensional construct. This was performed to 
determine what the data was suggesting about the structure of the measure, 
and whether it was appropriate to analyse the responses as one single scale or 
if a set of multiple scales were more appropriate. Findings, therefore, would 
have implications for how to score the responses and determine a scoring 
system, important for further use of the measure in practice. Two 
methodological techniques were employed for this purpose; multi-trait 
scaling and factor analysis. Both techniques are used for the analysis of 
patient-reported health status data such as symptoms and quality of  life, and 
either are sufficient and appropriate [86]. For methodological interest and for 
the purpose of applying a comparative statistical approach, both multi-trait 
scaling and factor analysis were used in this study. Multi-trait scaling was 
chosen as the primary method for analysis and exploratory factor analysis 
(EFA) was performed as a secondary ‘sensitivity’ analysis. Details and reasons 
for this approach are described in the paragraphs below.  
 
Sample size for assessing construct validity 
There are no general rules for calculating a sample size for performing 
statistical tests on the structure of the data, and requirements will vary 
depending on factors such as the number of items and the distribution of 
responses (which is difficult to know in advance). Sample sizes have been 
based on a “rule of thumb” commonly described in the literature. It is 
estimated that an appropriate sample sizes should be at least five to seven, or 
10 times the number of items, with a minimum sample of 100 recommended 
[86,109]. Analysis of scale structure in the current study was initially 
conducted with data from the cohort study, which had a sample size that was 





was then applied to data from the pilot RCT, to serve as a method of 
independent validation of the scale structure. 
 
Initial examination of item correlations 
Observations of very high correlations (>0.9) can suggest that items may be 
very similar or overlapping and can inform decisions on whether items may 
be redundant and removed before conducting further analyses of the scale 
structure [46]. Before conducting multi-trait scaling or factor analyses, 
correlations of all pairs of items and additional questions were first explored 
in data from the cohort study using Pearson’s correlation coefficient 
(Pearson’s r). Item-item correlations of 0.9 or above were examined for 
similarity and therefore possible redundancy and exclusion in subsequent 
analysis of the underlying structure of the measure [46].  
 
Multi-trait scaling analysis 
Multi-trait scaling analysis to examine the underlying structure of an outcome 
measure can be used when there is a hypothesised structure for the data [84]. 
It is a relatively simple technique that has been used extensively for 
evaluating health status measures that aim to assess underlying health 
domains or ‘traits’ [86]. Multi-trait scaling is based on an examination of 
estimated Cronbach’s alpha coefficients for items within a hypothesised scale 
structure; that is, the underlying domain or set of domains (‘multiple traits’) 
that the measure is intended to assess. Co-efficients are drawn up in a 
correlation matrix for items within the hypothesised scales (item-scale 
correlations). Correlations must be corrected for overlap (of the item in the 
item-trait relationship) so estimates of a relationship are not inflated [84]. 





one item and all of the hypothesised scales (defined by the sum of items 
comprising each scale). Each column contains correlations between the scores 
for one scale and all the individual items in the analysis [84].  
Multi-trait scaling works on the principles of convergent and discriminant 
validity. Convergent validity refers to the extent that items within a scale 
correlate with each other. Discriminant validity refers to demonstrating that 
items from another scale do not correlate well with items from a different 
scale [84]. Evidence of discriminant validity suggests that items in different 
scales are unrelated, demonstrating that separate scales to measure the 
underlying construct is appropriate [86]. Multi-trait scaling is simpler that 
other statistical techniques employed to examine the dimensionality of the 
data, such as factor analysis, however it is considered to be adequate and 
sufficient for analysing symptoms and health-related quality of life data [84].  
Multi-trait scaling was selected as appropriate, therefore, as a primary 
method for evaluating the underlying structure of the SSI measure because of 
its suitability for use in the measurement of symptoms and health-related 
quality of life issues. It was planned to explore hypothesised scales in 
advance. Two a priori hypotheses for the scale structure of the new measure 
were proposed by the study team, based on expert opinion and knowledge of 
the condition. The first was a unidimensional construct for ‘SSI’, 
hypothesising that all items correlate together to measure SSI in a single scale. 
The second was a proposed more complex hypothesised multi-dimensional 
construct for SSI, informed by clinical experience and knowledge of the 
literature within the study team of how signs, symptoms and interventions 
may occur together. The conceptual multi-dimensional construct consisted of 






Table 2-2. Hypothesised multi-dimensional conceptual structure of the SSI 








in scale Item 
Inflammation 4 1. Was there redness spreading away from the wound? 
(erythema/cellulitis) 
  2. Was the area around the wound warmer than the surrounding skin? 
  5. Has the area around the wound become swollen? 
  7. Has the wound been painful to touch? 
Wound 
leaking 
5 3. Was any part of the wound leaking fluid? 
  3a. Was it clear fluid? (serous exudate) 
  3b. Was it blood-stained fluid? (haemoserous exudate) 
  3c. Was it thick and yellow/green fluid? (pus/purulent exudate) 
  10. Has anything been put on the skin to cover the wound? 
Dehiscence 3 4. Have the edges of any part of the wound separated/gaped open on 
their own accord? (spontaneous dehiscence) 
  4a. Did the skin separate? 
  4b. Did the deeper tissue separate? 
Wound care 
interventions 
7 9. Have you sought advice because of a problem with your wound, other 
than at a planned follow-up appointment? 
  12. Have you been given antibiotics for a problem with your wound?   
11. Have you been back into hospital for treatment of a problem with 
your wound? 
  13. Have the edges of your wound been deliberately separated by a 
doctor or nurse? 
  14. Has your wound been scraped or cut to remove any unwanted 
tissue? (debridement of wound) 
  15. Has your wound been drained? (drainage of pus / abscess) 
  16. Have you had an operation under general anaesthetic for treatment 
of a problem with your wound? 
Smell 1 6. Has the wound been smelly? 






Performing the multi-trait scaling analyses 
First, a simple model with one single scale was tested with data from the 
cohort study. Analyses were performed separately for participant self-
reported and observer data for methodological interest to compare the fit of 
the model when the measure was used as a PROM or an observer-completed 
tool. Item-scale correlations for a single scale were examined. Next, a more 
complex model to reflect the hypothesised multi-dimensional scale structure 
was tested. Item-scale correlations were examined for convergent and 
discriminant validity, the established method for testing the fit if the data to 
the model, as described. Item convergence was supported if an item 
correlated substantially (correlations of 0.30 or higher) with the hypothesised 
scale (examined in matrix columns). Item discrimination was supported if the 
highest correlation (examined in matrix rows) was between the item and its 
own hypothesised scale, compared with other scales in the model [84]. 
 
Factor analysis 
Factor analysis is an alternative statistical approach to examine the structure 
of the data in the development of a new outcome measure [46,84]. Factor 
analysis can be distinguished as exploratory factor analysis (EFA) and 
confirmatory factor analysis (CFA). Exploratory factor analysis is performed 
when there is no strong a priori theoretical or conceptual expectation of the 
number or type of factors. As the name suggests it is an exploratory technique 
and is suitable for use early on during the development of a new 
measurement instrument. Confirmatory factor analysis is more suitable when 
there is a defined or hypothesised scale structure and more common for the 
validation of a new measurement instrument. In CFA, a model is tested to see 





scaling. Factor analysis originates from the field of education although has 
widely been adopted in psychology and for psychometric testing of 
measurement instruments including quality of life and symptom 
questionnaires [46,86]. 
 
Exploratory factor analysis was used as second statistical approach to 
evaluate the underlying structure of the SSI measure for two reasons. First, to 
explore whether items clustered together in a way that had not been 
hypothesised a priori and therefore could not be tested using multi-trait 
scaling, and second, as a ‘sensitivity analysis’ to examine the differences 
between multi-trait scaling and factor analysis for exploring the 
dimensionality of the data for methodological interest. 
 
There are several assumptions and choices when using factor analysis. One is 
the appropriateness of the dataset. Traditionally, factor analysis is regarded as 
a method more suitable for continuous data with a normal distribution. The 
response options in the new measure meant that data were ordinal categorical 
data. A technique has been developed to allow factor analysis to be applied to 
data where the assumption of a normal distribution is not met (e.g. skewed 
data). This uses a polychoric matrix rather than a correlation matrix to apply 
the factor analysis [86,110]. Another choice in factor analysis is the method of 
estimation that can be used for selecting a model, with several methods 
available [84]. This study chose maximum-likelihood (ml), recommended as a 
suitable method to use that is robust when data do not meet all the 
assumptions [86]. Following analysis, researchers also have the choice to 
perform ‘rotation’ to the factor structure to aid interpretation. Rotation 





number of factors. It aims to load items more on to one factor without 
changing the number of factors in the model. Whichever method and choices 
are made in factor analysis, interpretation of the model and the factors must 
always be clinically meaningful [86].  
 
Performing the exploratory factor analyses  
Factor analyses were performed to explore possible data structures using data 
from the cohort study, separately for patient and observer data. Analyses 
were run specifying the maximum number of factors to be retained as one, 
two and three factors, in three separate models and in that order. The single 
factor model was used as a comparator for the single scale model in the multi-
trait scaling analyses. The two and three factor models were used to examine 
whether the items clustered together in a set of multi-item scales in a different 
way to that hypothesised (Table 2-2) by examining the item factor loadings on 
to each factor.  The suitability of the one, two and three factor models was 
explored by examining and comparing eigenvalues [86].  
 
Validation of the scale structure  
The most suitable model fitting data from the cohort study was examined for 
replicability of good fit using data from the pilot RCT (as a method of 
independent validation for the scale structure, described above). The model 
was finally applied to the combined data (cohort study and pilot RCT data 






Sensitivity analysis: factor analysis with a polychoric matrix 
Response options to the items in the measure were categorical (not at all, a 
little, quite a bit, a lot) or binary (yes, no) meaning that data were ordinal or 
dichotomous. Standard methods for factor analysis assume that data are 
continuous and follow a normal distribution. As a sensitivity analysis, 
therefore, and to account for any skewed distribution of the data, factor 
analysis using a polychoric matrix was applied and compared with the 
traditional correlation matrix [110,111]. Combined data from the cohort and 
pilot RCT were used. 
 
Internal consistency of the scales 
Internal consistency is a measure of the extent to which items in a scale assess 
the same construct [46]. It is defined as the degree of relatedness among the 
items in a scale [88]. Internal consistency can be assessed by Cronbach alpha 
coefficient. As part of the evaluation of the scale structure of the new measure, 
internal consistency for the scales in the derived structure (determined from 
the multi-trait scaling and EFA) were examined using Cronbach alpha 
coefficients. Values greater than 0.7 were considered to have good internal 
consistency, in line with thresholds used in the literature[46].  
 
2.9.7. Criterion validity 
Criterion validity is defined as ‘the degree to which the scores of a 
measurement instrument are an adequate reflection of a gold standard’ [88]. 
When a reference standard for measuring the construct of interest exists, this 
allows for an assessment of how well the new measure performs compared to 





measures designed for use as diagnostic tests for a condition or disease [46]. It 
was a measurement property that was, therefore, important to consider in the 
context of SSI. 
 
Sensitivity and specificity for SSI diagnoses 
A key objective in the current study was to explore the ability of the new 
measure to correctly classify individuals as having SSI or no SSI. This can be 
assessed by two parameters, sensitivity and specificity. Sensitivity can be 
described as the proportion of true positives correctly identified as positive 
[112]. In the context of the current study, that translates to the proportion of 
participants correctly identified as having SSI. Specificity can be described as 
the proportion of true negatives correctly identified as negative [112]. In the 
context of the current study that translates to the proportion of participants 
correctly identified as not having SSI. To estimate the parameters of 
sensitivity and specificity, each individual needs to be classified using a ‘gold-
standard’ or reference assessment. 
 
Reference SSI assessments 
In the current study, a face-to-face assessment of whether SSI had occurred 
since the time of surgery using the CDC criteria and definition was used as 
the reference standard for comparison with the new measure [32]. As 
described in Chapter 1, the CDC definition is the most commonly used 
definition for SSI in practice and is widely accepted as the best definition 
currently available [11,44]. It was, therefore, selected as the most suitable 






Participants were invited to attend for a face-to-face study appointment 
between four and eight weeks after surgery. In the cohort study, an 
opportunistic subset of patients was invited, aiming for 25% of the cohort due 
to limitations of study resources (staff and room availability, and costs). 
Participants for the face-to-face assessment were sampled by convenience and 
to maximise the number of possible SSIs in the sample, by inviting patients 
that reported problems with wound healing during the telephone follow-up. 
Appointments were arranged to coincide with a routine hospital visit if 
possible. In the pilot RCT, all participants were invited to attend for a face-to-
face follow-up assessment as part of the study design.  
 
Reference assessments were performed at the face-to-face appointment by a 
clinical member (for example, a surgeon, surgical trainee or research nurse 
trained in assessing wounds for SSI) of the Bluebelle study team, blinded to 
the responses on the patient-completed measure (self-assessment) and 
observer-completed measure (telephone assessment), where possible. The 
clinical assessor checked through each CDC criteria using information from 
the patient, hospital records or any other available information and indicated 
on a study data collection form whether any of the criteria had been met since 
the time of surgery. The criteria were then used to give a diagnosis of: i) none; 
ii) superficial; iii) deep, or; iv) organ/space SSI using the CDC classification 
[32]. 
 
Receiver operating characteristic (ROC) curve 
Methods to examine criterion validity, and the strength of the relationship 
between a new measure and a reference standard, depend on the level of 





common methods when the new measure has a continuous or ordinal scale 
and the reference standard is dichotomous (that is, condition/disease or no 
condition/disease), as is the case for the current study, are to use sensitivity 
and specificity parameters to plot a receiver operating characteristic (ROC) 
curve [46]. A ROC curve is a plot of sensitivity against 1-specificity for 
different levels of cut-off in the continuous/ordinal score of the new measure 
[112].  
 
Patient self-assessment was used to calculate sensitivity and specificity 
parameters of the new measure. Self-assessment data were used rather than 
observer assessment data due to the interest in the criterion validity of the 
measure for potential use as a post-discharge patient-reported tool for 
assessing SSI in future applications.  
 
Plotting the ROC curve 
Plotting the ROC curve was done through a series of steps: 
i) Participants’ self-assessment total score on the new measure was 
calculated. An appropriate scoring system to calculate the total score 
was informed by findings from the analysis of the scale structure 
(methods described earlier in this chapter). Data from participants’ 
reference SSI assessment (from the face-to-face appointment using the 
CDC criteria) were used to create a dichotomous variable of ‘no SSI’ or 
‘SSI of any type’. 
ii) A cross-tabulation of frequencies of participants’ total score against the 
reference SSI assessment was examined to compare the total scores on 





iii) Data were subsequently used to calculate sensitivity and specificity 
values for different levels of cut off score on the new measure using the 
following formulae:  
sensitivity =    number of true positives 
number of true positives + number of false negatives 
 
specificity =    number of true negatives 
number of true negatives + number of false positives 
iv) All values of sensitivity against 1- specificity were used to plot a ROC 
curve.  
 
The area under the curve and 95% confidence intervals were examined to 
assess how well the new measure correctly classified individuals as having 
had an SSI and not having had SSI against the reference assessment. An AUC 
values approaching 1.0 indicates high sensitivity and specificity, that is, good 
discrimination, whereas a value of 0.5 indicates no ability to discriminate at 
all [112]. 
 
Interpretation of criterion validity in the absence of a perfect 
reference standard  
Often in practice, a true ‘gold’ standard diagnostic test does not exist. There 
may be known limitations to the existing tool, for example, or there may be 
differences between the measured value and the true value (measurement 
error) [113]. Several options are available for evaluating the diagnostic 





is imperfect. Examples include validation of the reference standard with 
future clinical events (if these are relevant and available), or using statistical 
methods to correct for the degree of imperfection of the reference standard 
[113]. In the current study a face-to-face SSI diagnosis determined from using 
the CDC criteria was used as the reference standard for comparison with the 
new measure. While the CDC definition and criteria are widely accepted and 
commonly used to diagnose SSI [11], there are known limitations regarding 
its subjectivity and problems with measurement, as detailed in the 
introductory chapter of this thesis (Chapter 1) [11]. The use of statistical 
methods to correct for this ‘imperfect’ reference standard was not, however, 
possible, as there is no reliable information on the degree of imperfection of 
CDC diagnoses in the field of SSI measurement. Sensitivity and specificity of 
the new SSI measure against the CDC reference standard, therefore, were 
made with consideration of these known limitations. This limitation is 
returned to in the Discussion chapter of this thesis (Chapter 6). 
 
Justification for no further tests for validity 
As described in the introduction to this chapter, construct validity can be 
broken down into three types: structural validity, hypotheses-testing and 
cross-cultural validity. The current analysis focused on examining structural 
validity of the new measure. While methods for hypothesis testing (for 
example, ‘known-group’ comparisons) and cross-cultural validity exist 
[46,86], these were considered to be outside the scope of the current study. 






Hypothesis testing using known-group comparisons 
A valuable test for construct validity of a new measurement instrument can 
be to examine the ability of the measure to discriminate between ‘known-
groups’ where you would expect there to be a difference between scores or 
performance on the new measure. Indeed, construct validity has been defined 
as ‘the degree to which the scores of a measurement instrument are consistent 
with hypotheses’ [88]. In the current study in abdominal surgery, aside from 
SSI diagnosis, there was no hypothesised grouping of patients where a 
difference in scores on the new measure may be expected, using clinical 
criteria that could reliably and accurately be collected as part of the study. 
Known-group comparison was, however, in part addressed by the ROC curve 
analysis where the self-assessment total score was compared for those 
diagnosed with and without an SSI, using the reference SSI assessment. 
Statistical tests to compare of mean scores in the new measure for participants 
grouped by SSI diagnosis were, therefore, considered to be unnecessary. In 
the absence of other known groups for which expected differences in scores in 




Examination of cross-cultural validation would require translated or 
culturally adapted versions of the measure. A study of cross-cultural validity 
would be suitable for future studies with resources to do so. This is an area 
for further work that is being considered and is returned to in the Discussion 





2.9.8. Modifications to produce the final measure  
Common practice in the development of outcome measures is to use field-
testing studies to inform any final necessary modifications to the measure, 
including the need to modify or drop any items from the measure completely 
[46,85,86]. Findings from Phase 4 of the current study were, therefore, used to 
inform a final round of modifications to produce a final version of the new SSI 
measure. Evidence on how the items were performing was evaluated on an 
item-by-item basis by using data from the debriefing questionnaire, missing 
data, test-retest reliability, patient and HCP agreement and scaling structure. 
Potentially problematic or seemingly redundant items were discussed with 
the study team (experts in the development and validation of outcome 
measures and experts in SSI assessment) and final decisions on whether to 
drop any items were made through discussion. The clinical relevance of items 
was paramount to any decisions on whether items should be dropped from 
the outcome measure. The following chapter will describe the results of all the 
analyses described here, concluding with the final version of the measure 
ready for use in trials and clinical practice. 
 
2.9.9. Summary 
This chapter has described in detail the methods for the development and 
validation of a new outcome measure for SSI. It describes how the essential 
properties of an outcome measure were addressed in the study, including 
content, construct and criterion validity, reliability and acceptability. Robust, 
established methodology was used to ensure these properties were 
addressed, with a particular emphasis on a novel ‘universal-reporter’ design 





professional completion. The chapter describes the methods applied in four 
chronological phases of the study: 1) a content analysis and semi-structured 
interviews with key stakeholders to identify content domains; 2) design of the 
outcome measure including item formulation, response categories and 
instructions for completion; 3) cognitive interviews with patients and 
healthcare professionals to pre-test the preliminary measure; and 4) field-
testing the measure in a large sample of patients following surgery. 
Throughout the chapter, the theory and rationale for using the applied 






CHAPTER 3.  RESULTS:  STUDY 1 
D E V E L O P M EN T  AN D  V A LI D AT I O N  OF  A  N E W  
O U T C O M E  ME A S UR E  F O R  S S I  
 
3.1. Introduction 
This chapter describes the results of the development and validation of a new 
outcome measure for surgical site infection, for patient or healthcare 
professional completion. The chapter is structured to mirror the methods 
described in the previous chapter. It concludes with a brief discussion, 
including of the strengths and limitations of this study. 
 
An overview of each of the study phases, and the essential property of the 
new outcome measure being addressed during its development and 
validation, are provided as a reminder in Table 3-1. The datasets and final 






Table 3-1. Overview of the study phases, methods and datasets included in 
the development and validation of the SSI outcome measure 
































Phase 4:  
Field-testing 
Analysis of data from 










3.2. Phase 1 - Identification of important 
domains: content validity 
 
3.2.1. Content analysis of existing SSI tools 
Identification of existing SSI assessment tools 
The existing systematic review published by Bruce et al. in 2001 [11,31] 
identified the most commonly used definitions and grading scales for 
defining and diagnosing SSI. Two (one definition and one grading scale) were 
found to be most commonly used. These were the CDC definition and the 
ASEPSIS grading scale [32,51]. The scoping review performed as part of the 
current study confirmed these were still the most common tools for SSI 
assessment used in current practice.  
 
CDC criteria and associated tools  
As described in Chapter 1, when the CDC definition has been employed in 
practice, there are examples where the diagnostic criteria in written definition 
have been converted into a ‘checklist’ tool for healthcare professionals to 
complete to aid data collection and diagnosis. Checklists of criteria as tools to 






A longstanding and widely used example of a checklist tool based on the 
CDC criteria was known to the study team. This was the tool used by the PHE 
SSISS programme, described in Chapter 1 [34]. The PHE SSISS surveillance 
data collection forms include a list of SSI criteria with an adjacent box to be 
ticked if that criterion is met (Appendix 15). The tool is intended for 
designated surveillance staff within the hospital to complete. The PHE SSISS 
tool was selected as an appropriate exemplar of a CDC checklist tool to 
include in the content analysis for the current study due to its wide and 
standard use.  
 
In addition to the checklist for surveillance staff completion, the PHE SSISS 
also uses an optional post-discharge questionnaire for patients to complete 
within 30 days following surgery. The questionnaire is also based on the CDC 
criteria for SSI and includes 12 questions (items) to collect information about 
relevant symptoms and wound management (Appendix 4). Data from the 
questionnaire are used to supplement other data collected from hospital 
records as a method for identifying SSI that develop post-discharge. As 
previously described in Chapter 1, the questionnaire is not intended as a 
patient-reported outcome measure for SSI and has not undergone any formal 
development or validation. The items are, however, based on some of the 
CDC criteria therefore it was considered a relevant tool for including in the 
content analysis to inform the development of the new outcome measure in 








As described in Chapter 1, the ASEPSIS grading scale was developed for use 
in hospital, for completion by a healthcare professional. The tool includes a 
list of wound characteristics considered to be important for defining SSI. 
These are serous exudate, erythema, purulent exudate and separation of deep 
tissue. A ‘points’ grading system is used, assigning points based on the 
proportion of the wound affected [51]. Further objective criteria are assessed, 
and more points added if the criteria are met, including antibiotic 
administration, drainage of pus, debridement, microbiology results and 
extended hospital stay (Appendix 16). Points are combined to give an overall 
score.  
 
An associated patient questionnaire has since been designed by authors of the 
ASEPSIS scale. [57,58]. Intended for completion by patients after leaving 
hospital, the questionnaire has been used to determine SSI in conjunction with 
data collected in hospital using the clinical tool [57,114]. The questionnaire for 
patients consists of 10 questions, derived from the wound characteristics and 
criteria in the grading scale, with conditional yes/no response options 
(Appendix 5). Whilst the questionnaire did not have patient input in its 
development and has not been formally validated, it has been used as a post-
discharge questionnaire to collect SSI data from patients in research studies 
[57,114]. It was, therefore, considered a relevant tool to inform the 
development of the new outcome measure in the current study and was 








A total of four source documents, therefore, were identified and obtained for 
the content analysis of existing tools: i) the PHE SSISS checklist of SSI criteria 
based on the CDC definition, ii) the PHE SSISS post-discharge patient 
questionnaire, iii) the ASEPSIS grading scale, and, iv) the ASEPSIS-associated 
patient questionnaire. Table 3-2 summarises these source documents. At the 
time of conducting the current study, current version of the PHE SSISS 
checklist and post-discharge questionnaire were obtained from the PHE 
surveillance protocol, available online [34]. The ASEPSIS grading scale and 
associated patient questionnaire were obtained from published literature 
[51,57].  
 









criteria/items Response categories 
PHE SSISS 
checklist 
HCP 11 Tick boxes 




Numerical score based on 




Patient 10 Yes/no options 
PHE SSISS: Public Health England Surgical Site Infection Surveillance Service; PQ: patient 






Verbatim text was extracted from the source documents. These included: 
i) specific checklist criteria from the PHE SSISS data collection 
form;  
ii) items from the PHE SSISS post-discharge questionnaire for 
patients; 
iii) wound characteristics and objective criteria listed in the 
ASEPSIS grading scale; 
iv) items from the ASEPSIS-associated patient questionnaire 
A total of 42 verbatim criteria and items, and their response categories, were 





Table 3-3. Individual criteria, items and response categories extracted from existing SSI tools 
Existing 
tool  




1 Abscess or other evidence of infection found during a re-operation, by radiology 
or histopath examination 
Tick box 
2 Antibiotics prescribed by GP for SSI (patient reported only) Tick box 
3 Aspirated fluid/swab of surgical site yields organisms and pus cells are present Tick box 
4 Fever (temperature 38ºC or more) Tick box 
5 Heat Tick box 
6 Incision spontaneously dehisces or opened by surgeon Tick box 
7 Clinician’s diagnosis Tick box 
8 Localised pain and tenderness  Tick box 
9 Localised swelling Tick box 
10 Purulent drainage Tick box 
11 Redness Tick box 
 
PHE PQ 
12 Have you had any problems with the healing of your wound? Yes / No 
13 Was there any discharge or leakage of fluid from any part of the wound? Yes / No 
14 If yes, was it either 
Clear or blood stained 
Yellow/green (pus) 
Other – please specify 
Tick box 
15 Pain or soreness in addition to the discomfort experienced following the operation Tick box 
16 Redness or inflammation spreading from the edges of the wound Tick box 
17 The area around the wound felt warmer/hotter than the surrounding skin Tick box 
18 The area around the wound became swollen Tick box 







Criteria / item  Response option 
20 Did any health care worker take a sample from your wound to send to the 
laboratory? 
Yes / No 
21 If you saw a health care worker because of these symptoms, please indicate who 
you saw from the list (GP/district nurse/midwife/doctor or nurse at the 
hospital/other - please specify) 
Tick box 
22 Have you been prescribed antibiotics for an infection in the wound? 
[If yes, who prescribed them? ___] 
Yes / No 
23 Have you been re-admitted to hospital with an infection of the surgical wound? 
To the hospital at which the operation was carried out? 
To another hospital? [If yes, which one? _______] 




24 Serous discharge/exudate % of wound affected  
25 Erythema % of wound affected  
26 Purulent exudate % of wound affected  
27 Separation of deep tissues % of wound affected  
28 Antibiotics  Unspecified* 
29 Drainage of pus under local anaesthesia  Unspecified* 
30 Debridement of wound (general anaesthesia) Unspecified* 
31 Isolation of bacteria Unspecified* 





33 Have the wounds healed without any problem at all? Yes / No 
34 Has the wound been red? Yes / No 
35 Has the wound discharged clear yellow fluid?  Yes / No 
36 Has the wound discharged pus? Yes / No 







Criteria / item  Response option 
38 Have you been given antibiotics for wound infection? Yes / No 
39 Has a district nurse had to dress the wound? Yes / No 
40 Has a doctor opened/drained an abscess? Yes / No 
41 Have you been admitted to hospital elsewhere? Yes / No 
42 Has the wound been opened and cleaned under general anaesthetic in hospital? Yes / No 
*original publication does not detail a response option; however, criteria require a dichotomous response (either yes/no or tick box) 




Categorisation into SSI domains 
Extracted criteria and items were categorised into SSI domains, defined as 
broad aspects of the effect of SSI on the patient, as described in Chapter 2. One 
criterion, “clinician’s diagnosis” (extracted from the PHE SSISS), was 
excluded. The subjectivity of this criterion is recognised as a problem in 
existing literature [37,38,53]. It was considered by the study team to be too 
broad and unspecific to be useful for inclusion in the new outcome measure. 
In total, the 42 criteria/items were categorised into 18 domains: eight domains 
related to the signs or symptoms indicative of SSI (for example, ‘wound 
redness’ and ‘wound pain’) and 10 domains related to SSI interventions and 





Table 3-4. Categorisation of criteria and items from existing tools into SSI domains 
SSI Domain Criteria / item from existing tool Source (existing tool) 
1 Wound healing • Have you had any problems with the healing of your wound? PHE PQ 
  • Have all of these wounds healed without any problem at all? ASEPSIS-associated PQ 
2 Wound heat • The area around the wound felt warmer/hotter than the 
surrounding skin 
PHE PQ 
  • Heat ASEPSIS-associated PQ 
3 Wound redness • Has the wound been red? ASEPSIS-associated PQ 
  • Redness or inflammation spreading from the edges of the 
wound 
PHE PQ 
  • Erythema ASEPSIS scale 
  • Redness PHE checklist 
4 Wound discharge  • Has the wound discharged clear yellow fluid?  
• Has the wound discharged pus? 
ASEPSIS-associated PQ 
ASEPSIS-associated PQ 
  • Purulent drainage PHE checklist 
  • Was there any discharge or leakage of fluid from any part of 
the wound? 
If yes, was it either  




  • Serous discharge/exudate 
• Purulent exudate 
ASEPSIS scale 
ASEPSIS scale 
5 Layers separating 
- spontaneous 
• Has the wound broken open? ASEPSIS-associated PQ 





SSI Domain Criteria / item from existing tool Source (existing tool) 
 • Separation of deep tissues ASEPSIS scale 
  • Incision spontaneously dehisces [/opened by surgeon] PHE checklist 
6 Wound swelling • The area around the wound became swollen PHE PQ 
  • Localised swelling PHE checklist 
7 Wound pain • Pain or soreness in addition to the discomfort experienced 
following the operation 
PHE PQ 
  • Localised pain and tenderness  PHE checklist 
8 Fever • Fever (temperature 38ºC or more) PHE checklist 
9 Contact with 
healthcare 
professional 
• If you saw a health care worker because of these symptoms, 
please indicate who you saw from the list  
(GP/district nurse/midwife/doctor or nurse at the 
hospital/other - please specify) 
PHE PQ 
10 Dressing needed • Has a district nurse had to dress the wound? ASEPSIS-associated PQ 
11 Antibiotics needed • Have you been given antibiotics for wound infection? ASEPSIS-associated PQ 
  • Have you been prescribed antibiotics for an infection in the 
wound? 
If yes, who prescribed them? 
PHE PQ 
  • Antibiotics prescribed ASEPSIS scale 
  • Antibiotics prescribed by GP for SSI (patient reported only) PHE checklist 
12 Layers separating 
- deliberate 
• Incision opened by surgeon [/spontaneously dehisces] PHE checklist 
13 Hospital 
admission 





SSI Domain Criteria / item from existing tool Source (existing tool) 
  • Have you been re-admitted to hospital with an infection of the 
surgical wound? 
To the hospital at which the operation was carried out? 
To another hospital? 
PHE PQ 
14 Drainage needed • Drainage of pus under local anaesthesia (including vac 
therapy) 
ASEPSIS scale 
  • Purulent drainage PHE checklist 
15 Wound cleaning • Has the wound been opened and cleaned under general 
anaesthetic in hospital? 
ASEPSIS-associated PQ 
  • Debridement of wound (general anaesthesia) ASEPSIS scale 
  • Purulent drainage PHE checklist 
16 Abscess • Has a doctor opened/drained an abscess? ASEPSIS-associated PQ 
  • Abscess or other evidence of infection found during a re-
operation, by radiology or histopath examination 
PHE checklist 
17 Microbiology • Did any health care worker take a sample from your wound to 
send to the laboratory? 
PHE PQ 
  • Aspirated fluid/swab of surgical site yields organisms and 
pus cells are present 
PHE checklist 
  • Isolation of bacteria ASEPSIS scale 
18 Prolonged hospital 
stay 
• Stay as inpatient prolonged over 14 days ASEPSIS scale 




3.2.2. Interviews with patients and healthcare 
professionals 
Participants 
Some 28 potential participants (15 patients, 13 healthcare professionals) 
expressed interest in the study and 19 (67.9%) consented to be interviewed. 
Reasons for not being interviewed are provided in Figure 3-1. Interviews were 
conducted with nine patients and 10 healthcare professionals. Participant 
demographics are shown in Table 3-5. 
  










•1 too unwell 
•1 died 







•1 left hospital 
trust 
•1 could not 
commit to 
interview 









Table 3-5. Participant demographics for Phase 1 interviews: identification of 
important domains.  





Gender Female 6 4 
 Male 4 5 
Role Consultant 5  
 Midwife 1  
 Nurse 1  
 Registrar 3  
Specialty Obstetrics 4  
 Paediatric 3  
 Stoma care 1  
 Upper GI 2  
Type of surgery Upper GI benign  2 
Upper GI cancer  1 
Lower GI cancer  1 
Lower GI benign  3 
Appendicectomy  2 
Wound 
infection 
Confirmed  2 
Suspected  1 
Absent  2 
 Missing data  4 
GI: gastrointestinal  
 
 
Emerging themes relevant to the content for the new 
outcome measure 
The aim of the interview component of this study was to identify a list of 
themes relevant to the assessment and management of wound for SSI to 
consider for inclusion in the new outcome measure, as described in the 
methods (Chapter 2). The findings are presented as a list of these themes. 
Findings were classified into two overarching themes, organised under the 
topics guiding the interviews. Broadly, these were i) SSI signs and symptoms, 






SSI signs and symptoms 
The following specific themes within the broader category of SSI signs and 
symptoms were described by participants as being indicative of infection or 
experienced by patients: 
• cellulitis or redness around the wound 
• discharge of pus 
• tenderness 
• pain or soreness of the wound 
• breakdown/opening of the wound 
• feeling generally unwell, often associated with a temperature or fever 
• hot wound 
• abscess 
• swelling 
• raised white blood cell count 
• smell 
 
Wound management care and SSI treatment interventions 
Specific themes within the broader category of wound management care and 
interventions identified from interviews as key to the experience of having an 
SSI or important for its diagnosis/management included: 
• prescription of antibiotics 
• wound drainage 
• dressing changes 
• cleaning of wound 
• taking swabs 





Views on existing tools: item wording and response 
categories  
As well as exploring participants’ experience of having an SSI or managing 
patients with SSI to identify relevant content for the new outcome measure, 
interviews also sought views on the existing PHE and ASEPSIS tools to 
inform the development of the new outcome measure. Interviews with 
patients identified some problems with the language used in existing tools. 
Several words used in items were found to have a lack of understanding of 
their meaning or had differences in interpretation. These words were “pus”, 
“discharge” and “abscess”. In addition, interviews with patients who had 
experienced a wound infection identified that the word ‘infection’ was not 
always used to describe accounts of their experiences. Instead there was a 
preference for describing wound healing and issues around wound healing. 
 
A further finding from the interviews of relevance to the design of the new 
outcome measure was the importance of the spectrum of infection. 
Participants described how signs and symptoms of infection ranged from 
mild to severe. Participants expressed a need and requirement for a range of 
response categories, currently not available in the existing clinical and patient 
tools so that the severity or frequency of some signs/symptoms could be 
adequately reported.  
 
3.2.3. Synthesis of findings 
Findings from the content analysis of existing tools and interviews were 
combined. It was possible to directly map all the themes relating to signs, 





18 SSI domains identified from the content analyses of existing tools. The 
exception was one theme (smell) which was identified from the interview 
data and not a component of the existing SSI tools. Adding smell to the list of 
domains, therefore, resulted in a total of 19 different SSI domains to consider 






Table 3-6. Identified SSI domains and data source of origin 






1. Wound healing x   
2. Wound heat 
   
3. Wound redness 
   
4. Wound discharge  
   
5. Layers separating – 
spontaneous 
   
6. Wound swelling 
   
7. Wound pain 
   
8. Fever  x  
9. Contact with HCP x  x 
10. Dressing needed x   
11. Antibiotics needed    
12. Layers separating - 
deliberate 
 x  
13. Hospital admission x   
14. Drainage needed  x  
15. Wound cleaning    
16. Abscess    
17. Microbiology    
18. Prolonged hospital stay  x x 
19. Smell x x  





3.3. Phase 2 - Designing the preliminary 
measure: content and face validity 
 
3.3.1. Operationalisation of domains into items: a 
novel approach combining plain language 
and medical terminology  
All 19 SSI domains identified in Phase 1 were initially considered for 
inclusion in the new measure. There were two domains that were, however, 
subsequently deemed not suitable for a measure that was intended for patient 
completion. These were microbiology and prolonged hospital stay (domains 
17 and 18). The study team considered that it was unlikely that information 
regarding microbiology could be reliably reported by a patient, if indeed 
information was even known. Similarly, it was considered that patients may 
not reliably be able to report whether their hospital stay was prolonged or as 
expected. These two domains were, therefore, excluded from further 
consideration. The remaining 17 domains were formatted (operationalised) 
into items for the new outcome measure.  
 
Items were written in plain language, informed by wording in existing tools 
with consideration of the issues raised in patient interviews surrounding any 
problematic words. Plain language descriptions were used, for example, to 
describe discharge and pus. In accordance with interviews findings, these 
words were considered to be medical terminology. They were, therefore, 





outcome measure as a single tool for patient and healthcare professional 
completion, as described in the methods (Chapter 2). It was possible to 
include medical terminology in parentheses at the end of eight items/sub-
items. Medical terminology was not included in other items simply because 
no relevant medical description existed for that sign, symptom or intervention 
and therefore a medical term was not considered necessary to include. For 
example, the item ‘Has the wound been painful?’ did not have a relevant 
medical description.  
The first version of the measure prior to pre-testing (version 1.0) was 
structured to have 13 main items, with further information on 
signs/symptoms and wound care interventions captured using 11 additional 
questions (sub-items), is applicable (Table 3-7). This approach to use items 
and sub-items was taken with the aim to streamline the measure for quick 
completion, requiring the responder to only complete sub-items that were 
relevant. For example, if the response to the main item was “not at all” or 
“no”, the responder could skip the associated sub-items and move on to the 
next main item (indicated by an arrow).  
Resource use items 
Of note, the preliminary version of the measure was designed to include 
additional sub-items purely to collect resource use data for the wider 
Bluebelle feasibility study. For example, information on the type of healthcare 
professional from whom advice was sought (for example, doctor or nurse), 
who dressed the wound and where (for example, doctor/nurse in the 
community or hospital, or family member/friend at home) and the type of 
antibiotic administered was collected, when applicable. These sub-items were 
not directly relevant to assess signs/symptoms and wound care interventions 




Table 3-7. Items and response categories in the first version of the SSI measure 
prior to pre-testing (version 1.0) 
 Item description Response categories 
1 Have you had any problems with the healing of 
your wound(s)? 
Yes / No 
2 Was the area around the wound warmer than the 
surrounding skin? (calor) 
Not at all / A little / Moderately 
/ Quite a bit / Very much 
3 Was there redness spreading away from the 
edges of the wound? (erythema and cellulitis) 
Not at all / A little / Moderately 
/ Quite a bit / Very much 
4 Was any part of the wound leaking fluid? Not at all / A little / Moderately 
/ Quite a bit / Very much 
 a) Was it clear fluid? (serous exudate) Not at all / A little / Moderately 
/ Quite a bit / Very much 
 b) Was it blood-stained? (haemoserous 
exudate) 
Not at all / A little / Moderately 
/ Quite a bit / Very much 
 c) Was it thicker and yellow or green? (pus 
/ purulent exudate) 
Not at all / A little / Moderately 
/ Quite a bit / Very much 
 d) I do not know Single tick box 
5 Have the edges of any part of the wound 
separated?  
Not at all / A little / Moderately 
/ Quite a bit / Very much 
 a) Did just the skin separate?  Not at all / A little / Moderately 
/ Quite a bit / Very much 
 b) Did the deeper tissue also separate?  Not at all / A little / Moderately 
/ Quite a bit / Very much 
6 
Has the area around the wound become swollen?  
Not at all / A little / Moderately 
/ Quite a bit / Very much 
7 Has the wound been smelly?  Not at all / A little / Moderately 
/ Quite a bit / Very much 
8 Has the wound been painful?  Not at all / A little / Moderately 
/ Quite a bit / Very much 
9 Have you had a raised temperature? (fever 
>38oC) 
Not at all / A little / Moderately 
/ Quite a bit / Very much 
10 Have you seen anyone because of your wound? Yes / No /Don’t know 
11 Did anyone put a dressing on the wound? Yes / No /Don’t know 
12 Have you been back into hospital for treatment 
of a problem with your wound? 
Yes / No /Don’t know 
 a) Were you given antibiotics (as tablets or 
into a vein) for a wound infection, or 
wound abscess? 
Yes / No /Don’t know 
 b) Was your wound reopened by a doctor 
or nurse? 





 Item description Response categories 
 c) Was your wound cleaned or drained? 
(debridement of 
wound/abscess/purulent drainage) 
Yes / No /Don’t know 
 d) Did this include an operation under 
general anaesthetic? (debridement of 
wound, general anaesthetic) 
Yes / No /Don’t know 
13 Have you had treatment for your wound 
elsewhere, for example at the GP surgery or at 
home? 
Yes / No /Don’t know 
 a) Were you given antibiotics for your 
wound? 
Yes / No /Don’t know 
 b) Was your wound reopened by a nurse or 
doctor, for example at the GP surgery or 
at home? 




3.4. Phase 3: Pre-testing the measure: content 
and face validity 
3.4.1. Participants  
Contact details of 41 interested patients (approached in hospital by surgical 
trainees and research nurses) were passed on to the author of this thesis. Of 
these 28/41 (68%) agreed to take part. Some 14 healthcare professionals that 
were contacted directly by the author of this thesis for participation and all 
(100%) agreed to take part. A total of 42 participants (28 patients; 14 
healthcare professionals) were, therefore, recruited to take part in cognitive 
interviews to pre-test the measure (Figure 3-2). As described in the methods,  
modifications to the measure were subsequently tested with new participants 
(rather than being tested by the same participants) meaning each cognitive 
interview was undertaken with a different participant. Participant 






Figure 3-2. Patients and healthcare professionals approached and recruited to 
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Table 3-8. Phase 3 participants: pre-testing the SSI outcome measure  





Gender Female 10 11 
 Male 4 17 
Age at time of interview (years)  
 21 to 30 0 1 
31 to 40 7 2 
41 to 50 3 2 
51 to 60 3 6 
>60 1 17 
Role   
 Surgical trainee 4 - 
 Hospital/Research nurse 3 - 
 Midwife 3 - 
 General practitioner 3 - 
 Practice/Community nurse 1 - 
Specialty 
 Upper/Lower GI surgery 6 - 
 General practice/community 4 - 
 Obstetrics 3 - 
 Intensive care 1 - 
Length of time qualified (years) 
 <10 1 - 
10-20 7 - 
 >20 6 - 
Time since surgery (weeks) 
 <1 - 1 
1-2 - 2 
2-4 - 9 
>4 - 16 
Type of surgery   
 Lower GI - 10 
 Upper GI  - 9 
 Hernia repair - 6 







3.4.2. Cognitive interview findings 
One-to-one cognitive interviews were conducted with each participant, with a 
median duration of 27 minutes (range 13 to 52 minutes). The mean time 
between patients’ surgery and pre-testing the measure was 46 days (range 6 
to 208 days). 
 
Throughout the cyclical process of interviews and analysis, interviews 
identified issues with item interpretation, understanding, and ambiguity.  
Many of these issues only became apparent because the combined use of plain 
language and medical terminology in items enabled the issues to be 
identified. For example, the inclusion of a medical term alongside plain 
language was found to directly affect the way an item was interpreted and, 
consequently, participants’ responses in a way that enabled a problem with 
the plain language description to be identified. Specific examples of these 
findings are provided below. It was, therefore, an unexpected discovery 
during this phase of the work that the novel approach to combine plain 
language and medical terminology in items revealed to be a beneficial method 
to maximise content validity in outcome measure development. This 
methodological consideration to optimise questionnaire design has been 
published in detail [50].  
 
Interview findings are summarised below under two themes: i) item 






i) Item interpretation and understanding 
Interviews highlighted where there was a need to modify items that were not 
interpreted or understood as intended. This occurred for several reasons, 
including a lack of precision and ambiguity in wording. Interviews also 
highlighted how the use of medical terminology improved understanding by 
focusing participants’ response.    
Example 1 – lack of precision  
For example, the item intending to assess debridement of the wound (that is, 
the medical removal of dead, damaged, or infected tissue) was initially 
phrased “Has your wound been cleaned out? (debridement)”. It became 
apparent that some participants who focused on the plain language 
description were interpreting the item differently to participants who also 
read and understood the medical terminology (Box 4). In this example, quotes 
are presented from two patient participants who responded “yes” to the item 
because the wound had been washed with saline solution or ‘superficially’ 
cleaned, demonstrating that the item was not being interpreted as precisely as 
intended. 
Two quotes from healthcare professional participants further demonstrate 
that the plain language description was not an adequate reflection of the 
medical terminology. As a result of these observations, more detail was added 
to the plain language description to improve precision and ensure it more 
accurately reflected the wound care intervention intended to be assessed 
(debridement). The item was revised for testing in subsequent interviews and 
no further misinterpretations were found. This example demonstrates how it 
was the inclusion of medical terminology that specifically highlighted that the 
plain language description was ambiguous or insufficiently reflected the 





Box 4: Item interpretation and understanding: lack of precision of the 
underlying issue to be measured
 
Item: Has your wound been cleaned out? (debridement of wound) 
Participant: “ [reading] ‘Has your wound been cleaned out?’...Yes it has been cleaned 
out...with this little plastic thing of liquid…saline stuff. They squirt this liquid in…put it 
on some gauze.” 
Patient participant, 1083  
Participant: “I think... urm…when I had the staples taken out I think it was pretty 
standard practice for the nurse to just clean the wound before.… I don’t know what she 
put on but it was a bit of cotton wool and she just rubbed…something.” 
Patient participant, 1104  
Participant: “To me…cleaned out and debridement…isn’t the same thing. Cleaned out is 
washing with saline and debridement is picking…slough…like yellow stuff out…or 
cutting dead skin away or scabs.” 
Healthcare professional participant, 3000 
Participant: “When you say cleaning out of the wound do you just mean, like, getting 
some water?...“That [debridement] actually, to me, involves cutting…debridement is 
when you actually remove by cutting…or scraping…some dead tissue. Cleaned out, to me, 
just implies…oh, um, that you just gave it a bit of a clean…I completely understand what 
debridement of the wound means but, to me, cleaned out is not the same.” 
Healthcare professional participant, 1142 
 
Revised item: Has your wound been cleaned out to remove any dead tissue? 










Example 2 - ambiguity 
Interviews further revealed ambiguity of some items that were written using 
plain language only, without a medical term. For example, some participants 
did not understand the meaning of the plain language description of the item 
‘Have the edges of any part of the wound separated?’ (Box 5). The item was 
shown to be ambiguous and not specific enough to measure the intended 
underlying issue (wound dehiscence; cases where the wound had broken 
down). It was also found that that there was overlap with another item in the 
measure which intended to assess whether the wound edges had been 
intentionally separated by a doctor or nurse. As a result of these observations 
and with the aim to reduce ambiguity, a medical term (‘spontaneous 
dehiscence’) was added to the item and the plain language description was 
revised to ‘Have the edges of any part of the wound separated on their own 
accord’. Subsequent interviews found that the inclusion of this medical term 
helped healthcare professionals to interpret this item correctly and ensured 
that only the more serious cases of wound breakdown were reported in the 





Box 5: Item interpretation and understanding: ambiguity of the underlying 




Example 3 – use of medical terminology to focus participants’ response 
One participant reported how their response to an item was directly 
influenced by the inclusion of the medical term, explaining that they would 
have interpreted the item differently, and subsequently responded differently, 
had the medical term not been included. The example is from a participant 
who experienced some bruising of the skin around the wound and explained 
how understanding the medical term focused their response (Box 6). 
Item: Have the edges of any part of the wound separated? 
Participant: “so what does that one mean?…so…it is separated…because it’s not 
stitched up”…The actual wound was left open because they couldn’t stitch it up.” 
Patient participant, 1079   
Participant: “What does that [separated] mean – like cut or something? Got 
bigger?” 
Patient participant, 1076  
Revised item: Have the edges of any part of the wound separated on their 










Box 6: Item interpretation and understanding: use of medical terminology to 
focus participants’ response 
 
 
ii) Acceptability  
Participants’ acceptability of the measure was overall positive. The format, 
length and response categories did not demonstrate problems, with only 
some minor modifications required. These are summarised below.  
 
Views on the use of medical terminology alongside lay language in items 
were varied. Generally, patients reported that the inclusion of medical terms 
in parentheses was acceptable with the majority paying attention only to the 
lay wording. Some patients reported that they found the medical terms 
interesting and educational. Other patients reported that they only read the 
Item: Was there redness spreading away from the edges of the wound? 
(erythema and cellulitis) 
Participant: “In that first one [item], because I was describing the redness under the 
skin – more deeper redness, purple - when I read that first question, it was the fact that I 
had some idea of what erythema and cellulitis are…I thought, well it wasn’t those…but 
ended up saying a little because of the redness… it probably was erythema…but I 
wasn’t sure.”  
Interviewer: “And if we didn’t have that erythema and cellulitis in there?…” 
Participant: “Yeh, I would then have probably thought...that it was [asking about] that 
[bruising]... but because I recognised those [erythema and cellulitis]…I think I know 
more or less what those two things are.”  






plain language and ignored or did not notice the medical terms (Box 7). 
Patients did not report any concerns over the inclusion of medical 
terminology alongside plain language within the same item. In two 
interviews with healthcare professionals, however, concerns were expressed 
that the use of medical terminology in a questionnaire intended for patients 
may potentially generate worry or confusion. These healthcare professionals 
suggested that patients might be prompted to look up words on the internet 
and see distressing images. This was explored in subsequent interviews with 
patients. While two patients reported that they might look up the medical 
term on the internet out of curiosity, neither expressed any concerns that this 






Box 7: Acceptability of using plain language combined with medical 




Participant: “I just skipped over it…I did say ‘What’s that?’ but it didn’t concern me 
because I could answer the question…I did make the comment of what [is that] but I 
didn’t worry about it and I just went on to the next bit.” 
Patient participant, 1107 
 
Participant: “I was...you know...interested [in the medical terms]. I didn’t look at all of 
it…um, a couple I thought was interesting because it was Latin. That’s what I thought. 
And also spontaneous dehiscence...I thought, gosh…so yeah I found it quite 
interesting.” 
Interviewer: “Did you find them[medical terms] confusing?” 
Participant: “No…For instance that first one… I don’t think I even saw…” 
Patient participant, 1104 
 
Participant: “If I was...on my own receiving this I am a bit of a google searcher so I 
would probably have looked them up.” 





3.4.3. Modifications to the preliminary version of 
the measure (version 1.0) 
Summary of changes  
In summary, pre-testing the preliminary measure (version 1.0) in a cyclical 
process of 42 interviews and analyses resulted in a total of eight versions (1.0 
to 1.7) of the measure being tested.  
 
Changes to wording and phrasing 
The majority of changes during pre-testing concerned the wording and 
phrasing of items. Examples where plain language descriptions needed 
modifying have been described in the quotes in the previous paragraphs. 
Changes made to the wording and phrasing of items between the initial 
preliminary version (v1.0) and the final version after pretesting (v2.0) are 
presented in Table 3-9.  
 
Changes to response categories 
The response options for signs and symptom items were changed as a result 
of the pre-testing from five to four categories. The middle response option 
(‘moderately’) for items that assessed severity of signs/symptoms was 
dropped as participants reported that it was not a meaningful response option 
and had arbitrary interpretation. The response option ‘very much’ was 
changed to ‘a lot’ as it was found to make more grammatical sense when 






Changes to format and layout for effective completion of the measure 
The format and layout of the measure was modified during pre-testing and 
subsequent revisions. Initially, items collecting information on wound care 
intervention were structured to first address whether participants had been 
back into hospital and/or seen in a primary care setting. Further sub-items 
then collected more detail on the wound care interventions that had occurred 
within each setting. Pre-testing found this to be a less streamlined layout for 
completing the measure than initially anticipated. The measure was therefore 
restructured so that participants were required to answer all items relevant to 
wound care interventions had occurred (regardless of the setting). This 
slightly increased the number of items that all participants were required to 
answer but reduced the number of sub-items, making it clearer for 
participants which items they were expected to complete than in earlier 
versions. The order of two items (assessing wound heat and wound redness) 
were reversed so the item assessing wound heat was not the first item in the 
measure. This modification was based on findings from cognitive interviews 
that wound heat may not always be straightforward for participants to 
answer (they may, for example, need to ask other people if they could not feel 
the wound area themselves due to numbness or if dressings are in place). 
Item order is important in questionnaire design and is known to influence 
response and participant engagement [115]. It was considered, therefore, 
important for the initial item in the measure to be an item that all participants 
could respond to easily in order to avoid potential disengagement from 
participants that may impact on participants’ willingness to continue 





Table 3-9. Changes to items in the preliminary version of the SSI measure as a 
result of pre-testing (Phase 3) 
Original item in preliminary version 
before pre-testing (version 1.0) 
Item after pre-testing phase 
(version 2.0) 
Summary and reason 
for change 
1 Have you had any problems 
with the healing of your 
wound(s)? 
n/a Item removed - due to 
contradiction in 
reporting 
2 Was the area around the wound 
warmer than the surrounding 
skin? (calor) 
Was the area around the wound 
warmer than the surrounding 
skin?  
Medical term 
dropped – found not 
to be commonly used 
in practice. No 
replacement term 
identified/required 
3 Was there redness spreading 
away from the edges of the 
wound? (erythema and 
cellulitis) 
Was there redness spreading 
away from the wound? 
(erythema/cellulitis) 
Wording abbreviated 
– dropped “the edges 
of” 
4 Was any part of the wound 
leaking fluid? 




a) Was it clear fluid? 
(serous exudate) 




b) Was it blood-stained? 
(haemoserous exudate) 




c) Was it thicker and 
yellow or green? (pus / 
purulent exudate) 
Was it thick and yellow/green? 
(pus / purulent exudate) 
Minor grammatical / 
punctuation change 
d)  
d) I do not know 
I do not know 
No change 
5 Have the edges of any part of 
the wound separated?  
Have the edges of any part of the 
wound separated/gaped open on 
their own accord? (spontaneous 
dehiscence) 
Wording expanded – 
added “/gaped open 
on their own accord” 
Medical term added 
a)  
a) Did just the skin 
separate?  
Did the skin separate? 
Wording abbreviated 
– dropped “just” 
b)  
b) Did the deeper tissue 
also separate?  
Did the deeper tissue separate? 
Wording abbreviated 
– dropped “also” 
6 Has the area around the wound 
become swollen?  
Has the area around the wound 
become swollen?  
No change 
7 Has the wound been smelly?  Has the wound been smelly?  No change 
8 Has the wound been painful?  Has the wound been painful to 
touch? 
Wording expanded – 
added “to touch” 
9 Have you had a raised 
temperature? (fever >38oC) 
Have you had, or felt like you 
have had, a raised temperature or 
fever? (fever >38oC) 
Wording expanded – 
added “or felt like 
you have had” 
10 Have you seen anyone because 
of your wound? 
Have you sought advice because 
of a problem with your wound, 
other than at a planned follow-up 
appointment?  
 
Major rephrase – 






Original item in preliminary version 
before pre-testing (version 1.0) 
Item after pre-testing phase 
(version 2.0) 
Summary and reason 
for change 
11 Did anyone put a dressing on 
the wound? 
Has anything been put on the 
skin to cover the wound? 
(dressing) 
Major rephrase – 
meaning found to be 
unclear 
Medical term added 
12 Have you been back into 
hospital for treatment of a 
problem with your wound? 
Have you been back into hospital 




a) Were you given 
antibiotics (as tablets or 
into a vein) for a wound 
infection, or wound 
abscess? 
Have you been given antibiotics 
for a problem with your wound? 
If “Yes”, 
Were the antibiotics given as 
tablets/liquid? 
Were the antibiotics given via a 
drip? 
Restructured as one 
main item and two 
sub-items 
Rephrased - removed 
“or wound abscess” 
b)  b) Was your wound 
reopened by a doctor or 
nurse? 
Have the edges of your wound 
been deliberately separated by a 
doctor or nurse? 
Restructured as a 
main item  
Major rephrase 
c)  c) Was your wound 




Has your wound been scraped or 
cut to remove any unwanted 
tissue? (debridement of wound) 
 
Has your wound been drained? 
(drainage of pus /abscess) 




d) Did this include an 
operation under general 
anaesthetic? 
(debridement of wound, 
general anaesthetic) 
Have you had an operation under 
general anaesthetic for treatment 
of a problem with your wound? 
Major rephrase 
One medical term 
dropped - meaning 
found to be unclear 
13 Have you had treatment for 
your wound elsewhere, for 
example at the GP surgery or at 
home? 
n/a Item removed – 
accounted for in 
restructure 
a)  
a) Were you given 
antibiotics for your 
wound? 
n/a 
Item removed – 
accounted for in 
restructure 
b)  
b) Was your wound 
reopened by a nurse or 
doctor, for example at 
the GP surgery or at 
home? 
n/a 
Item dropped – 





Final version of the measure after pre-testing (v2.0) 
The version of the measure after pre-testing (version 2.0) included 16 items 
and five sub-items (Table 3-10). Of these, eight items (items 1 to 8) assessed 
SSI signs and symptoms and eight items (items 9 to 16) related to 
interventions for managing wounds and SSI. The five sub-items collected 
additional information on type of leaking fluid and wound dehiscence, when 
applicable. Medical terms were included in brackets in nine of the items/sub-
items.  
 
As previously described, additional sub-items (n=12) were included in the 
questionnaire to collect information on resource use purely for the purpose of 
the wider Bluebelle study. These were not directly relevant to SSI assessment 








Table 3-10. Items and response categories in the version of the SSI measure 
after pre-testing (version 2.0) 
 Item Response categories 
1 
Was there redness spreading away from the 
wound? (erythema/cellulitis) 
Not at all / A little / 
Quite a bit / A lot 
2 
Was the area around the wound warmer than the 
surrounding skin? 
Not at all / A little / 
Quite a bit / A lot 
3 Was any part of the wound leaking fluid? 
Not at all / A little / 
Quite a bit / A lot 
 a) Was it clear fluid? (serous exudate) 
Not at all / A little / 
Quite a bit / A lot 
 
b) Was it blood-stained fluid? (haemoserous 
exudate) 
Not at all / A little / 
Quite a bit / A lot 
 
c) Was it thick and yellow/green fluid 
(pus/purulent exudate) 
Not at all / A little / 
Quite a bit / A lot 
 d) I do not know Single tick box 
4 
Have the edges of any part of the wound 
separated/gaped open on their own accord? 
(spontaneous dehiscence) 
Not at all / A little / 
Quite a bit / A lot 
 a) Did the skin separate? 
Not at all / A little / 
Quite a bit / A lot 
 b) Did the deeper tissue separate? 
Not at all / A little / 
Quite a bit / A lot 
 c) I do not know Single tick box 
5 Has the area around the wound become swollen? 
Not at all / A little / 
Quite a bit / A lot 
6 Has the wound been smelly? 
Not at all / A little / 
Quite a bit / A lot 
7 Has the wound been painful to touch? 
Not at all / A little / 
Quite a bit / A lot 
8 
Have you had, or felt like you have had, a raised 
temperature or fever? (fever >38oC) 
Not at all / A little / 
Quite a bit / A lot 
9 
Have you sought advice because of a problem with 
your wound, other than at a routine planned follow-
up appointment? 
Yes / No 
10 
Has anything been put on the skin to cover the 
wound? (dressing) 
Yes / No 
11 
Have you been back into hospital for treatment with 
a problem with your wound? 





 Item Response categories 
12 
Have you been given antibiotics for a problem with 
you wound? 
Yes / No / Don’t know 
13 
Have the edges of your wound been deliberately 
separated by a doctor or nurse? 
Yes / No / Don’t know 
14 
Has your wound been scraped or cut to remove any 
unwanted tissue? (debridement of wound) 
Yes / No / Don’t know 
15 
Has your wound been drained? (drainage of 
pus/abscess) 
Yes / No / Don’t know 
16 
Have you had an operation under general 
anaesthetic for treatment of a problem with your 
wound? 






3.5. Phase 4 - Field-testing the measure: 
acceptability, reliability, construct and 
criterion validity 
The methods chapter for this study described how field-testing was 
undertaken by administering the measure in two multicentre studies (a cohort 
study and a pilot RCT). Data from these two studies were combined in order 




i) Cohort field-testing study 
The cohort study ran between August 2015 and January 2016. Screening 
information was not formally collected as part of the cohort study protocol 
and therefore proportions of eligible and approached patients cannot reliably 
be reported. A total of 416 participants were recruited. Two participants were 
excluded shortly after recruitment (one died soon after surgery and one did 
not provide contact details). Data from the remaining 414 participants were 
available for analysis (Figure 3-3).   
 
ii) Pilot RCT 
The Bluebelle pilot RCT ran between March and November 2016. Of 1115 
patients screened; 699 (73.4%) were eligible and approached; 415 (59.4%) of 





participants were available for analysis (Figure 3-3). A consort diagram flow 
diagram of participants in the pilot RCT is provided in Appendix 17.  
 
Available data from the cohort study and pilot RCT were combined, 
providing a total of 792 participants to contribute to the evaluation of the SSI 
measure (Figure 3-3). Participant demographics are presented in Table 3-11. 
 
 
Figure 3-3. Participants and data contributing to the validation of the SSI 
measure. 
  
Total participants included in analysis n=792 
Numbers with follow-up data 
SSI measure; self-assessment: n=561 
SSI measure; observer assessment: n=597 


















Participant preference (n=9) 
Died (n=2) 
Randomisation failed (n=2) 
Clinician decision (n=2) 





Table 3-11: Participant demographic, surgical and clinical details for field-




Age, years, mean (SD) 53.2 (17.5) 0 
Male sex, n (%) 364 (46.0) 0 
Ethnicity, n (%)  29 
White 713 (93.4)  
Asian/Asian British 21 (2.8)  
Black/African/Caribbean/Black British 18 (2.4)  
Mixed/multiple ethnic groups 6 (0.8)  
Other 5 (0.7)  
Employment status*, n (%)  389 
Full-time 138 (34.2)  
Part-time 40 (9.9)  
Self-employed 15 (3.7)  
Homemaker 12 (3.0)  
Retired 161 (40.0)  
Unable to work 18 (4.5)  
Unemployed 9 (2.2)  
Student 10 (2.5)  
Marital status*, n (%)  398 
Married/civil partnership 247 (62.7)  
Divorced 19 (4.8)  
Cohabiting 36 (9.1)  
Separated 7 (1.8)  
Single 63 (16.0)  
Widowed 22 (5.9)  
Duration of surgery, n (%)   40 
Less than 1 hour 213 (28.3)  
1 to 2 hours 182 (24.2)  
2 to 3 hours 139 (18.5)  
More than 3 hours 218 (29.0)  
Type of operation, n (%)  12 
Cholecystectomy 102 (13.1)  
Caesarean section 95 (12.2)  
Colectomy/hemicolectomy 95 (12.2)  
Rectal/anterior resection  72 (9.2)  
Groin hernia repair 61 (7.8)  
Appendicectomy 57 (7.3)  
Pancreaticobiliary resection  38 (4.9)  
Small bowel resection 38 (4.9)  
Abdominal wall hernia repair 37 (4.7)  
Diagnostic laparoscopy / laparotomy 31 (4.0)  
Hartmann’s procedure / reversal 21 (2.7)  
Stoma closure/reversal alone  19 (2.4)  
Oesophagogastric resection / gastrectomy  17 (2.2)  
Anti-reflux surgery  12 (1.5)  
Adhesiolysis 12 (1.5)  















*Details collected for cohort participants only  
 
3.5.2. Items for analysis 
Version 2.0 of the new outcome measure was administered in the field-testing 
studies. All 16 items and five sub-items collecting further information on 
signs and symptoms were included for initial analysis. Participants’ responses 
to these items and sub-items, showing the distribution of responses across the 
response options, are provided in Table 3-12. A graphical representation of 
the distribution of patients’ responses is provided in Appendix 18. Sub-items 
that were included in the questionnaire purely for the purpose of collecting 
resource use data for the wider Bluebelle study (n=12) were not included in 
the analysis because they were not applicable to measuring SSI, as described 
previously.     
 
Bariatric surgery  6 (0.8)  
Other 56 (7.2)  
Type of surgery, n (%)  47 
Elective  606 (81.3)  
Unplanned 139 (18.7)  
Risk factor   
Smoking, n (%)  16 
current 114 (14.7)  
Ex <1 month 236 (30.4)  
No 426 (54.9)  
Diabetes, any type, n (%) 60 (7.7) 17 
ASA score, n (%)  61 
I 232 (31.7)  
II 373 (51.0)  
III 118 (16.1)  
IV 8 (1.1)  




Table 3-12. Distribution of responses for items from participant self-assessments (n=561) and HCP observer assessments (n=597) 
 Distribution of responses  
Not at all A little Quite a bit A lot 
Item n % n % n % n % 
1 Was there redness spreading away from the wound? 
(erythema/cellulitis) 
 
 Participant self-assessments  314  56.78 192 34.72 36 6.51 11 1.99 
 HCP assessments 416 69.80 130 21.81 33 5.54 17 2.85 
2 Was the area around the wound warmer than the surrounding 
skin? 
 
 Participant self-assessments 312 57.56 189 34.87 32 5.90 9 1.66 
 HCP assessments 444 74.50 108 18.12 34 5.70 10 1.68 
3 Was any part of the wound leaking fluid? 
 Participant self-assessments 351 63.93 125 22.77 45 8.20 28 5.10 
 HCP assessments 419 71.02 116 19.66 26 4.41 29 4.92 
3a) Was it clear fluid? (serous exudate)         
 Participant self-assessments 48 40.34 51 42.86 17 14.29 3 2.52 
 HCP assessments 80 51.61 58 37.42 10 6.45 7 4.52 
3b) Was it blood-stained fluid? (haemoserous exudate)         
 Participant self-assessments 45 28.48 77 48.73 24 15.19 12 7.59 
 HCP assessments 77 46.67 56 33.94 18 10.91 14 8.48 
3c) Was it thick and yellow/green fluid? (pus/purulent exudate)         
 Participant self-assessments 71 57.26 27 21.77 18 14.52 8 6.45 
 HCP assessments 96 61.94 30 19.35 13 8.39 16 10.32 
4 Have the edges of any part of the wound separated/gaped 
open on their own accord? (spontaneous dehiscence) 
 
 Participant self-assessments  423 78.04 93 17.16 17 3.14 9 1.66 
 HCP assessments 489 83.59 76 12.99 11 1.88 9 1.54 
4a) Did the skin separate?         
 Participant self-assessments 41 28.52 78 52.35 20 13.42 10 6.71 





4b) Did the deeper tissue separate?         
 Participant self-assessments 93 75.61 15 12.20 11 8.94 4 3.25 
 HCP assessments 77 79.38 10 10.31 4 4.12 6 6.19 
5 Has the area around the wound become swollen?         
 Participant self-assessments  345 63.07 160 29.25 35 6.40 7 1.28 
 HCP assessments 481 80.70 96 16.11 12 2.01 7 1.17 
6 Has the wound been smelly?         
 Participant self-assessments  488 90.54 36 6.68 9 1.67 6 1.11 
 HCP assessments 547 91.78 31 5.20 13 2.18 5 0.84 
7 Has the wound been painful to touch?         
 Participant self-assessments  207 37.77 274 50.00 50 9.12 17 3.10 
 HCP assessments 351 58.79 180 30.15 51 8.54 15 2.51 
8 Have you had, or felt like you have had, a raised temperature 
or fever? (fever >38oC) 
 
 Participant self-assessments  462 85.40 57 10.54 11 2.03 11 2.03 
 HCP assessments 524 87.92 37 6.21 15 2.52 20 3.36 
          
  No Yes     
  n % n %     
9 Have you sought advice because of a problem with your 
wound, other than at a routine planned follow-up 
appointment? 
 
 Participant self-assessments  396 71.10 161 28.90     
 HCP assessments 442 75.04 147 24.96     
10 Has anything been put on the skin to cover the wound? 
(dressing) 
 
 Participant self-assessments  333 60.00 222 40.00     
 HCP assessments 396 66.78 197 33.22     
11 Have you been back into hospital for treatment with a problem 
with your wound? 
 





Percentages shown for the distribution of response across the response categories do not include missing data
 HCP assessments 548 95.30 27 4.70     
          
  No Yes Don’t know   
  n % n % n %   
12 Have you been given antibiotics for a problem with you wound? 
 Participant self-assessments  463 83.88 82 14.86 7 1.27   
 HCP assessments 511 86.32 81 13.68 0 0   
13 Have the edges of your wound been deliberately separated by 
a doctor or nurse? 
 
 Participant self-assessments  532 96.03 16 2.89 6 1.08   
 HCP assessments 572 96.46 21 3.54 0 0   
14 Has your wound been scraped or cut to remove any 
unwanted tissue? (debridement of wound) 
 
 Participant self-assessments  539 98.36 6 1.09 3 0.55   
 HCP assessments 588 98.99 6 1.01 0 0   
15 Has your wound been drained? (drainage of pus/abscess)         
 Participant self-assessments  518 95.40 21 3.87 4 0.74   
 HCP assessments 580 97.97 11 1.86 1 0   
16 Have you had an operation under general anaesthetic for 
treatment of a problem with your wound? 
 
 Participant self-assessments  542 99.27 2 0.37 2 0.37   






Response rates  
 
i) Patient-completed assessments (self-assessments) 
A total of 561/792 (70.8%) participants completed and returned self-
assessments (Figure 3-4). Attempts to collect reasons for non-completed self-
assessment were not part of the study designs, therefore reasons for non-
response are unknown. Demographics and operative details of the responders 
are reported in Table 3-13. Participants had a mean age of 56.3 (SD 16.5), 
approximately half were male (n=278; 49.6%) and most had undergone 
elective surgery (n=453; 80.8%). Self-assessments were completed a median of 
29 days (inter-quartile range 24 to 33 days) after surgery. 
 
ii) Healthcare professional (observer)-completed assessments  
Observer assessments were completed for 597/791 (75.5%) participants 
(Figure 3-4). The reason for non-completed observer assessments was 
primarily due to not being able to contact the participant by telephone or 
meet them face-to-face. Observer assessments were undertaken a median of 
37 days (inter-quartile range 32 to 48 days) after surgery.  
 
iii) Non-responders (participants for whom a self- and/or observer-
completed assessment was not available) 
A self-assessment and/or an observer assessment was available for 688/792 
(86.9%) participants. The remaining 104/792 (13.1%), therefore, were 





not possible to conduct an observer assessment via telephone or face-to-face) 
(Figure 3-4). Demographics and operative details of these participants were 
similar to those who completed a self-assessment (Table 3-13). A higher 
proportion of non-responders, however, had unplanned surgery compared 
with those who completed and returned a self-assessment (n= 34; 34.3% 
versus n=76; 14.4% versus respectively, p<0.001).  
 
Figure 3-4. Participant self- and observer assessments available for analysis 
 
  
Participants included in analysis  
n=792 
Observer assessments completed 
n=597 













Table 3-13. Demographics and operative details for participants who 
completed the self-assessment (n=561), compared with participants for whom 











Male (%) 278 (49.6) 43 (41.4) 
Mean age (SD) 56.3 (16.5) 47.0 (18.4) 
ASA grade (%)   
I 146 (28.6) 37 (38.1) 
II 277 (54.3) 39 (40.2) 
III 81 (15.9) 20 (20.6) 
IV 6 (1.2) 1 (1.0) 
missing 51 7 
Surgery (%)   
Elective 453 (85.6) 65 (65.7) 
Unplanned 76 (14.4) 34 (34.3) 






Answers to debriefing questions 
The debriefing questionnaire was posted to participants in the cohort study 
only. Data were available from 302/414 (72.9%) responders.  
The majority of responders 276/302 (91.4%) reported that it took less than 10 
minutes to complete a self-assessment. Very few participants required help to 
complete any of the items or found any of the items difficult or confusing to 
answer (Table 3-14).  
 
Table 3-14: Feasibility and practicality of completing the SSI measure 
(participant self-assessment; n=302) 
Debriefing item n (%) 
Time taken to complete the outcome measure (%)   
<5 mins 167 (55.3) 
6-10 mins 109 (36.1) 
>10 mins 26 (8.6) 
Help needed to answer >1 item (%) 15 (5.0) 
Confusion / difficulty answering >1 item (%) 18 (6.0) 
 
Available free text responses providing reasons for needing help to answer 
items, or why items were difficult or confusing, were summarised into 
categories (Table 3-15). Reasons included practical issues such as not being 
able to see or touch the wound easily due to its location. Other reasons were 
due to uncertainty on whether the item was applicable for a minority of 
participants. One participant need help to with translating the items despite 
lack of ability to read/understand English being an exclusion criterion for 




Table 3-15. Reported reasons for needing help to complete items in the SSI measure 





reason Example free-text quotes from debriefing questionnaire 
Uncertainty whether item or 
response option was applicable 
6 
“Didn’t have any pain but did if you pressed it”  
“Stitch was pulled out and left tiny wet hole – I did not know if this applied” 
“Pain and discomfort may be low when relaxed but significant when active or have a cold” 
“I found it confusing as temperatures might have nothing to do with the wound” 
 
 
“I was looking for an option that said 'blood'. I selected 'blood stained fluid' as this was the closest option” 
“My response didn't fit any category i.e. I 'did know' but the 3 options didn't fit my answer 'orange fluid'.” 
Location of wound 
5 
“All pains under bottom, rely on help” 
“Stoma bag [problem with seeing wound]” 
  “Asked wife about was it warmer” 
Lack of knowledge  
2 
“What constitutes a dressing”  
“Not sure how to describe plaster/dressing. Perhaps a number of options could be offered.” 
Recall  
2 
“… would have been useful to have the questionnaire while my wound was at the early stages- not 1 month in.” 
“… many wounds will have healed before 1 month so it’s difficult to remember early stages.” 
No context / prior experience of 
wounds  
2 
“Difficult to answer some of the questions without any context. I’ve never had another wound, so I don’t know 
what 'a little' fluid is.” 
“Without any previous experience of wounds it’s difficult to know the difference between answers- a little/quite 
a bit” 





As described previously, sub-items were not expected to be completed if the 
response to the main item was “not at all” or “no”. For all other responses, the 
sub-items were expected to be completed. Missing data are described 
separately for i) items and ii) sub-items due to a substantial observed 
difference in the degree of missing responses. 
 
i) Items 1 to 16 
Missing data for items 1 to 16 were few, ranging from 0.7% to 3.9% in 
participant self-assessments and 0.0% to 3.7% in observer assessments. (Table 
3-16). Participant self-assessments had fewer than 2.7% of responses missing 
for 10 of the 16 items, and fewer than 3.9% of responses missing for any of the 
16 items overall. Observer assessments had fewer than 2.0% of responses 
missing for all items with the exception of Item 11 (missing 3.7% of 
responses). One explanation for the higher level of missing data for this item 
compared to other items could because Item 11 was the last item on the 
second page before continuing over on the final page. It may, therefore, have 
been missed in error. 
 
ii) Sub-items 3a, 3b, 3c and 4a, 4b 
A total of five sub-items were included in the outcome measure to collect 
more information on the type of leaking fluid (sub-items 3a, 3b and 3c) and 
the extent of wound dehiscence (sub-items 4a and 4b). These sub-items were 
intended to be completed if the response to the main item was anything other 







Missing responses to the sub-items ranged between 5.0% and 43.4% of 
participant self-assessments (Table 3-16). Missing responses to these sub-
items in observer assessments were fewer (ranging between 6.3% and 16.7%) 
although the levels were still concerning. Levels of missing data over 15% 
were considered not acceptable [46], as defined in the methods (Chapter 2). A 
closer examination of these data showed that, in some cases, there was 
inconsistency in completed responses. Some respondents did not complete 
any of the sub-items when a response would have been expected. Other 
respondents completed only one of the sub-items rather than all of them, as 
intended. For example, responses to sub-item 3a “Was it clear fluid?” were 
completed, whereas the remaining sub-items 3b “Was it blood-stained fluid?” 
and 3c “Was it thick and yellow/green fluid?” were left missing when they 
were intended to be completed. If the participant had not experienced the 
type of leaking fluid the response was intended to be marked as ‘not at all’. 
Instead, data indicated that respondents were skipping sub-items that were 
not relevant to them. The high level of missing responses to the sub-items 
indicted the current design was suboptimal and highlighted a need to 








Table 3-16. Levels of missing data for items in participant self-assessments 
(n=561) and observer assessments (n=597) 





 Item* n %** n %** 
9 Have you sought advice because of a problem with your 
wound, other than at a routine planned follow-up 
appointment? 
4 0.71 8 1.34 
10 Has anything been put on the skin to cover the wound? 
(dressing) 
6 1.07 4 0.67 
13 Have the edges of your wound been deliberately 
separated by a doctor or nurse? 
7 1.25 4 0.67 
1 Was there redness spreading away from the wound? 
(erythema/cellulitis) 
8  1.43 1 0.17 
12 Have you been given antibiotics for a problem with you 
wound? 
9 1.60 5 0.84 
3 Was any part of the wound leaking fluid? 12 2.14 7 1.17 
7 Has the wound been painful to touch? 13 2.32 0 0 
14 Has your wound been scraped or cut to remove any 
unwanted tissue? (debridement of wound) 
13 2.32 3 0.50 
5 Has the area around the wound become swollen? 14 2.50 1 1.17 
16 Have you had an operation under general anaesthetic for 
treatment of a problem with your wound? 
15 2.67 7 1.17 
11 Have you been back into hospital for treatment with a 
problem with your wound? 
17 3.03 22 3.69 
15 Has your wound been drained? (drainage of pus/abscess) 18 3.21 5 0.84 
2 Was the area around the wound warmer than the 
surrounding skin? 
19 3.39 1 0.17 
4 Have the edges of any part of the wound 
separated/gaped open on their own accord? 
(spontaneous dehiscence) 
19 3.39 12 2.01 
8 Have you had, or felt like you have had, a raised 
temperature or fever? (fever >38oC) 
20 3.57 1 0.17 
6 Has the wound been smelly? 22 3.92 1 0.17 
4a) Did the skin separate? 6 5.04 6 6.25 
4b) Did the deeper tissue separate? 27 22.69 16 16.67 
3b) Was it blood-stained fluid? (haemoserous exudate) 47 23.74 14 8.19 
3c) Was it thick and yellow/green fluid? (pus/purulent 
exudate) 
81 40.61 23 13.45 





*Items are ordered in ascending (fewest to most) order of missing data in participant self-
assessments  
**shows proportion of participants missing a response to that item in otherwise completed 
questionnaires. For sub-items, shows the proportion of participants missing a response if a 




A total of 44/50 (88.0%) participants completed the self-assessment on two 
separate occasions to examine test-retest reliability of the measure. The 
median time between test-retest assessments was five days (inter-quartile 
range: four to seven days). This was within the one-week interval period 
intended. There was no change in any of the participants’ health between the 
test-retest time period, based on responses to the ‘anchor’ question (Item 11; 
“Have you been back into hospital for treatment of a problem with your 
wound?”).  
Test-retest reliability was good for the majority of items, with Kappa statistic 
values within the range (0.4 to 0.75) considered to be fair to good agreement  
[46]. Observed agreement in responses between the test-retest assessments 
was high, with over 86% agreement for all 16 items. For some items, 
calculation of a kappa statistic was not reliable because there were too few 
observations in any one cell of the cross-tabulation. When numbers in 
contingency tables were sufficient and it was possible to produce kappa 
statistics, values were greater than 0.6 for the majority of items (Table 3-17). 
Stability of responses for items with a 4-category response option between 
test-retest assessments are shown in Figure 3-5. The proportion of participants 
with identical responses (values of 0) or moving only one category (values of -




Table 3-17. Patient assessment test-retest reliability for each item (sub-sample 
of cohort study; n=44) 









3a Was it clear fluid? (serous exudate) 4 100.00 87.50 1.0000 
4a Did the skin separate? 8 100.00 87.50 1.0000 
4b Did the deeper tissue separate? 6 100.00 87.50 1.0000 
11 Have you been back into hospital for 
treatment with a problem with your 
wound? 
44 100.00 83.47 1.0000 
15 Has your wound been drained? 
(drainage of pus/abscess) 
41 100.00 95.24 1.0000 
10 Has anything been put on the skin to 
cover the wound? (dressing) 
44 97.73 50.62 0.9540 
4 Have the edges of any part of the 
wound separated/gaped open on 
their own accord? (spontaneous 
dehiscence) 
43 97.67 84.41 0.8509 
12 Have you been given antibiotics for a 
problem with you wound? 
43 95.35 75.88 0.8072 
3b Was it blood-stained fluid? 
(haemoserous exudate) 
11 93.94 74.10 0.7660 
3c Was it thick and yellow/green fluid 
(pus/purulent exudate) 
5 86.67 54.67 0.7059 
3 Was any part of the wound leaking 
fluid? 
43 92.25 73.79 0.7043 
9 Have you sought advice because of a 
problem with your wound, other than 
at a routine planned follow-up 
appointment? 
43 86.05 55.98 0.6830 
5 Has the area around the wound 
become swollen? 
44 93.18 81.82 0.6250 














8 Have you had, or felt like you have 
had, a raised temperature or fever? 
(fever >38oC) 
43 96.12 93.74 0.3804 
6 Has the wound been smelly? 43 97.67 96.34 0.3645 
2 Was the area around the wound 
warmer than the surrounding skin? 
38 88.60 82.46 0.3500 
1 Was there redness spreading away 
from the wound? (erythema/cellulitis) 
41 86.18 80.11 0.3051 
13 Have the edges of your wound been 
deliberately separated by a doctor or 
nurse? 
43 97.67 97.67 0.0000 
14 Has your wound been scraped or cut 
to remove any unwanted tissue? 
(debridement of wound) 
39 94.87 95.00 -0.0263 
16 † Have you had an operation under 
general anaesthetic for treatment of a 
problem with your wound? 
40 100.00 - - 
*Items ordered in descending (highest to lowest) values of Kappa statistic. Values between 0.4 
and 0.75 were considered to be fair to good agreement [46] 
†Expected agreement and Kappa statistic not possible to compute as all observations were of 




Figure 3-5. Stability of responses between test-retest assessments for items 
















Movement between response categories
Item 1: Was there redness spreading away 












Movement between response categories
Item 2: Was the area around the wound 
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Movement between response categories
Item 4: Have the edges of any part of the 
wound separated/gaped open on their 
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Movement between response categories








Comparison of responses between participant self- and 
observer assessments 
Data from both a participant self-assessment and an observer assessment 
were available for 470/791 (59.4%) participants (Figure 3-4). Median time 
between self- and observer assessments was eight days (inter-quartile range 
two to 16 days). Overall, responses in the self- and observer assessments were 
similar, demonstrated in graphical format in Figure 3-6 (individual data) and 
Figure 3-7 (group data). Numerical data are available in Table 3-12. 
Agreement in cross-tabulations of self- and observer responses for each 
participant was generally high. Levels of observed agreement was greater 
than 84.3% for all items. Where it was possible to calculate a Kappa statistic, 
values were between 0.40 and 0.74 (indicating fair to good agreement) with 













Movement between response categories
Item 8: Have you had, or felt like you have 














Movement between response categories











Figure 3-7. Comparison of responses to items in self- and observer 













Item 1: Was there redness spreading away 













Item 2: Was the area around the wound 

















































































Item 4: Have the edges of any part of the 
wound separated/gaped open on their 



































































Item 8: Have you had, or felt like you have 














Item 9: Have you sought advice because of 
















Item 16: Have you had an operation under 
general anaesthetic for treatment of a 













Item 10: Has anything been put on the skin 











Item 11: Have you been back into hospital 












Item 13: Have the edges of your wound 















Item 12: Have you been given antibiotics 


























Item 14: Has your wound been scraped or 







 Table 3-18: Agreement between responses in participant and HCP 










12 Have you been given antibiotics for a 
problem with you wound? 
454 96.26 76.89 0.8379 
3 Was any part of the wound leaking 
fluid? 
458 93.96 76.48 0.7432 
10 Has anything been put on the skin to 
cover the wound? (dressing) 
464 84.70 53.33 0.6721 
3a Was it clear fluid? (serous exudate) 67 90.55 71.43 0.6691 
4b) Did the deeper tissue separate? 43 91.03 74.68 0.6456 
4 Have the edges of any part of the 
wound separated/gaped open on their 
own accord? (spontaneous dehiscence) 
447 95.15 86.85 0.6314 
9 Have you sought advice because of a 
problem with your wound, other than 
at a routine planned follow-up 
appointment? 
461 85.90 61.77 0.6312 
6 Has the wound been smelly? 454 97.43 93.72 0.5911 
3b Was it blood-stained fluid? (haemoserous 
exudate) 
89 86.74 68.55 0.5784 
4a) Did the skin separate? 56 88.56 74.57 0.5501 
8 Have you had, or felt like you have 
had, a raised temperature or fever? 
(fever >38oC) 
454 94.93 89.44 0.5203 
13 Have the edges of your wound been 
deliberately separated by a doctor or 
nurse? 
456 96.93 93.64 0.5175 
3c Was it thick and yellow/green fluid 
(pus/purulent exudate) 
71 84.68 68.47 0.5143 
11 Have you been back into hospital for 
treatment with a problem with your 
wound? 
437 95.65 91.06 0.5138 
2 Was the area around the wound 
warmer than the surrounding skin? 
454 89.06 79.75 0.4597 
1 Was there redness spreading away 
from the wound? (erythema/cellulitis) 














15 Has your wound been drained? 
(drainage of pus/abscess) 
445 97.08 94.94 0.4221 
14 Has your wound been scraped or cut to 
remove any unwanted tissue? 
(debridement of wound) 
454 98.68 97.82 0.3936 
7 Has the wound been painful to touch? 462 84.34 74.96 0.3748 
5 Has the area around the wound become 
swollen? 
459 88.16 82.86 0.3092 
16 Have you had an operation under 
general anaesthetic for treatment of a 
problem with your wound? 
449 99.78 99.78 0.0000 
*Items ordered in descending (highest to lowest) values of Kappa statistic. Values between 0.4 




Notable observations in comparisons of responses  
Signs and symptoms  
Although responses in self- and observer assessments were similar, a trend 
for patients to report signs and symptoms a little more severely than 
healthcare professionals was observed. This is demonstrated in Figure 3-7, 
where the percentage of responses of ‘not at all’ and ‘a little’ differs slightly 
between self- and observer assessments. The difference, however, was small 
and not significant.  
 
‘Major’ wound care interventions  
Data showed that the more ‘major’ wound care interventions, that is, 
interventions that required a degree of surgical intervention such as wound 





(assessed by Items 13 to 16) were rare in the study sample. Reports that these 
interventions had occurred were as low as 1-3%. Although these interventions 
were rare, examination of the raw data showed that there was slight 
discrepancy in agreement between self- and observer reports of whether they 
had occurred (Table 3-19). For example, six patients reported that their wound 
had been scraped or cut to remove unwanted tissue (item 14), however only 
2/6 (33.3%) of the observer’s assessment agreed (that is, the healthcare 
professional agreed with the patient that the intervention had occurred). 
Conversely, observer assessments reported that two patients had had their 
wound scraped or cut to remove unwanted tissue which was not indicated by 
the patient themselves (that is, the patient disagreed with the healthcare 
professional that the intervention had occurred). This suggests a degree of 
misunderstanding or lack of awareness of these interventions for a very low 
number of participants. 
 
Table 3-19: Comparison of participant and HCP agreement for reports of 










Item n n (%) 
13 Have the edges of your wound 
been deliberately separated by a 
doctor or nurse? 
14 8 (57.1%) 
14 Has your wound been scraped or 
cut to remove any unwanted 
tissue? (debridement of wound) 
6 2 (33.3%) 
15 Has your wound been drained? 
(drainage of pus/abscess) 
16 5 (31.3%) 
16 Have you had an operation under 
general anaesthetic for treatment of 
a problem with your wound? 




3.5.5. Construct validity 
Initial examination of item correlations 
Correlations of responses for all pairs of items and sub-items to identify 
potential item redundancy are provided in Appendix 19. A very high 
correlation (0.94 in participant self-assessment data) was observed between 
Item 4 and the sub-item 4a. These were “Have the edges of any part of the 
wound separated/gaped open on their own accord? (spontaneous 
dehiscence)” and “Did the skin separate?”. An examination of the raw data 
confirmed that participants’ responses to these items were identical for almost 
all respondents. The issues intended to be measured by these two items were 
reconsidered by the study team, and it was recognised and agreed that they 
were addressing the same thing. Question 4a was therefore deemed 
redundant and excluded in further analysis of the scale structure. 
 
Multi-trait scaling analysis 
Two a priori hypotheses for the scale structure of the new SSI measure were 
proposed, as described in the methods (Chapter 2). These were a 
unidimensional construct (single scale) and a multi-dimensional construct 
(consisting of four multi-item scales and two single items, informed by 
clinical and expert knowledge). 
 
First, the single scale model was tested in data from the cohort study, 
separately for data from self- and observer assessments. Item-scale 
correlations are reported in Table 3-20. Values above 0.30 suggested 
substantial correlation, as described in the study methods [84]. Results 
supported convergence of items to a single scale with the majority of item-





items (two items assessing signs/symptoms of swelling and pain in data from 
self-assessments, and two items assessing the wound care interventions 
debridement and reoperation in data from self- and observer-assessments). 
For these items, item-scale correlations were between 0.07 and 0.23 (that is, 
below the 0.30 threshold for an acceptable correlation [84]). The low 
correlation values for the items assessing debridement and reoperation may 
be explained by the very low number of cases occurring in the dataset (<n=4 
in the cohort study data) rather than a poor fit of a single scale model.  
 
Next, the multi-scale model (four multi-item scales and two single items) was 
tested. Item-scale correlations are reported in Appendix 20 (self-assessment 
data) and Appendix 21 (observer data). Convergence of items to their 
hypothesised scales was supported, with item-scale correlations ranging 
between 0.24 and 0.73 (self-assessment data), with only one exception (Item 
16, with an item-scale correlation of 0.05). There was, however, weak evidence 
for item discrimination. Correlations between items and their hypothesised 
scales were similar to correlations with other scales in the model, providing 
low evidence to suggest that more than one scale exists [86]. Data showed 
Item 1, for example, had item-scale correlations of 0.42, 0.32, 0.40 and 0.31 





Table 3-20. Multi-trait scaling: item-scale correlations for a single scale 








Number of items in scale 20 20 






3 Was any part of the wound leaking fluid? 0.74 0.75 
3b Was it blood-stained fluid? (haemoserous exudate) 0.67 0.58 
12 




Have you sought advice because of a problem with your 




Have the edges of any part of the wound separated/gaped 
open on their own accord? (spontaneous dehiscence) 
0.55 0.66 
3c Was it thick and yellow/green fluid (pus/purulent exudate) 0.52 0.59 
1 




Have you been back into hospital for treatment with a 
problem with your wound? 
0.49 0.41 
3a Was it clear fluid? (serous exudate) 0.48 0.30 
4b Did the deeper tissue separate? 0.46 0.46 
15 Has your wound been drained? (drainage of pus/abscess) 0.38 0.31 
2 








Have the edges of your wound been deliberately separated 
by a doctor or nurse? 
0.33 0.41 
6 Has the wound been smelly? 0.32 0.39 
8 
Have you had, or felt like you have had, a raised 
temperature or fever? (fever >38oC) 
0.31 0.44 
5 Has the area around the wound become swollen? 0.23 0.37 
14 
Has your wound been scraped or cut to remove any 
unwanted tissue? (debridement of wound) 
0.17 0.21 
7 Has the wound been painful to touch? 0.16 0.31 
16 
Have you had an operation under general anaesthetic for 
treatment of a problem with your wound? 
0.07 (no observations) 
*Items are ordered in descending (highest to lowest) values of item-scale correlation for 






Exploratory factor analysis was performed as an alternative, second statistical 
approach to examine construct validity. As described in the methods (Chapter 
2), a second statistical approach was undertaken i) to explore whether items 
clustered together in a way that had not been hypothesised a priori and 
therefore could not be tested using multi-trait scaling and, ii) for 
methodological interest (to compare the findings of multi-trait scaling and 
factor analysis) for exploring the dimensionality of the data.  
Data from both participant self-assessments and observer assessments fitted a 
single scale model satisfactorily (Table 3-21). Item factor loadings were 
positive for all items, with the majority with values ranging between 0.30 and 
0.87. The exceptions were four items (two items assessing swelling and pain 
in data from self-assessments, and two items assessing debridement and 
reoperation in data from self- and observer-assessments), identical to the 
results from the multi-trait scaling analysis. Data for these items did not fit the 
single scale model well (demonstrated by low factor loadings of less than 
0.27) or were dropped from the model by the software because of a lack of 
variability in the data (meaning too few participants in the dataset reported 
that these interventions had occurred and therefore it was not possible to 
include these items in the model). In general, item factor loadings were higher 
in data from the observer assessments compared to data from the self-
assessments, indicating that, although both data fitted the single scale model 
well, the observer data fitted the single scale model even more satisfactorily.  
There was no evidence from the exploratory analysis to support a two or 
three factor model in favour of a single factor model. Parameters from a three-





Appendix 23 (observer data). Eigenvalues indicated that a single factor 
explained most of the variance in the data [86].  
Table 3-21. Factor loadings for a single factor model, ml method of estimation 













3 Was any part of the wound leaking fluid? 0.8685 0.8110 
3b Was it blood-stained fluid? (haemoserous 
exudate) 
0.7467 0.6262 
12 Have you been given antibiotics for a problem 
with you wound? 
0.6599 0.6845 
9 Have you sought advice because of a problem 
with your wound, other than at a routine planned 
follow-up appointment? 
0.5934 0.5963 
4 Have the edges of any part of the wound 
separated/gaped open on their own accord? 
(spontaneous dehiscence) 
0.5620 0.6980 
3a Was it clear fluid? (serous exudate) 0.5127 0.3917 
15 Has your wound been drained? (drainage of 
pus/abscess) 
0.5106 0.3289 
11 Have you been back into hospital for treatment 
with a problem with your wound? 
0.5028 0.3712 
4b Did the deeper tissue separate? 0.4837 0.5110 
3c Was it thick and yellow/green fluid 
(pus/purulent exudate) 
0.4642 0.6368 
6 Has the wound been smelly? 0.4456 0.3524 
1 Was there redness spreading away from the 
wound? (erythema/cellulitis) 
0.4178 0.6425 
13 Have the edges of your wound been deliberately 
separated by a doctor or nurse? 
0.4134 0.3891 
10 Has anything been put on the skin to cover the 
wound? (dressing) 
0.4072 0.5158 
8 Have you had, or felt like you have had, a raised 
temperature or fever? (fever >38oC) 
0.2962 0.4221 
14 Has your wound been scraped or cut to remove 
any unwanted tissue? (debridement of wound) 
0.2894 0.0426 
7 Has the wound been painful to touch? 0.2701 0.3063 
2 Was the area around the wound warmer than the 
surrounding skin? 
0.2234 0.5743 
5 Has the area around the wound become swollen? 0.1724 0.3231 
16† Have you had an operation under general 
anaesthetic for treatment of a problem with your 
wound? 
- - 
† Model dropped this item because of zero variance (self-assessment data) and collinearity 
(observer data; all scores were equal to zero) 





Summary of findings for construct validity (multi-trait 
scaling and factor analyses) 
Overall, examination of the data using both multi-trait scaling and factor 
analysis techniques supported a unidimensional (single) scale for measuring 
the underlying construct of SSI. This made clinical and practical sense. 
Findings meant that a simple approach to scoring the new measure could be 
taken, adding scores for responses to all of the items together to provide a 
single overall total score. 
 
Validation of the scale structure 
As a method of independent validation for the single scale structure 
determined from the cohort study data, the single factor model was applied to 
data from the pilot RCT to test for replicability of good fit. Evidence for a 
good fit was even stronger in the RCT data than the cohort study data, with 
generally higher item factor loadings (Appendix 24). Findings, therefore, 
supported a single scale model, validating the unidimensional structure of the 
SSI measure.  
 
The single scale model was finally applied to the entire dataset (cohort study 
and pilot RCT data combined). Parameters are shown in Table 3-22. Evidence 
of fit was even stronger with the combined data, with factor loadings all 
above 0.30 and most 0.4 or higher. The exception was for Item 14 assessing 
debridement (in data from the observer assessment) with an item factor 
loading of 0.03. As described earlier, this is likely to be explained by the low 






Table 3-22. Factor loadings for a single factor model, ml method of estimation 













3 Was any part of the wound leaking fluid? 0.8681 0.8503 
3b Was it blood-stained fluid? (haemoserous 
exudate) 
0.7183 0.5804 
4 Have the edges of any part of the wound 
separated/gaped open on their own accord? 
(spontaneous dehiscence) 
0.6769 0.6317 
12 Have you been given antibiotics for a problem 
with you wound? 
0.6536 0.6746 
9 Have you sought advice because of a problem 
with your wound, other than at a routine planned 
follow-up appointment? 
0.6133 0.5854 
4b Did the deeper tissue separate? 0.5875 0.4291 
3c Was it thick and yellow/green fluid 
(pus/purulent exudate) 
0.5731 0.6398 
3a Was it clear fluid? (serous exudate) 0.5654 0.4504 
6 Has the wound been smelly? 0.4864 0.4268 
1 Was there redness spreading away from the 
wound? (erythema/cellulitis) 
0.4528 0.6557 
11 Have you been back into hospital for treatment 
with a problem with your wound? 
0.4513 0.3485 
10 Has anything been put on the skin to cover the 
wound? (dressing) 
0.4186 0.5364 
13 Have the edges of your wound been deliberately 
separated by a doctor or nurse? 
0.4068 0.4012 
8 Have you had, or felt like you have had, a raised 
temperature or fever? (fever >38oC) 
0.3946 0.3898 
15 Has your wound been drained? (drainage of 
pus/abscess) 
0.3820 0.3338 
7 Has the wound been painful to touch? 0.3635 0.3697 
14 Has your wound been scraped or cut to remove 
any unwanted tissue? (debridement of wound) 
0.3368 0.0324 
2 Was the area around the wound warmer than the 
surrounding skin? 
0.3173 0.5637 
5 Has the area around the wound become swollen? 0.3159 0.3589 
16† Have you had an operation under general 
anaesthetic for treatment of a problem with your 
wound? 
- - 
† Model dropped this item because of collinearity  
*Items are ordered in descending (highest to lowest) values for item-factor loading for 
participant self-assessment data




Sensitivity analysis: factor analysis with a polychoric matrix 
Factor analysis with a polychoric matrix was run as a sensitivity analysis to 
account for skewed categorical data. Similar to the item-item correlation 
matrix using Pearson’s coefficients, the polychoric matrix for patient data 
showed a very high correlation (0.99) between item 4 and the sub-item 4a 
suggesting high overlap of these items (Appendix 25). Sub-item 4a was, 
therefore, excluded from the polychoric factor analysis. In addition, the 
software also removed items 14 and 16 from the polychoric matrix (due to the 
very low number of observations for these wound care interventions in the 
dataset meaning values could not be computed). Polychoric factor analysis 
supported the standard factor analyses, demonstrating a good fit of the data 
to a single factor model with high factor loadings (all above 0.42) (Appendix 
26).  
 
Internal consistency of the scales 
The internal consistency of the single SSI scale was good. Cronbach’s alpha 
coefficients using combined cohort study and pilot RCT data (excluding sub-








3.5.6. Criterion validity  
Reference SSI assessments determined by face-to-face assessment of the 
wound using the CDC criteria were completed for 417/792 (53.0%) 
participants: 115/414 (27.8%) participants in the cohort study and 302/378 
(79.9%) participants in the pilot RCT. As explained in the methods (Chapter 
2), a subset of participants were invited for a reference assessment in the 
cohort study, whereas all participants in the pilot RCT were invited for a 
reference assessment. Reference assessments were made a median of 44 days 
(inter-quartile range 36 to 52 days) after surgery. 
 
Plotting the ROC curve 
To plot the ROC curve, first participant self-assessment total scores for the 
new outcome measure were calculated. A total score was derived by adding 
the scores of responses to the individual items without any item weightings, 
demonstrated to be appropriate from the analysis of the scale structure. This 
excluded sub-item 4a that was deemed redundant due to item overlap (see 
earlier, section 3.5.5). A possible total score could range from 0 to 44. Actual 
total scores in the self-assessment data ranged between 0 and 30.  
 
Cross-tabulations of total scores against the dichotomous reference 
assessment of ‘SSI of any type’ or ‘no SSI’ were examined (Table 3-23). 
Sensitivity and specificity values were calculated for different levels 
(thresholds) of cut-off score on the new measure (Table 3-24) and used to plot 
the ROC curve. Findings showed the sensitivity and specificity of the self-






of any type and those who had not had an SSI was high, with an area under 
the ROC curve of 0.906 (95% confidence interval 0.827 to 0.984) (Figure 3-8). 
From the current data, a cut-off score around 6 to 8 appeared to be a 
reasonable threshold for suggesting SSI / no SSI compared with the reference 
assessment, with relatively few misclassifications.  
 
Table 3-23.  Tabulation of participant self-assessment total score against the 





(no. of participants) Total number of participants 
No SSI  SSI of any type   (n) % cumulative % 
0 43 2 45 21.6% 21.6% 
1 43 0 43 20.7% 42.3% 
2 20 1 21 10.1% 52.4% 
3 31 0 31 14.9% 67.3% 
4 14 1 15 7.2% 74.5% 
5 6 3 9 4.3% 78.8% 
6 6 0 6 2.9% 81.7% 
7 2 2 4 1.9% 83.7% 
8 7 1 8 3.8% 87.5% 
9 2 1 3 1.4% 88.9% 
10 0 2 2 1.0% 89.9% 
11 1 2 3 1.4% 91.3% 
12 0 2 2 1.0% 92.3% 
13 1 2 3 1.4% 93.8% 
15 0 4 4 1.9% 95.7% 
17 0 3 3 1.4% 97.1% 
18 0 1 1 0.5% 97.6% 
19 0 1 1 0.5% 98.1% 
20 0 1 1 0.5% 98.6% 
26 0 1 1 0.5% 99.0% 
28 0 1 1 0.5% 99.5% 
30 0 1 1 0.5% 100.0% 






Table 3-24. Sensitivity and specificity for incremental cut-off values in the self-











>= 0 100.00 0.00 15.38 
>= 1 93.75 24.43 35.10 
>= 2 93.75 48.86 55.77 
>= 3 90.63 60.23 64.90 
>= 4 90.63 77.84 79.81 
>= 5 87.50 85.80 86.06 
>= 6 78.13 89.20 87.50 
>= 7 78.13 92.61 90.38 
>= 8 71.88 93.75 90.38 
>= 9 68.75 97.73 93.27 
>= 10 65.63 98.86 93.75 
>= 11 59.38 98.86 92.79 
>= 12 53.13 99.43 92.31 
>= 13 46.88 99.43 91.35 
>= 15 40.63 100.00 90.87 
>= 17 28.13 100.00 88.94 
>= 18 18.75 100.00 87.50 
>= 19 15.63 100.00 87.02 
>= 20 12.50 100.00 86.54 
>= 26 9.38 100.00 86.06 
>= 28 6.25 100.00 85.50 
>= 30 3.13 100.00 85.10 






Figure 3-8. Receiver operating characteristic (ROC) curve for participant self-




3.5.7. Modifications for producing the final 
measure (version 3.0) 
Evidence from the acceptability, reliability and validity analyses described 
above were considered by the study team. This led to further modifications of 
the measure to produce a version ready for use in future studies (version 3.0). 
These modifications are listed in Table 3-25. In summary, modifications were: 
1) dropping one sub-item due to overlap; 2) restructuring three former sub-
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a result of the restructuring of sub-items). The final items and their response 
categories following these modifications, ready for use in future studies, are 
shown in Table 3-26. The full final version of the measure formatted as a 
questionnaire is provided in Appendix 27. 
 










1 Sub-item 4a “Did the 
skin separate?” 
Sub-item dropped Tests for construct 
validity and 
examination of raw 
data demonstrated 
substantial overlap 
with preceding item 4 
“Have the edges of any 
part of the wound 
separated/gaped open 




3a “Was it clear fluid? 
(serous exudate)” 

















High levels of missing 
data where a response 
would have been 
expected suggested 
problems with 





should have been 
completed.  
3 Item 3 “Was any part 
of the wound leaking 
fluid?” 
Item dropped Item now redundant 







Table 3-26. Items and response categories in the final version of the SSI 
measure after analysis 
 Item Response categories 
1 Was there redness spreading away from the wound? 
(erythema/cellulitis) 
Not at all / A little / 
Quite a bit / A lot 
2 Was the area around the wound warmer than the surrounding skin? Not at all / A little / 
Quite a bit / A lot 
3 Has any part of the wound leaked clear fluid? (serous exudate) Not at all / A little / 
Quite a bit / A lot 
4 Has any part of the wound leaked blood-stained fluid? 
(haemoserous exudate) 
Not at all / A little / 
Quite a bit / A lot 
5 Has any part of the wound leaked thick and yellow/green fluid 
(pus/purulent exudate) 
Not at all / A little / 
Quite a bit / A lot 
6a Have the edges of any part of the wound separated/gaped open on 
their own accord? (spontaneous dehiscence) 
Not at all / A little / 
Quite a bit / A lot 
 (Subitem 6b): Did the deeper tissue separate? Not at all / A little / 
Quite a bit / A lot 
7 Has the area around the wound become swollen? Not at all / A little / 
Quite a bit / A lot 
8 Has the wound been smelly? Not at all / A little / 
Quite a bit / A lot 
9 Has the wound been painful to touch? Not at all / A little / 
Quite a bit / A lot 
10 Have you had, or felt like you have had, a raised temperature or 
fever? (fever >38oC) 
Not at all / A little / 
Quite a bit / A lot 
11 Have you sought advice because of a problem with your wound, 
other than at a routine planned follow-up appointment? 
Yes / No 
12 Has anything been put on the skin to cover the wound? (dressing) Yes / No 
13 Have you been back into hospital for treatment with a problem with 
your wound? 
Yes / No 
14 Have you been given antibiotics for a problem with you wound? Yes / No 
15 Have the edges of your wound been deliberately separated by a 
doctor or nurse? 
Yes / No 
16 Has your wound been scraped or cut to remove any unwanted 
tissue? (debridement of wound) 
Yes / No 
17 Has your wound been drained? (drainage of pus/abscess) Yes / No 
18 Have you had an operation under general anaesthetic for treatment 
of a problem with your wound? 






Reflections on other notable observations and justification for not 
implementing them in revisions to the measure 
More than 90% of participants reported that their wound had not been smelly 
at all (item 6). Similarly, 85% of patients reported that they had not had, or felt 
like they had had, a raised temperature or fever (item 8). Item-scale 
correlations and factors loadings for these items in a single scale structure 
were moderate. The study team considered the importance of these items for 
SSI diagnosis and whether they should remain included in the measure. A 
conservative approach was taken to keep them included, to enable them to be 
examined further in future studies where these symptoms may be more 
prevalent in other patient groups and surgical specialties. 
 
Item 14 (“Has your wound been scraped or cut to remove any unwanted 
tissue?”) and item 16 (“Have you had an operation under general anaesthetic 
for treatment with a problem with your wound?”) were shown to be very rare 
interventions in this dataset, with only 1% of the study sample reporting that 
these interventions had occurred. However, due to the high clinical relevance 
of these intervention for determining whether SSI has occurred, and because 
they may be more frequent in different surgical populations, the study team 








This chapter has reported the findings from the development and validation 
of a new outcome measure for SSI. It describes the results of tests for content, 
construct and criterion validity, reliability and acceptability. First, content 
validity was addressed by i) a content analysis of the most commonly used 
tools for assessing SSI (two clinical tools and two unvalidated questionnaires 
for patients) and ii) an analysis of data from 19 interviews with patients and 
healthcare professionals. Some 19 important content domains to include in the 
new measure were identified. Next, content validity and acceptability were 
further addressed in 42 cognitive interviews to pre-test the new outcome 
measure.  
 
Pre-testing and revisions were conducted as an iterative process, producing a 
version of the new measure ready for further validation. Findings from a 
large field-testing study including data from 792 participants are reported. 
The measure was found to be acceptable to patients and demonstrated good 
response rates, with low levels of missing data. Analyses supported a single‐
scale structure to assess SSI that made clinical and practical sense. Test–retest 
reliability was high, and agreement between participants and observers was 
good. The measure demonstrated high sensitivity and specificity for SSI 
discrimination compared with a face‐to‐face reference SSI assessment using 








Established and widely used methodology was applied for the development 
and validation of the new outcome measure. An existing framework and 
recommended methods to identify develop, pre-test and field-test the 
measure were applied to address content, construct and criterion validity and 
reliability [85,89]. The study included mixed methodology to add strength to 
the development of the measure. For example, synthesising findings from 
qualitative interviews and a content analysis of existing tools to identify the 
important content domains [85]. Further methodological strengths for this 
study include the purposive sampling of participants with experience of SSI 
to ensure that the views of all key stakeholders were considered in the 
development of the measures [46]. The perspectives of patients, surgeons, GPs 
and nurses were all considered. Rigorous pre-testing, again with both patients 
and healthcare professionals, was undertaken to ensure face and content 
validity with relevance to future stakeholders. The inclusion of a wide range 
of abdominal operations provided a diverse sample, adding strength to the 
generalisability of the findings. A further methodological strength of this 
study is the approach used to analyse data. Two statistical approaches, multi-
trait scaling and factor analysis, were taken to examine construct validity and 
explore the underlying scale structure [86]. A method of independent 
validation was applied by splitting the dataset (cohort study versus pilot RCT 
data) and testing replicability of the most suitable model identified. A 
sensitivity analysis was also performed using polychoric data. The concordant 
results from these approaches strengthen the finding that the outcome 
measure appropriately measures SSI with a single scale allowing for a simple 






for developing the outcome measure was for the assessment of SSI in the 
context of an outcome in clinical trials. During the course of the PhD work, it 
has become apparent that the tool could be used for additional purposes, such 
as a screening tool to warrant a face to face assessment of the wound and the 
need for further treatment. This is discussed in more detail in the Discussion 
chapter. An alternative scale structure, for example, that separates items that 
assess ‘symptoms of infection’ and items that assess ‘management/treatment’ 
may be useful in this context and warrants further research.  
 
A total of 19 participants were interviewed to inform the content of the new 
measure. The issue of sample size in qualitative studies is a long-standing 
topic of debate, with qualitative sample sizes often criticised as being too 
small and under-representative [116]. Interviews, however, provide a rich 
data source because they allow for detailed, contextual information to be 
collected. Best practice is to interview a number of participants until data 
saturation is reached, that is, no new themes are identified from subsequent 
interviews [109]. The current study adhered to these recommendations and 
participants were interviewed until no new SSI domains were identified. To 
ensure methodological rigour of the study methods and any potential 
limitation of a relatively small qualitative sample, synthesis of data from the 
content analysis of existing SSI tools was performed. This increased the 








Identification of important domains: content analysis of existing tools for 
measuring SSI 
The Bruce et al. systematic review of existing SSI definitions and grading 
scales was conducted nearly 20 years ago [31]. Based on a scoping search 
conducted at the start of this PhD, a formal update of the full systematic 
review was not performed. This may mean that some tools exist that have not 
been identified. This, however, is unlikely. As described earlier in this 
chapter, evidence that the tools identified in the Bruce et al. review were still 
the most commonly used tools in the field is demonstrated in recent Cochrane 
reviews of studies of interventions to reduce SSI [20,117]. This is further 
supported with empirical evidence based on the practices of PHE [34], NICE 
quality standards [118] and expert knowledge from within research networks 
such as WReN and the NWCSP, as . Although the tools selected for the 
content analysis (the CDC diagnostic criteria and the ASEPSIS grading scale) 
have limitations as previously described in Chapter 1, they are supported in 
the field as the most comprehensive for diagnosing SSI. Other criteria and 
grading scales do exist, as identified in the Bruce et al. 2001 review, although 
these are not widely used and have not been validated [31]. They are 
comprised of similar but fewer SSI domains compared to the CDC criteria and 
ASEPSIS grading scale [11]. It was considered that a content analysis of these 








Identification of important domains: interviews with patients  
It is recognised that only two of the nine patient participants interviewed 
were confirmed to have had an SSI (one participant had suspected wound 
infection, two had no infection and four had missing data on wound 
infection). Collection and completeness of these data by the author of this 
thesis was not possible as it occurred during a period of maternity leave. 
However, this was not considered to be a significant limitation as data were 
synthesised with domains from existing SSI tools as well as interviews with 
healthcare professionals. 
 
Analysis of the measurement properties   
The evaluation of the measurement properties of the new outcome measure is 
limited, to date, to the current dataset and study sample. Reports of more 
major wound care interventions (such as debridement and drainage) were 
very rare and this may have had an impact, for example, on analyses of the 
scale structure. It is unknown how a dataset with higher frequencies of these 
types of wound care interventions may affect the item correlations and 
subsequently the underlying scale structure. Data from other studies and 
independent samples are needed for further validation and to see how the 
measure performs in different populations. This work has been started and 
will be described in more detail in Chapter 6 (section 6.7 ‘Future research’). 
Whilst being aware that other statistical techniques are available to shrink or 
attenuate performance statistics to compensate for same sample data 
(“shrinkage”) [112], the use of these techniques were not applied in the 
current study. Instead, there was an opportunity to split the sample to 






in half the dataset, including only participants from the cohort study (n=414 
participants). The scale structure was then applied to data from the pilot RCT 
(n=378 participants). This was considered to be a suitable independent 
validation technique for the purpose of the current study with adequate 
sample sizes for the validation of outcome measures [109].  
 
The validation study used recommended statistical methods to examine 
construct validity and the underlying scale structure of the new outcome 
measure, specifically factor analysis and multi-trait scaling [46]. These 
statistical methods are widely used in the development and validation of 
similar outcome measures such as quality of life questionnaires [46,86]. The 
methods, however, were primarily developed for continuous data and have 
recognised limitations when applied to the type of data derived from 
questionnaires with categorical responses [86]. To address these limitations, 
the current study chose to apply both factor analysis and multi-trait scaling 
and to compare the findings. The scale structure was supported by both 
statistical approaches. In addition, a sensitivity analysis using polychoric data 
was conducted. Again, findings supported a single scale.  
 
Some discrepancy was observed between participant and healthcare 
professional reports of the more ‘major’ wound care interventions. For 
example, 16/445 (3.6%) participants self-reported that their wound had been 
drained. Of these, only 5/16 (31.3%) healthcare professional reports (observer 
assessments) agreed that this intervention had occurred. Although very few 
examples of this were apparent in the current data, this may be important for 






fidelity of participant responses to these items. This discrepancy may be 
important to consider and warrants further investigation in other datasets. It 
may, for example, have implications for studies relying solely on patient self-
assessment for collecting outcome data.  A limitation of the current study is 
that these wound care interventions were very rare in the dataset, making it 
difficult to know the scale of this discrepancy in participant and observer 
reports in a sample where these interventions were more frequent. 
 
A further limitation to the analysis of the measurement properties is in 
relation to criterion validity. The selected reference standard for SSI was a 
face-to-face assessment of the wound using the CDC criteria. This was chosen 
as the best available reference standard for comparing scores on the outcome 
measure as it is the most commonly used and widely regarded method for 
diagnosing SSI [20,31]. Despite this, the CDC criteria still require a degree of 
subjective judgement from the person making the assessment. A gold 
standard diagnosis of SSI, without subjective bias, is lacking, meaning tests of 
criterion are limited [113]. The use of the CDC as the reference assessment in 
this study also introduces an element of circularity to the data analysis. The 
content of the new outcome measure was largely derived from the CDC 
criteria used to define SSI. It could be argued, therefore, that a good ROC 
curve result (that is, the ability of the new measure to discriminate between 
SSI and no SSI) using a CDC diagnosis as the reference standard is not 
surprising. Without a ‘better’ or true standard as alternative comparator, tests 








Mode of administration  
Current validation of the new outcome measure is limited to its use as a 
postal questionnaire. It is unknown whether an alternative method of 
administration, such as an electronic version of the measure, may have an 
impact on the findings. For example, higher or lower response rates may have 
been achieved. The mode of administration (that is, postal or electronic) may 
introduce bias into the study population by inadvertently selectively 
sampling participants from a specific demographic, for example, older or 
younger ages. This could have implications for the analysis if there is an 
association between the participant characteristics and the study outcome of 
fewer or more wound problems. The new outcome measure is suitable for 
conversion to electronic data collection. An electronic version allows forced 
item completion and has benefits to data collection by improving convenience 
and reducing missing responses to individual items [119]. Items from the new 
outcome measure were included in the online survey in the evaluation phase 
of the method for obtaining digital images from patients (Study 2). This was 
for exploratory purposes only and formal validation of the outcome measure 
in an electronic format was not an intended aim of the study. Further work to 
examine this is warranted. 
 
The next chapters in this thesis now turn to the second study in this PhD 
research. This is the development and evaluation of a method intended to be 
complementary to the new outcome measure, for improving the assessment 
of SSI after patients leave hospital. The method focuses on the use of digital 
images, taken and transmitted by patients themselves, for remote wound 






CHAPTER 4.  METHODS: 
STUDY 2  
D E V E L O P M EN T  AN D  E VAL U A T I ON  OF  A  
M E T H OD  F OR  R E M OT E  W OU N D  AS S E S S M E N T  
U S I N G  P AT I EN T - G E N ER AT E D  D I GI T A L  
I M A G E S   
 
4.1. Introduction  
The introductory chapter of this thesis (Chapter 1) described the purpose and 
value of digital images for assessing wounds. Whilst it is recognised that 
images are not sufficient on their own for SSI assessment because 
unobservable symptoms (for example, pain and heat) are important criteria, 
images can be used to enhance other data to improve diagnostic accuracy 
[70,120]. The use of patient-generated images for remote assessment of SSI has 
many potential benefits and is a growing area of interest in research and 
clinical practice [62,73,78].  
 
Obtaining images from patients remotely comprises two steps. First, it 
requires patients to take a standardised image of their wound. Next it 
requires patients to transmit the image. Work to explore whether it is possible 






usable using their own mobile devices has not, however, been widely 
investigated. There is a need to explore whether a method for patients to take 
and transmit digital images of their wounds after leaving hospital using their 
own mobile device is feasible, acceptable and can provide images of sufficient 
quality for identifying SSI remotely.  
 
This chapter describes the methods undertaken to develop and evaluate a 
method for obtaining patient-generated digital images after hospital 
discharge. The chapter begins by describing the rationale for the 
methodological approach taken, before stating the study aims and objectives. 
Next, it describes the development and pre-testing of the two necessary 
components to the method: 1) instructions for patients to take a standardised 
image of their wound using their own mobile device and 2) a process for 
patients to transmit the image to the study team. Finally, the chapter describes 
the methods used to evaluate the photography instructions and transmission 
process for potential use in a research or clinical context; testing to see 
whether they are feasible, usable, acceptable and ultimately able to provide an 
image that is suitable for SSI assessment after hospital discharge. 
 
4.2. Aims and objectives of the current study  
The aim of the current study was to develop and conduct an evaluation of a 
method for patient to take and transmit a standardised image of their wound 
for remote SSI assessment. The intention for the images was that they could 






wound care interventions indicative of SSI, such as that collected by the SSI 
measure developed and validated as part of this PhD work (Chapters 2 and 
3). Combined use of such data could optimise remote wound assessment for 
detecting and diagnosing SSI [70]. The use of patients’ own mobile devices to 
take and transmit the images without the need to develop an app or new 
electronic platform was key to this study as discussed in Chapter 1, to 
minimise costs and resource use to maximise the potential widespread use of 
the method in the future. 
 
Specific objectives of the study, as outlined in Chapter 1, were: 
1) to develop a method for patients to take and transmit wound images:  
i) develop photography instructions for patients to take a 
standardised image of their wound after leaving hospital;  
ii) adapt existing IT software for patients to transmit wound 
images to a research/healthcare team using their own mobile 
device; 
2) to pre-test and refine the method for taking and transmitting images 
with patients; 
3) to examine the feasibility, usability and acceptability of the method 
taking and transmitting images with a large sample of patients after 
having surgery, including an examination of image quality.  
 
It was recognised at the outset that fulfilment of the study objectives would 
enable the initial evaluation the method to be achieved. An evaluation of 






method in a research or clinical setting was possible. Further testing of the 
method, to establish its feasibility and usability when an actual assessment of 
the wound for SSI is required (for example, for outcome assessment in a 




4.3. Methodological framework for 
developing and evaluating a method for 
obtaining patient-generated images 
 
4.3.1. Patients as photographers: smartphones and 
technologies 
The increasing ownership of, or access to, personal mobile devices such as 
smartphones and tablet computers provides an opportunity to advance the 
field of wound assessment after the patient had left hospital, as described in 
Chapter 1. Firstly, the high proportion of these devices with built-in cameras 
provides an opportunity for patients to take digital images of their wounds. 
Secondly, the facility of these devices to access the internet provides an 
opportunity for digital transmission of the images to healthcare providers or 
researchers after leaving hospital. Guidelines and standard operating 






example, for medical illustration departments in hospital trusts [77,121]. 
These have, however, primarily been developed for use by trained 
professionals (e.g. medical illustrators) using high-quality digital cameras in a 
clinical setting, such as a hospital wards or theatres. Guidelines that are 
suitable to instruct patients to take images of their wound using their own 
mobile device after leaving hospital are lacking.  
 
There are multiple ways for patients to transmit images from mobile devices 
to healthcare teams or researchers, for example, via the internet to secure 
websites or servers [73]. As described in Chapter 1, mobile phone applications 
(apps) that allow patients to take and transmit digital images have been 
developed in the US and Europe specifically for remote monitoring of 
wounds for SSI surveillance [83]. Also described in Chapter 1, however, the 
development of such an app for obtaining images comes with a burden of cost 
and resource use implications. Other platforms besides apps, however, exist 
that allow the collection of data from patients at minimal cost to healthcare 
providers or researchers making them pragmatic for use in research and 
routine practice. Existing IT software systems, such as electronic databases 
with survey facilities, for example, are available and are frequently used in 
both research and clinical practice settings. Many have been designed to be 
easily accessible from a mobile device with internet access, providing the 
functionality to make them suitable for remote data collection after the patient 
has left hospital. There are some that provide a facility for uploading images, 
making them particularly suitable for the potential collection of wound 
images. An evaluation of the feasibility, usability and acceptability of such a 






undertaken to ensure it is suitable for the remote collection of wound images 
after the patient has left hospital. 
 
4.3.2. Rationale for methodological approach used 
Two methodological approaches were utilised in the current study. Firstly, 
the approach drew on some of the principles for PROM development and 
validation (described in detail in the context of developing the new outcome 
measure in Chapter 2). This approach was chosen for several reasons. There 
was a need, for example, to address content validity of the photography 
instructions to ensure they included the necessary content for patients to take 
a standardised wound image. There was also a need to ensure that the 
instructions were comprehensible and acceptable to patients. These parallels 
with PROM development and validation, and the key properties being 
addressed, will be described in detail below. Secondly, the approach drew on 
some of the principles for developing and evaluating electronic systems for 
collecting data from patients. This approach was considered relevant due to 
the requirement for patients to use digital devices and technology to take and 
transmit wound images. Specifically, an evaluation of human-system 
interaction (usability) was undertaken. Evaluations of human-system 
interaction and tests of usability are an emerging methodological approach in 
the field of healthcare where established scientific methods for evaluating 
electronic data collection systems are lacking. Details of this methodological 
approach and the key properties being addressed will also be described 







The use of the two methodological approaches in the current study had 
additional advantages for this PhD work. Firstly, it allowed for application 
and extension of the author’s existing experience and knowledge of PROM 
development and validation to a novel context. Secondly, it provided an 
opportunity for developing knowledge and skills in the advancing field of 
digital health and an insight into suitable methods for their evaluation, such 
as tests of usability. 
 
4.4. Study design and application of 
methodology 
As described above, obtaining patient-generated images for remote wound 
assessment comprises two steps (Figure 4-1). First it requires patients to take 
and image of their wound, and secondly, it requires to transmit the image. 
Development of a method for obtaining images needs, therefore, two 
components to reflect these steps. These components were: 1) instructions for 
patients to take a wound photograph using their own mobile devices and 2) a 






Figure 4-1. Overview of the method for obtaining patient-generated digital 
images for remote wound assessment  
 
The methods used in the current study were selected with consideration to 
the two methodological approaches, where relevant and available. Firstly, 
methods were selected to address content validity of the photography 
instructions for patients, to ensure they had the relevant content for patients 
to take a standardised image of the wound and that they were 
comprehensible and easy to follow [69]. Next, methods were selected to 
address feasibility; that is, to examine whether taking and transmitting 
wound images was practical and possible for patients to be able to do it 
[75,113]. Methods were applied to examine whether taking and transmitting 
images was effective and efficient; so that images can be obtained without 
problems and in a timely way without too much burden or need for extra 
resources [114]. Methods were also applied to address acceptability; that is, to 
Patient’s home 
Step 1: 
Patient follows wound 
photography instructions 
to generate a 
standardised image  
Step 2: 
Patient transmits image 











examine the appropriateness of the photography instructions and process for 
transmitting images so that patients were willing to do it [75]. Finally, 
methods were applied to assess the quality of the images received from 
patients, to examine whether they were suitable for potential SSI assessment 
remotely. Without rigorous methodology to ensure these key principles were 
met, future use of the method to obtain patient-generated wound images may 
be futile. 
Phases of the study 
Figure 4-2 shows how the study was broadly designed to be conducted in two 
consecutive phases to reflect the development and evaluation of the method 
for patient to take and transmit images of their wound. Figure 4-2 also details 
how the key principles of approaches to developing PROMs and evaluating 
human-system interactions were addressed in each phase. 
Phase 1: Development and pre-testing  
In Phase 1, the two components of the method for obtaining patient-generated 
images were developed and pre-tested. Specifically, Phase 1 involved:  
i) an analysis of existing literature to identify important features for 
producing standardised wound images to inform photography 
instructions for patients, 
ii) adaptation of an existing IT software system for patients to transmit 
images, 
iii) one-to-one cognitive interviews with observation to pre-test and 
iteratively refine the photography instructions and process to 






Phase 2: Evaluation  
In Phase 2, the separate components of the method developed and pre-tested 
in Phase 1 were combined and evaluated together. The feasibility, usability 
and acceptability of the complete method, and the quality of the wound 
images obtained, were examined. This included: 
i) Remote (that is, at home; unsupervised) use of the method by a large 
sample of participants discharged home following surgery; 
ii) Follow-up telephone calls with a sub-sample of patient participants; 
iii) Reviewing the obtained images to assess their quality for SSI 
assessment. 
  









Figure 4-2. Development, pre-testing and evaluation of the method for 
obtaining patient-generated wound images: study phases, methods applied 
and key properties addressed 
   
(iii) One-to-one 
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(ii) Adaptation of 
existing IT software for 
transmitting images 
(i) Remote use of the method by a 
large sample of patients after 
leaving hospital  
(ii) Follow-up telephone calls with 
sub-sample of participants 
(iii) Assessment of the quality of the 
images for suitability for assessing 
the wound for SSI  
Pre-testing 
and refining 

















4.5. Patient and Public Involvement (PPI)  
Patients and members of the public were consulted for advice to help design 
the study. The purpose of patient and public involvement (PPI) was to ensure 
that the research had relevance to patients and that the study would be as 
effective as possible, with the proposed methods and written information 
appropriate and acceptable to potential participants [122]. Before commencing 
the study, PPI work was conducted i) with a PPI group from an existing 
surgical feasibility study (the Bluebelle study [1]); and ii) on hospital wards 
talking to patients who had recently undergone surgery.  
PPI members were consulted about the:  
i) concept of the study and the aims and objectives 
ii) content of the study participant information leaflet (PIL) 
iii) preferred acronym for the study name from a list of options, for 
optimising recruitment and participation. 
Views of the public were further sought as part of a public engagement event 
held at the Colston Hall in Bristol in May 2018. A small grant and 
opportunity to have a display stand at the Research without Borders festival 
was awarded to the author of this thesis following an application to be part of 
the event. The event was held prior to the start of recruitment to the study. 
Discussions with people during their visits to the stand provided an 
opportunity to present the study design and plans to members of the general 
public and to seek their views on the concept of the study, the feasibility and 
acceptability of taking and transmitting images of wounds after leaving 
hospital. This provided an opportunity to incorporate any suggestions before 






4.6. Phase 1 – Development and pre-testing 
4.6.1. Objectives for Phase 1 
The objectives for this phase of the study were: 
• to develop a method for patients to take and transmit wound images:  
i) develop photography instructions for patients to take a 
standardised image of their wound after leaving hospital;  
ii) adapt existing IT software for patients to transmit wound 
images to a research/healthcare team using their own mobile 
device; 
• to pre-test and refine the method for taking and transmitting images 
with patients. 
 
4.6.2. Assessing content validity 
Component 1: photography instructions for patients 
An informal scoping search conducted in an electronic database of published 
medical literature (PubMed) and the internet by the author of this thesis 
identified no existing guidelines for developing instructions for patients to 
take wound images. In the absence of specific relevant guidelines for 
developing instructions for patients, the relevance of established methods for 
developing PROMs was considered. Methods for PROM development were 






take a standardised wound photograph was deemed to involve several key 
principles likened to aspects of developing a new PROM. 
 
Parallels with the principles of PROM development  
Similar to a PROM, it was considered important that the photography 
instructions for patients included relevant content to ensure a suitable, 
standardised wound photograph was taken. The content of the instructions, 
therefore, needed to be informed by appropriate sources and they needed to 
be pre-tested to ensure they were acceptable, comprehensible and easy to 
follow. These principles are akin to the measurement property of content 
validity in PROM development [46]. Reflecting on these parallels with PROM 
development, it was chosen to adopt a similar methodological approach for 
the development of the photography instructions. The approach drew, 
therefore, on the first three phases of PROM development as described in the 
methods for Study 1 (Chapter 2). First, the important features for 
photographing a wound needed to be identified, much like the identification 
of important content domains for a new PROM [46,45]. This is required so 
that the image is standardised and of suitable quality for clinical use to assess 
the wound for SSI. Second, the identified features would need to be 
operationalised and drafted into instructions for patients to take an image 
using their own mobile devices, much like the operationalised of the 
important content domains into items in PROM development [85]. Finally, the 
instructions would require pre-testing with a sample of the target users and 








i) Content analysis of existing literature 
To address content validity of the photography instructions for patients, a 
content analysis of existing literature on how to take a wound photograph 
was performed. This was to ensure the important key features for taking a 
standardised image of a wound were identified, for consideration to include 
in the instructions for patients.  
 
Sampling and identification of source documents 
Sampling of existing literature on how to take standardised images of wounds 
for clinical purposes was undertaken, informed by a scoping search of 
published literature and expert knowledge within the study team and 
discussion with colleagues within the Wounds Research Network (WReN; 
within which the author of this thesis was involved, described in more detail 
later in this thesis; Chapter 6) and the Bristol Medical School. Of particular 
relevance, published guidance for professional medical illustrators taking 
images for clinical use in hospital settings was known to be available [77]. 
Studies of wound care interventions that used images for outcome 
assessment, and had wound photography protocols written for study 
personnel, were identified through discussion with colleagues. Further 
relevant documents describing wound photography were identified through 
a scoping search the of literature on the use of digital images in wound care, 
conducted by the author of this thesis. Due to the identification of source 
documents through these sampling methods, a systematic literature search for 
publications describing how to take standardised wound images was not 
considered necessary. This was because it was considered that the key 






included in sufficient detail in this identified sample of documents, in 
particular in the guidance for professional medical illustrators.  
 
Obtaining source documents 
Electronic versions of source documents were downloaded from relevant 
websites, where freely available. Further source documents, such as 
unpublished wound photography protocols for study personnel were 
obtained by request from the relevant study teams. 
 
Data extraction 
Source documents were scrutinised and any detail on how to prepare for, or 
take, a standardised wound image was extracted as verbatim text. Data 
extraction was broad to include any relevant information, with the intention 
to be as inclusive as possible so that subsequent analysis and identification of 
key features for taking standardised images was driven by the data, with no 
pre-determined framework influenced by the author of this thesis [91]. This 
approach ensured that all potentially relevant information on how to take a 
wound photograph could be considered for inclusion in the instructions for 
patients. Data were transcribed verbatim into a Microsoft Excel spreadsheet. 
Data extraction was performed by the author of this thesis. 
 
Data analysis 
Inductive, open coding of data was conducted, drawing on the approach for 






organised into categories or groups based on the aspect of photography that 
they related to, for example, lighting or framing of the image. Categories were 
modified and adapted as more data was extracted in an iterative, inductive 
manner [91]. Categorisation of the data was reviewed and discussed with the 
study team to maximise robustness of the research and minimise subjectivity 
of the author when analysing data. 
 
ii) Drafting the photography instructions  
After grouping data into categories of the key features for taking a clear and 
standardised wound image, categories were examined for their relevance for 
including in photography instructions for patients. For the purpose of the 
study, it was necessary that the key features for photographing wounds were 
relevant to taking images after hospital discharge and using a camera on a 
mobile device. Relevant features were then formulated (operationalised) into 
an item (that is, an instruction) for a preliminary version of photography 
instructions for patients [46]. General information relevant to the instructions 
for patients was also drafted, explaining, for example, the overall objective of 
taking the wound image, the device that could be used, and that help from 
others to take the image was permitted, with the intention of providing as 
much information thought to be required to follow the instructions 
effectively. Drawing from the principles of PROM development, all 
instructions were written in plain language without technical terminology, 







Expert members of the study team were consulted to help draft the 
preliminary version of the photography instructions. This was to confirm that 
they met clinical and practical requirements for photographing wounds. 
Experts included two consultant surgeons (J.R, J.M.B) and a medical 
photographer (A.S.). Comments and suggestions were iteratively 
incorporated to revise the earlier versions of the instructions before they were 
pre-tested with study participants (described in more detail later in this 
chapter; section 4.6.3). 
 
Component 2: process for transmitting images 
The second key component of the method for obtaining patient-generated 
wound images remotely was for patients to be able to digitally transmit the 
images that had been taken. The second objective of the study was, therefore, 
to adapt existing IT software with the appropriate facility to enable patients to 
transmit wound images to a healthcare team or research group. The use of 
existing software without the need to develop an app or new electronic 
platform was important in this study, to minimise complexity, costs and 
resource use and maximise the potential use of the method in future research 
and clinical settings.  
 
An important feature of the IT software for patients to transmit images was 
considered to be its suitability and compatibility for use with a mobile device. 
This is because it was intended that participants would use their smartphones 
or tablet computer to take the image of their wound, where possible. 






images, ii) a suitable interface to use with a mobile device and iii) safe and 
secure transmission of data.  
 
Suitable software for collecting electronic data from study participants known 
to the author of this thesis was utilised for this study. Developed specifically 
for research studies, REDCap (Research Electronic Data Capture) software is a 
secure web application for building and managing online surveys [123]. The 
software has the facility to collect most types of data, including digital images. 
REDCap software is well established and tested. As of March 2020, it has been 
used in nearly 4000 institutions in 136 countries, 857,000 projects and by over 
1.2 million users [124]. REDCap was therefore chosen as the software to use in 
the current study because it addressed all the requirements for patients to 
upload and transmit images remotely for the current study, including an 
interface that is suitable for use with a mobile device (Box 9).  
 
Box 9. Functionality of REDCap software relevant to the requirements for 
obtaining images from patients remotely 
i) secure data transfer, addressing privacy and patient safety concerns 
ii) easy to use and manage data 
iii) low cost for implementation and supported by the University of Bristol 
iv) easy to access from anywhere with a secure web connection 
v) customisable survey / data collection forms including the facility to 
collect images 
vi) advanced features including automated reminders 







Designing the process for transmitting images: an online 
survey for participants  
The process for participants to transmit images of their wounds was designed 
as an online survey that included the facility to upload images. The survey 
was designed using the survey developer built into the REDCap software, in 
conjunction with an expert REDCap administrator employed by the 
University of Bristol (A.H.).  
The online survey and steps for uploading the images were tested by the 
author of this thesis and other members of the study team during the survey 
development. This was to ensure that the steps to upload images worked as 
intended and was appropriate for different devices before the next phase of 






4.6.3. Assessing acceptability: pre-testing the 
photography instructions and process for 
transmitting images 
After the two components of the method to obtain images from patients – that 
is, the preliminary version of the photography instructions and the process for 
transmitting images - were developed, they were pre-tested with a sample of 
potential users. Drawing from the principles for PROM development, the aim 
of pre-testing the photography instructions was to ensure that they were 
acceptable, comprehensible and comprehensive to effectively take an image of 
the wound [46]. Further aims were to explore the acceptability of the 
language, format and length of the photography instructions, and obtain 
general feedback and suggestions so that necessary revisions could be made 
for their improvement. Similarly, the aim for pre-testing the process for 
transmitting images was to ensure that it was acceptable to patients and 
functioned as intended [125,126]. 
 
Drawing further parallels with the methods used for PROM development, 
pre-testing was undertaken through one-to-one cognitive interviews with 
participants [46]. Interviews also included observation of participant whilst 
following the instructions to take wound images and whilst completing the 
process to transmit the images. Observation-based methods are 
recommended for pre-testing respondent’s responses to completing data 
collection instruments to identify where a problem may occur in carrying out 
any steps [127]. They were, therefore, considered appropriate for being able to 






photography instructions . The methods were also appropriate for the 
human-system interaction aspect of the procedure and the requirement for 
patients to use a digital device to take and transmit the images. The 
observation allowed for the author of this thesis to see how participants 
carried out the task of taking an image of their wound using their own mobile 
devices and any problems that were encountered, serving as a further test of 
acceptability. Potential barriers to taking and transmitting images could also 
be effectively explored and addressed, where possible, to ensure they could 
be addressed before further testing of the method with a larger sample of 
participants. 
 
a) Participants and recruitment 
The study to pre-test the method was named “The Selfi wound study: self-
taken images of surgical wounds (Phase A)”. Ethics approval was granted by 
the UK Health Departments Research Ethics Service NHS REC West 




Potential participants to pre-test the method for taking and transmitting 
wound images were sampled to be representative of the target population 
intended for SSI assessment after leaving hospital. These were patients who 
had recently undergone general abdominal surgery or vascular surgery. 
These specialties were selected because they have a relatively high rate of 






use of this method for remote SSI assessment in these patient groups. 
Participants were purposively sampled to ensure diversity across a range of 
demographic and surgical characteristics including age, site of surgical 
wound, size of surgical wound and characteristics of wound healing 
problems. This sampling technique was selected to address 
representativeness of the sample as much as possible. 
 
Inclusion criteria were: 
1. Patients with a closed primary surgical wound 
2. Aged 18 or over 
3. Ownership or access to a smartphone or digital camera 
4. Ability to receive and access emails in their home setting 
5. Willingness to remove wound dressing if appropriate and/or see their 
own wound 
6. Willingness to undergo a face-to-face cognitive interview  
 
Exclusion criteria were: 
1. Prisoners  
2. Adults lacking capacity to consent  
3. Lack of ability to read/understand English that would preclude 
successful following of the photography instructions or process to 






4. Patients with a complex open wound or a wound healing by secondary 
intention 
5. Patients with a wound on part of their body that would make them 
identifiable from a photograph. 
 
No pre-determined sample size was defined based on recommendations that 
saturation of data (that is, when all data are grouped into categories and no 
new categories are identified) in cognitive interviewing is considered to be 
more important than the number of patients interviewed, drawing from the 
approach for pre-testing PROMs [129].  
 
Identification of potential participants 
Potential participants were identified from pre- and post-surgical clinics and 
wards within two NHS hospital trusts (University Hospitals Bristol NHS 
Foundation Trust and North Bristol Hospital NHS Trust). Identification of 
potential patient participants was performed by research nurses within these 
hospitals, identified from clinic and ward lists and staff’s knowledge of 
patients on the ward. 
 
Recruitment and consent 
Potential participants were approached in person by research nurses at the 
participating hospital trusts. A verbal explanation of the study and a paper-
copy information leaflet were provided (Appendix 28). This leaflet included 
detailed information about the study to ensure the potential participant had 






and how their data would be used. Those who expressed an interest in taking 
part were asked to provide their contact details. These were documented by 
the research nurse on a study-specific data collection form. Contact details 
were passed on to the author of this thesis at the University of Bristol, 
including expected or actual date of discharge from hospital and the patient’s 
preference on when was best to contact them (day/time). Demographic and 
clinical data (including age, sex, date of surgery, type of surgery and location 
of wounds) was also included to inform the purposive sampling strategy 
(described above).  
 
After discharge from hospital, potential participants were contacted by the 
author of this thesis by telephone or email. A further opportunity to ask 
questions about the study was provided. A visit to conduct a cognitive 
interview with observation was arranged for those continuing to be interested 
in taking part in the study. Visits were scheduled to occur within 
approximately 30 days (the recognised timeframe within which an SSI 
typically occurs [32] and, therefore, appropriate for when the method would 
be intended to be used in practice) after having surgery at a convenient day 
and time to the participant. Written informed consent was taken at the time of 







b) Procedure for participants: cognitive interview with 
observation 
Cognitive interviews with observations were conducted face-to-face by the 
author of this thesis who is trained in qualitative research methods. These 
were single (one-off) interviews with observations, conducted with each 
participant in their preferred setting (home or other suggested location).  
 
Taking the wound images 
Participants were provided with a paper-copy of the photography 
instructions for taking a standardised image of their wound using their own 
smartphone or mobile device. Participants were asked to read through and 
follow the instructions to take the photograph as independently as possible. 
The use of a prop (e.g. a selfie-stick or mirror), if helpful, was available at the 
choice of the participant. To protect the participant’s privacy and dignity, the 
author of this thesis offered to step out of the room or told the participant that 
they were free to go into another room to take the wound photograph, as 
preferred. Whilst reading the photography instructions and taking wound 
images, participants were asked to ‘think aloud’ [101,127]. This involved 
verbalisation and articulation of thoughts as participants read and carry out 
the instructions. This served as a test of comprehensibility, to examine how 
the instructions were being interpreted and check they were being 







Transmitting the wound images 
During the visit, the author of this thesis used a laptop to access the study 
database (designed with REDCap software) and added the participant as a 
new participant on the database, along with their email address. This 
triggered an invitation email to be sent immediately to the participant 
including a hyperlink to access the online survey to enable them to transmit 
their wound images. Participants were then asked by the author to access 
their emails and click on the hyperlink to log in to the survey. The survey 
included a step-by-step process with written instructions on how to upload 
and transmit their wound image(s). The participant performed this task in the 
presence of the author, so that an observation of the process could be carried 
out and any problems identified. 
 
The author of this thesis took a non-participatory role and intervened as little 
as possible during the process of taking and submitting the wound images, 
unless the participant requested help or was visibly having problems with 
completing any of the steps. 
 
c) Data collection  
Basic demographic and clinical information were collected during the visit, to 
allow for a descriptive analysis of the study sample. Level of familiarity and 
experience with using mobile devices with digital camera facilities was also 
collected using a researcher-completed study-specific data collection form. 
Items were based on examples from a similar study in this field [81]. These 






ensure the sample was as broad as possible to be representative of the target 
population expected to undergo remote wound assessment. 
 
Cognitive interviews were audio-recorded with participants’ permission, 
using a hand-held audio-digital recorder to record verbal data for the author 
to refer to during subsequent analysis. To collect non-verbal data during 
observations, the author took written field notes [127], including 
documentation of any requirements for help from a third party (e.g. family 
member or author of this thesis) or the use of any props and whether any 
issues, problems or confusion were encountered when taking and 
transmitting images [101].  
 
After taking and transmitting the images, the author of this thesis discussed 
the process with the participant and followed-up on any observations or 
issues encountered, using probing questions aimed to explore problems or 
confusion further [101]. A pre-written prompt sheet was used to guide this 
process (Appendix 30). The prompt sheet was adapted throughout the course 
of the pre-testing phase of the study based on emerging findings, including 
new areas of focus derived from earlier interviews/observations. A set of pre-
defined, targeted ‘debriefing’ questions aimed to elicit further experiences 
and opinions on any aspects of the photography instructions or performing 








Audio-recordings of cognitive interviews were replayed and summarised in 
written memoranda (memos). This included bullet points of observations and 
any issues directly relevant to taking the photograph or transmitting the 
images. Key points and any other relevant feedback for improving the 
photography instructions or the process for transmitting images were 
summarised at the end of the memo. Field notes were incorporated into 
memos to add further details where relevant [101]. 
The photography instructions, written text within the online survey and the 
steps to transmit the images were revised as findings from the interviews 
emerged and analyses progressed. Urgent changes (e.g. changes that were 
crucial to be able to perform the tasks appropriately, such as necessary 
technical edits to the online survey) were made immediately before the 
following interview/observation with the next participant. Non-urgent 
changes (for example, suggested alternative wording) were made after a block 
of several interviews/observations to enable further exploration and 
understanding of the potential problem. Changes and revised versions of the 
photography instructions and system were tested with subsequent 
participants as an iterative process throughout the pre-testing phase [101].  
All changes were documented in an Excel file as an audit trail, with detail of 
the reason for the changes and participant interviews providing supporting 
evidence for the reason for the change. Interviews/observations and analyses 
continued until saturation, that is, until there was no further substantial 
evidence from interviews/observations that further changes were required to 







4.7. Phase 2 – Evaluation  
4.7.1. Objectives for Phase 2 
The objectives for this phase of the study were: 
• to examine the feasibility, usability and acceptability of the method 
taking and transmitting images with a large sample of patients after 
having surgery, including an examination of image quality.  
 
Phase 2 of the study focused on evaluating the method for obtaining patient-
generated wound images. This phase of the study was conducted to assess the 
potential use of the method for future widespread use in research or routine 
clinical practice. The evaluation phase involved testing of the method 
remotely with a large sample of patients who had recently undergone 
surgery. A new and larger sample of participants to those that were involved 
in the development phase were required, to collect data to test the method on 
a wider scale [46]. The methodological approach for evaluation of the method 
drew on the principles for field-testing a new PROM, including a need to test 
feasibility and acceptability of the method on a wider scale. The 
methodological approach also drew on principles relevant to the evaluation of 
electronic data collection systems and human-system interaction with digital 
technology, that is, a need to test usability. For the purpose of this study, 
usability was considered at a generic level, that is, the broad usability of the 
method for patients to take and transmit images using their own digital 
devices (rather than the specific usability, for example, of a particular make or 






the overall method, with a pragmatic view that future use of the method in 
practice, patients would have access to a wide variety of types of devices to 
take and transmit images. 
 
4.7.2. Principles for evaluating human-system 
interaction 
The method to obtain patient-generated images required patients to first take 
a digital image of their wound and then transmit the image electronically. 
Both these tasks required the use of digital devices and technology. The 
evaluation of a process that involves an interaction between humans and 
digital technology and/or electronic systems lends itself to a contemporary 
methodological approach; one that focuses on evaluating ‘usability’ of that 
technology/system. This approach draws on the principles specified by the 
International Organization for Standardization (ISO), an international 
standard for evaluating “human-system” interaction and the usability of 
digital systems [130,131]. The ISO approach is recognised as an emerging 
approach in the field of healthcare where there is a lack of scientific methods 
for evaluating electronic systems and mobile healthcare (mHealth). The ISO 
approach been adopted as an established method for evaluating electronic 
devices or systems intended for patient use. For example, NHS Digital, the 
national information and technology partner to the health and social care 
system, endorses the ISO requirements and recommendations for evaluating 
new digital tools [132]. The ISO approach and similar tests of usability have 
also been adopted in research studies worldwide to evaluate electronic 






have included images [83,126,133-136]. A study by Gunter et al. in the US, for 
example, used the ISO standard to guide the usability testing of a new 
smartphone app for surgical wound monitoring after hospital discharge [83].  
 
The ISO definition of usability is “the extent to which a system, product or service 
can be used by specified users to achieve specified goals with effectiveness, efficiency 
and satisfaction in a specified context of use”[131]. The ISO approach allows for 
an evaluation of how well a patient can perform the task of taking and 
transmitting digital images of their wounds, and whether the images are 
sufficient quality for remote SSI assessment. The ISO usability-testing 
approach was, therefore, chosen as a suitable methodological approach to 
include in the evaluation phase of the current study. More detail on the ISO 
definition of usability, specifically the components of effectiveness and 
efficiency, and how they measured in the current study are described later in 
this chapter (Section 4.7.7). Whilst it is recognised that satisfaction is also 
included as a component of the ISO definition of usability, satisfaction is 
further defined by ISO as the “extent to which the user experience that results from 
actual use meets the users’ needs and expectations”[130]. Assessment of 
satisfaction was considered to apply to a later, full stage of evaluation beyond 
the scope of this PhD research, when the method would be implemented in a 
research or clinical setting and the images used to make an assessment of the 
wound for SSI in practice. The current study focused on an initial evaluation 
of the method, with respect to its intended use to assess wounds for SSI in 
future applications of the method. An assessment of the whether the method 
met the users’ needs and expectations for SSI assessment, therefore, was not 







Specific objectives of the evaluation phase of the study and the key properties 
being addressed were: 
1. to evaluate feasibility: examine the number of participants approached 
and recruited, including reasons for declining or withdrawing from the 
study 
2. to evaluate usability:  
i) effectiveness: examine the proportion of participants successfully 
taking and transmitting wound images  
ii) efficiency: examine the time taken for participants to respond to 
the request to transmit images, and the need for any reminders. 
Examine participant’s reports of the time taken to take the wound 
photograph and whether any help was needed to take or transmit 
images.   
3. to evaluate acceptability: examine participant feedback and 
experiences to understand reasons for not taking or transmitting 
wound images, and problems that occurred or any issues encountered.  
4. to evaluate quality of the wound image(s). 
 
4.7.3. Participants and recruitment 
The evaluation of the method was the second phase of the “The Selfi wound 
study: self-taken images of surgical wounds”. Ethics approval was granted by 
the West Midlands - Coventry and Warwickshire Research Ethics Committee 
(18/WM/0096) in a single application with the development phase of the 







Similar to the pre-testing phase of the study, patients undergoing general 
abdominal or vascular surgery were sampled to test the method remotely. As 
previously described, these specialities were chosen because they have a 
relatively high rate of surgical site infection and therefore applicable for 
potential use of the method in future applications. Criteria for eligible 
participants were identical to those described for Phase 1 participants (section 
4.6.3), excluding the criterion “willingness to undergo a face-to-face cognitive 
interview”. Face-to-face interviews were not relevant to this phase of the 
study because evaluation focused on testing the method remotely. Potential 
participants were purposively sampled to be representative of a widespread 
target population potentially relevent for remote wound assessment in 
research studies or clinical practice. Diversity across a range of participant 
demographic and surgical characteristics was, therefore, required to evaluate 
the method in as broad a sample as possible. 
 
Identification of potential participants 
Research nurses and surgeons at the two recruiting hospital trusts (described 
in section 4.6.3) identified potential participants from pre- and post-surgical 
assessment clinics and ward lists. Research teams were asked to use a study-
specific screening log to record the number of patients approached for 
recruitment to assist with analysis of feasibility (described in detail below). 
Recruitment and consent 
Potential participants were approached in person by research nurses and 






the study and a participant information leaflet specific to this phase of the 
study were provided (Appendix 31). Potential participants were given as long 
as they required to consider the study before being re-approached to ask if 
they were interested in taking part. Opportunities to ask questions prior to 
making any decision on whether to participate were provided. Recruitment to 
the study was performed by the study nurses before the participant was 
discharged from hospital. Written informed consent was taken by the 
research nurse or surgeon at the time of recruitment. 
 
4.7.4. Procedure for participants: remote testing 
Approximately two to three weeks after the date of surgery (or later, if the 
participant had a prolonged stay in hospital), written study information and a 
paper copy of the photography instructions developed and pre-tested in 
Phase 1 were sent to the participant’s address via post. The two- to three-
week timeframe was chosen as it was relevant to the recognised timeframe for 
SSI assessment (up to 30 days) [32], and was, therefore, appropriate for future 
implementation of the method in research studies of routine practice. A paper 
copy of the photography instructions was provided rather than an electronic 
version based on participant preference determined in Phase 1 interviews. 
Preference to have a paper copy of the instructions that could be referred to 
whilst taking the photograph was reported. The written study information 
conveyed to the participant that they would receive an email to tell them how 
to transmit the image electronically. The email was automatically generated 
by the study REDCap database designed in Phase 1, co-ordinated by the 
author of this thesis to coincide with the participant receiving the 






email provided the participant with a hyperlink that led them directly to the 
online survey. As described in Phase 1 (section 4.6), the hyperlink was unique 
for each participant to enable any data entered by the participant to be 
securely recorded within that unique record. The survey included a step-by-
step process, developed and pre-tested in Phase 1 (section 4.6), for 
participants to upload their wound image(s) from the image library on their 
mobile device. After the step to upload the image(s), the survey included 
further items to assess participants’ familiarity and experience with 
technology, a set of ‘debriefing’ questions (Appendix 33) and the 18-item SSI 
outcome measure (described in Chapter 2 and 3). Reasons for including the 
debriefing questions and outcome measure are described in detail below. 
 
4.7.5. Data collection 
A schematic overview of the data collection for this phase of the study is 
shown in Figure 4-3. A detailed description of data collection follows in 










Figure 4-3. Data collection for evaluation of the method for obtaining patient-
generated wound images 
  
Patients undergoing abdominal / vascular surgery  
Demographic data / operation details 
Participant takes wound image(s)  
Participant completes online survey and transmits 
image(s)  
Data collected on familiarity and experience with 
devices, debriefing questions on 
taking/transmitting images 
Follow-up telephone call 
Acceptability, patient experience 
In hospital  
At home 
(2 to 3 weeks after surgery) 
Email or telephone reminder, if required 






i) Participant characteristics 
Demographics and operative data 
Participant demographic details were collected by the research nurse or 
surgeon at the time of recruitment. This included sex, age and whether they 
would be alone or with others immediately after leaving hospital following 
surgery (collected with relevance to evaluating whether help might be 
available for participants to take and transmit images, if required). Basic 
operative details were recorded including the type of surgery, urgency of 
surgery (that is, whether surgery was elective or unplanned), modality of 
surgery (for example, open or keyhole surgery) and location and number of 
wounds. Data were collected on a recruitment case report form using closed 
questions and primarily with multiple choice responses for ease of analysis. 
Collection of these data were in order to facilitate purposive sampling to 
ensure a representative sample as recruitment proceeded, and to potentially 
explore any characteristics that might explain particular problems or issues 
during analysis. Data were subsequently passed to the author of this thesis 
and entered on to the study database.  
 
Familiarity and experience with devices 
Data on familiarity and experience with devices were collected directly from 
the participant using closed questions and multiple choice as part of the 
online survey (described below). These data were collected to be able to 
describe the competency of the study participants in order to facilitate 








The online survey also included the 18-item SSI outcome measure developed 
as part of this PhD thesis (Chapters 2 and 3; Table 3-26). The purpose of 
collecting the SSI data was to explore electronic adaptation of the outcome 
measure for digital use. This was considered to be valuable to explore for 
further validation of the outcome measure as an electronic PROM following 
this PhD thesis. It was not intended to include these data in the current study 
analysis. 
 
Descriptive statistics (mean, median and inter-quartile ranges (IQR) for 
continuous data and numbers and percentages for categorical data) were used 
to summarise participants’ demographics, operative data and 
experience/familiarity with devices. Analysis were performed using STATA 
software version 14.0 [106]. 
4.7.6. Assessing feasibility: participant eligibility 
and recruitment  
An evaluation of feasibility was important to examine whether a method for 
taking and transmitting wound images was practical and possible for patients 
in the target population to be able to do it [46,125]. Feasibility was explored 
by examining the potential number of participants that might use the method 
if it were to be implemented in research or routine practice to assess wounds 
for SSI remotely. Specifically, this was examined by looking at screening and 
recruitment data and the number of participants that consented or declined to 






Screening and recruitment data  
Recruiting teams were asked to record data on patients that were approached 
to take part in the study. A study screening log was provided for centres to 
record anonymised patient details including date of birth, sex and surgical 
procedure. Any reasons for ineligibility or declining participation in the study 
were also recorded. This data was collected to assess the number of 
participants who were eligible for the study, for example, to identify the 
number of participants who owned or had access to a mobile device with a 
camera.  
Specific screening and recruitment data examined were: 
i) the number of participants eligible; 
ii) the number of participants approached and recruited; 
iii) reasons for declining the study. 
 








4.7.7. Assessing usability: effectiveness and 
efficiency 
An evaluation of usability was considered to be important for this study 
phase, to assess whether images could be obtained from patients using their 
digital devices without problems and in a timely way without too much 
burden or need for extra resources [131]. These properties are important 




The ISO definition of usability includes effectiveness, defined as “accuracy and 
completeness with which users achieve specific goals”[131]. In line with examples 
from other studies testing usability of electronic systems to collect PROM data 
and mobile phone apps, the ISO definition of effectiveness was interpreted as 
the ability of the users to complete pre-determined tasks [83,126,133]. With 
relevance to the current study, this can translate to how accurately and 
completely patients were able to take and transmit an image of their wound. 
The effectiveness of the system to collect participant-generated images was, 
therefore, evaluated by examining the number of participants who were able 
to i) successfully take an image of their wound and ii) successfully transmit 
their images. Specifically, number of online surveys that included a submitted 
image and further information collected via follow-up telephone calls with 







Descriptive statistics were used to describe the demographic and operative 
details of participants that successfully took and transmitted an image and 
those that did not complete the tasks (that is, did not complete step 1: taking 
the image or step 2: transmitting the image). Chi-squared tests for categorical 
data were used to compare demographic and operative details for these two 




The ISO definition of usability also includes efficiency, defined as “resources 
used in relation to the results achieved”, with typical resources including time, 
human effort, costs and materials [131]. In other similar studies this had been 
considered as the level of resource required to perform the task [126]. In line 
with these examples, the current study examined the efficiency of the method 
to obtain wound images from participants in four ways: 
a) the time taken to obtain images from participants;  
b) the need for reminders; 
c) time taken for participants to take the wound image; 
d) whether help from others was required for participants to take 
and/or transmit images. 
 
a) Time taken to obtain images from participants 
The time taken to obtain images from participants was calculated as the 






transmit their wound images. The REDCap software automatically recorded 
the date that the invitation email was sent to participants asking them to log 
in to the online survey and transmit their images. The date that participants 
submitted the survey data was also automatically recorded. These data were 
used to record the number of days for the participant to respond. 
 
b) The need for reminders 
The author of this thesis monitored the REDCap database regularly to 
identify new data (that is, survey responses and successfully transmitted 
wound images) that had been received from study participants. Participants 
for whom no data had been received within five days were sent a reminder. 
The reminder was either: i) a standardised email generated from the REDCap 
database, including the hyperlink to the individualised record, or; ii) a 
telephone call from the author of this thesis, depending on participant’s 
preference for the type of reminder asked at the time of recruitment, as an 
attempt to maximise responses.  
 
c) Time taken to take the wound image 
Participants reported how long it took to take the wound image(s) as part of 
the online survey. This was assessed with a single ‘debriefing’ item with a 
four-level categorical response option (“less than 5 minutes”, “5 to 10 







d) Help from others to take/transmit images 
Two debriefing questions were included in the online survey to examine 
whether help from another person was needed to take or transmit images. 
The first question asked whether the participant had taken the wound image 
themselves or if someone else had taken it for them. The second question 
asked whether help was needed to upload the image. These were closed 
questions with yes/no response options. 
 
4.7.8. Assessing acceptability: participant feedback 
and experiences  
Acceptability of the method for participants to take and transmit images was 
considered an important property to address when testing the method 
remotely. This was in order to assess its appropriateness and ensure that 
patients would be willing to use the method in future implementation of its 
use [46]. Two approaches were taken to explore acceptability of the 
photography instructions and process to transmit images, through the 
collection of feedback from participants and understanding their experiences.  
Methods included: 
a) Free text space (optional completion) as part of the online survey. The 
aim was to provide an opportunity for participants to include any 
further information or any feedback about taking or transmitting their 
images. 
b) Follow-up telephone calls to elicit participants’ views and feedback. A 






participants’ experiences (Figure 4-3). Participants were selected for a 
follow-up call if there was an indication of a problem in their response 
to the debriefing questions (for example, if participants had reported 
that help was needed), or were selected to be contacted for general 
feedback, at the choice of the author of this thesis. Follow-up calls were 
semi-structured, exploring participants’ experiences, views and 
opinions of taking and transmitting their wound images, facilitated by 
a prompt sheet (Appendix 34). The purpose of this follow-up call was 
to elicit feedback about taking and transmitting images to identify any 
critical changes that may be required to consider for future use of the 
method. 
 
The author of this thesis documented the date of telephone calls and made 
handwritten notes of key issues whilst talking to participants. Reasons 
participants gave for not taking and/or transmitting images were 
documented verbatim, if applicable. These were subsequently entered in an 
electronic spreadsheet (Excel).  
 
4.7.9. Assessing image quality  
As a final step of the evaluation of the method within the scope of this PhD, 
the quality of the images was assessed. A judgement of whether the images 
were considered to be of suitable quality to potentially assess the wound for 
SSI was sought from three independent clinical assessors. It was not the 
intention that the images were used to actually assess the wound for SSI in the 






effective in providing an image that would be fit for purpose to assess a 
wound for SSI, with respect to the intended clinical use in future applications 
of the method.  
 
Assessors were academic clinical lecturers from the Bristol Centre for Surgical 
Research, including two general surgeons (S.P. and N.B.) and one vascular 
surgeon (M.Q.). Assessors were selected because they were experienced in 
post-surgical follow-up and conducting assessments of the wound for SSI in 
clinical practice. It was considered, therefore, that these individuals would be 
appropriate for judging the suitability of the wound for remote assessment. 
Three assessors were selected to ensure methodological rigour and to allow 
for an examination of the consistency in the assessments across the different 
individuals [107]. The assessors independently (that is, individually and 
without the knowledge of the other assessors’ judgements) viewed each 
wound image on a desktop computer screen. Images could be magnified 
using the zoom function if required. The author of this thesis sat with the 
assessor as they viewed each image. The assessor was instructed by the 
author of this thesis to look at the image and judge the quality by answering 
the following question: “Is the image sufficient to appropriately assess the 
wound for surgical site infection?”. Verbal responses of ‘Yes’ or ‘No’ were 
requested and recorded by the author of this thesis. When the response was 
‘No’, further explanation of the reason was sought and documented in 
written notes. Reasons were categorised by the author of this thesis as being i) 
reasons that could be resolved with modification to the photography 
instructions and ii) reasons that could not be resolved with modification to 






between reasons that could be addressed in future revisions of the 
photography instructions, if needed, and reasons that could not be addressed 
by revisions to the method and that instead required a face-to-face assessment 
of the wound.  
 
An analysis of inter-rater agreement on judgement of the quality of the 
wound images was performed to examine consistency in the judgements 
across assessors [107]. Several statistical approaches are available to examine 
inter-rater agreement when there are three or more assessors, as in the case of 
the current study. Choice of which approach to use depends on various 
factors and assumptions. Where no missing ratings exist for any of the 
assessors and ratings are nominal (that is, categories without values such as 
‘yes’ and ‘no’), as is the case for the current data, calculating a percentage 
agreement and Krippendorff’s alpha coefficient is recommended [107]. Values 
between 0.4 and 0.75 are considered to indicate intermediate to good 
agreement (based on Fleiss’ kappa benchmark scale) [107]. A sensitivity 
analysis excluding images that were judged as insufficient for reasons that 
could not be improved with modifications to the photograph instructions. 
This was to examine whether the level of inter-rater agreement was improved 
when wounds that could not be sufficiently assessed without a face-to-face 








This chapter has described the aims, objectives, methodological approach and 
study design for the development and evaluation of a method to obtain 
patient-generated images of surgical wounds for SSI assessment after hospital 
discharge. It describes the rationale for combining two methodological 
approaches to develop and evaluate the method, drawing on principles from 
both PROM development and evaluations of human-system interaction. The 
essential properties required of the method to take and transmit images, and 
how they were addressed, are described, including content validity, 
feasibility, usability, acceptability and image quality. Patient and public 
involvement, and the importance of seeking advice and opinions to inform 
the study design and conduct are described.  
 
The chapter describes the study methods in two phases. In the first phase, the 
methods for developing photography instructions for patients to take a 
standardised image of their wound using own mobile devices are detailed. 
This includes a content analysis of existing literature on how to photograph 
wounds for use in clinical practice or research. The rationale for adapting an 
existing IT software system to develop a process for patients to transmit the 
images through an online survey is described. In the final part of the first 
study phase, methods to pre-test the photography instructions and process of 
transmitting images with patients are described. This included one-to-one 
cognitive interviews with observation of patients testing the method in the 
presence of the researcher. Next, the chapter described the methods applied 
in second phase of the study, to evaluate the method for patients to take and 






with a large sample of patients after leaving hospital following surgery. 
Methods for recruitment, data collection and analysis are described. The 







CHAPTER 5.  RESULTS: STUDY 2 
D E V E L O P M EN T  AN D  E VAL U A T I ON  OF  A  
M E T H OD  F OR  R E M OT E  W OU N D  AS S E S S M E N T  
U S I N G  P AT I EN T - G E N ER AT E D  D I GI T A L  
I M A G E S  
5.1. Introduction 
This chapter reports the findings from the development and evaluation of a 
method for patients to take and transmit images of wounds after leaving 
hospital, for potential use for remote SSI assessment. The chapter is structured 
to mirror the methods chapter and concludes with a brief discussion, 
including of the strengths and limitations of the study. 
The study was designed in two phases: 1) development and pre-testing of the 
method, and; 2) evaluation of the method. An overview of the study is 
provided as a reminder in Table 5-1, including the methods applied and the 







Table 5-1. Overview of the study phases, methods applied and number of 
participants, where applicable 
Study phase Methods applied 
Number of 
participants 
Phase 1 – 
Development 
and pre-testing  
Content analysis of existing wound photography 
literature 
n/a 
Operationalisation of key features for taking 
wound images to draft photography instructions 
for patients  
n/a 
Adaptation of existing IT software for 
transmitting images 
n/a 




Phase 2 – 
Evaluation 
Testing the method remotely with patients after 
surgery 
Follow-up telephone calls 









5.2. Patient and Public Involvement 
Advice and feedback from PPI consultations and the public engagement 
event were used to inform the study name and the PIL for optimising 
recruitment and participation. PPI contributors’ preferred study acronym was 
selected. Specific advice on content to include in the PIL included how to 
describe technical words such as ‘database’ and ‘upload’, to specify the timing 
of when participants would be expected to take a photograph, and to describe 
how the images would be used. Members of the PPI group also emphasised 
the importance of reassuring participants about the handling and storage of 
their wound images to maintain confidentiality. Further suggestions from PPI 
members on the study design were provided. Specifically, these were 
recommendations to collect data on the type of mobile device patients used to 
take images and to explore whether participants would have access to the 
right software to transmit images to allow a broader examination of feasibility 
of the method for future application of its use in the general population. A 
potential issue that some patients and/or their carers might not want to look 
at the wound was raised. This led to the inclusion of this topic in the prompt 
sheet for topic to discuss in the cognitive interview study to pre-test the 
method. In general, there was positive support for the study idea from PPI 
contributors and the members of the public that were consulted, with a view 








5.3. Phase 1 – Development and pre-testing 
Phase 1 of the study focused on developing the two components of the 
method required to obtain patient-generated images: i) photography 
instructions for patients and ii) a process for patients to transmit images.  
 
5.3.1. Assessing content validity 
Component 1: development of photography instructions for 
patients 
i) Content analysis of existing literature  
Source documents 
A total of 11 documents providing guidance on photographing surgical 
wounds for use in clinical practice or research were identified through expert-
knowledge and the scoping search. Documents included published guidelines 
for professional medical illustrators (n=1) [77] , published papers on wound 
photography or studies that evaluated wound photography (n=7) [59,121,137-
141] and unpublished photography protocols from research studies (n=3) 
[142-144].  
Identified key features for photographing wounds 
Data relevant to taking standardised images of the wound were extracted 
from the source documents and grouped into categories based on the feature 
of photography they related to. A total of 21 key features were identified from 
at least one of the source documents (Table 5-2).   




Table 5-2. Key features to consider for photographing wounds identified from existing literature 
Key feature 
Source document 
















1 Protecting dignity ✓ ✓ ✓ 
“Extraneous clothing should be removed by the 
patient (or carers) but the patients’ dignity 





✓ ✓ ✓ 
"In general, wounds and the surrounding area 
(particularly the perineum) should be cleaned 
before photography; otherwise there may be 






x ✓ ✓ 
“If the patient has a dressing in situ, 
photographing the wound should coincide with 
planned dressing changes” 
✓ 
4 
Setting: where the 
image is taken 
✓ ✓ x 
“Wherever possible, take the photo in a 
treatment room because the overhead lighting 
produces a better picture.” 
✓ 
5 
Equipment: type of 
camera 
✓ ✓ ✓ 
"Consideration must be made about whether 
photographs are taken on cameras or phones 
and whether the device used is owned by the 
clinician or the Trust" 
✓ 
6 Lighting/Flash ✓ ✓ ✓ 
“A flash is used in all settings to ensure 

























7 Background ✓ ✓ ✓ 
“Backgrounds should be plain and unobtrusive 
providing no distraction from the area of 
interest” 
✓ 
8 Position of participant ✓ ✓ ✓ 
“Comfortably positioned in the correct 
anatomical position” 
✓ 
9 Scaling tool (i.e. ruler) ✓ ✓ ✓ “A scaling tool is advised as appropriate” ✓ 
10 
How images are 
transmitted 
✓ ✓ ✓ 
“Photos should be immediately uploaded, 
deleted from the camera and/or device and 
shared drive once this is completed” 
x 
11 Storage ✓ ✓ ✓ 
“Stored securely and disposed 
of securely when no longer required” 
x 
12 Patient identifier x ✓ ✓ 
“Before photos were taken, a 15-cm ruler with 
clear millimeter divisions was placed next to the 
wound as well as a patient identification 





x ✓ ✓ 
“The photograph is framed by altering the 
distance between the lens and the wound or 
using the zoom function if present” 
✓ 
14 
Angle/plane of camera 
to wound 
✓ ✓ ✓ 


























15 Focus x ✓ ✓ “Auto focus” ✓ 
16 Reviewing the image x ✓ ✓ “Review the picture on the back of the camera” ✓ 
17 Multiple images x ✓ ✓ 
“A second photograph of all wounds is obtained 
to ensure at least 1 good-quality photograph” 
✓ 
18 Shadow x ✓ x “There should be no areas of shadow” ✓ 
19 Resolution x ✓ x 
“Good resolution (usable file size) and quality 





✓ ✓ ✓ 
“Where colour is an important factor, it is useful 
(where practicable) to include a calibrated 
colour chart and/or grey card in the frame or at 
the beginning of a series of images.” 
x 
21 Use of mirror as a prop ✓ x x 
“If a wound is located in an awkward position it 
may be helpful to use a large dental mirror” 
✓ 
*feature mentioned in at least one publication




ii) Drafting the photography instructions  
All 21 identified features from the content analysis of existing wound 
photography literature were considered for inclusion in the preliminary 
version of the photography instructions for patients. Five features were 
subsequently excluded as they were considered not relevant for inclusion in 
instructions for patients (Table 5-2). This was because they were not able to be 
controlled by the patient using their own mobile devices to take images (for 
example, resolution and colour calibration) or they related to later stages of 
the study (such as how images were transmitted and stored). Inclusion of a 
patient identifier number in the photograph was also excluded from the 
photography instructions as it was already determined for the specific study 
that images would be automatically stored within a unique participant record 
on a study database when the image was transmitted using the IT software 
(as described in the previous chapter). The remaining 16 features were 
formulated (operationalised) into items for a preliminary version of 
photography instructions for patients. One additional feature, handwashing, 
that was identified as important following review of the preliminary 
instructions by consultant surgeon was further included. Two symbols 
commonly used to illustrate the flash function and the reversed camera 
direction (“selfie mode”) were included alongside item text with the aim of 
enhancing participant understanding for those less experienced with using 







Component 2: process for transmitting images 
The online survey 
The process for participants to transmit images of their wounds was designed 
as an online survey using REDCap software, as described in the Chapter 4. 
This included a facility that enabled participants to upload their wound 
images.  
 The stages of survey and process for transmitting images were designed as 
follows: 
i) Invitation emails, including a hyperlink (underlined text for 
participants to click on) to log in to the survey, were generated 
automatically when a new study participant was added to the 
REDCap database by the author of this thesis. Hyperlinks were 
unique to each study participant and associated with an 
unidentifiable study ID.  
ii) After logging in to the survey on their mobile device, participants 
were instructed to follow instructions guiding them through a step-
by-step process to select and upload an image from their device’s 
photo library. After uploading an image, instructions invited the 
participant to upload further images, by repeating the same steps, 
until all images were uploaded. 
iii) The final stage of the survey asked participants to click on a 
‘submit’ box, following which the data entered, including uploaded 
images, were transmitted and saved to the REDCap database.  
iv) Researcher can then access the database to view and/or export data 






The survey was designed so that each step (for example, uploading of an 
image or survey item to collect information from participants) was suitable 
for different types of devices that participants potentially may use to complete 
the survey. For example, the survey was designed so that there was no 
requirement for participants to scroll down the screen on their mobile device 
regardless of whether it was a smart phone (with a smaller screen) or a tablet 
computer (with a bigger screen). This was considered necessary to make the 
process as simple as possible for any non-experienced users, following 
published recommendations to consider when designing electronic data 
capture systems for patients [125,145]. 
 
5.3.2. Assessing acceptability: pre-testing the 
components of the method 
Methods to pre-test the photography instructions and process to transmit 
images included cognitive interviews with observation, with participants who 
had recently undergone surgery. The pre-testing phase of the study, “The 
Selfi wound study: self-taken images of surgical wounds (Phase A)” ran 
between June 2018 and November 2018. 
 
i) Participants and recruitment 
Data from the study screening logs from the two recruiting hospitals showed 
that a total of 49 patients were approached for participation. Of these, 10 were 






Contact details for the 22 interested patients were passed on to the author of 
this thesis to telephone and discuss the study further. Of these, three could 
not be contacted, either because they were not available by telephone or did 
not respond to answerphone messages. One patient lived too far out of the 
feasible area for a home visit. Two patients declined participation in the 
study, one due to further health issues and one declining because they 
disliked the use of the term ‘selfie’ in the study name. The remaining 16 
interested patients agreed to take part in the study and a time and place for a 












Approached and invited to participate (n=49) 
Ineligible (n=10) 
• No access to camera/phone (n=4) 
• Inadequate English (n=3) 
• Not able to consent due to Alzheimer’s/confusion 
(n=3) 
Interested in participating in study (n=22) 
Eligible (n=39) 
Declined (n=17) 
• Not interested in the project/research (n=3) 
• Too unwell (n=2) 
• Did not want a visit from researcher (n=1) 
• Too much burden as having further treatment (n=1) 
• Didn’t want to use a computer (n=1) 
• Reason not recorded (n=9) 
Ineligible (n=4) 
• Uncontactable (n=3) 
• Too far for researcher to visit (n=1) 
Declined (n=2) 
• Further health issues (n=1) 









Participant demographics, operative details and familiarity/experience with 
devices are shown in Table 5-3. The majority of participants were female 
(n=11, 68.8%) and had undergone lower abdominal surgery (n=9, 56.3%). 
Participants’ ages were equally distributed across the age categories achieved 
by successful purposive sampling to invited participants across a broad 
spread of ages.  The median time between patients’ surgery and pre-testing 
the method was 28 days (range 12 to 69 days). The majority (n=13, 81.3%) of 
participants’ wounds had healed by the time of the study visit. One 
participant had wounds that had mostly healed, although one wound still 
had steri-strip in place when they took their photograph. Two participants 
had wounds that had not yet healed and had dressings on at the time of the 
study visit. One of these participants was changing their own dressing at 
home and removed it voluntarily to take a photograph during the study visit. 
The other participant had arranged the study visit to coincide with a district 
nurse home visit and dressing change.  
 
Experience with using devices ranged across the participant sample (Table 
5-3). All but one participant described themselves as somewhat / moderately 
experienced or very experienced / expert with using a smartphone. The 
majority of participants were experienced in taking photographs with a 
smartphone or tablet, frequently taking photographs on a monthly (n=5), 








Table 5-3. Phase A participants: pre-testing (n=16) 
Demographic/characteristic n % 
Sex Female 11 68.8 
 Male 5 31.3 
Age at time of interview (years) 
 21 to 30 2 12.5 
31 to 40 3 18.8 
41 to 50 3 18.8 
51 to 60 3 18.8 
61 to 70 2 12.5 
Over 70 3 18.8 
Time since surgery (days) 
 <7 0 0.0 
7-14 1 6.3 
15-30 8 50.0 
>30 7 43.8 
Type of surgery 
Upper gastro/intestinal  6 37.5 
Lower gastro/intestinal 9 56.3 
Vascular 1 6.3 
Experience with computers 




Very experienced/expert 7 43.8 
 Missing 1 6.3 
Experience with smartphones 




Very experienced/expert 6 37.5 
 Missing 1 6.3 
Experience with taking photos 
using smartphone/tablet 
  




Very experienced/expert 5 31.3 






Demographic/characteristic n % 
Frequency taking photographs 
using smartphone/tablet  
  
 Never 0 0 
Yearly 0 0 
Monthly 5 31.3 
Weekly 4 25.0 
Everyday 5 31.3 
 Missing 2 12.5 
Type of device   
 Android 7 43.8 
 iPhone 6 37.5 
 Tablet 1 6.3 
 Unsure 1 6.3 








ii) Findings from cognitive interviews with observation 
 
Taking and transmitting the wound images 
Several issues with taking and transmitting the wound images were identified 
during pre-testing. These are summarised below under three sections: i) 
relevance, comprehension and interpretation of the photography instructions; 
ii) feasibility/practical issues with photographing the wound, and; iii) 
technical issues with using the device to transmit images. 
 
a) Relevance, comprehension and interpretation of the photography 
instructions 
The overall aim of the photography instructions was to obtain a standardised 
image of the wound that would be suitable for remote assessment of the 
wound for SSI. During the iterative process of pre-testing and revisions, a 
number of issues with relevance, comprehension and interpretation of the 
instructions were identified. For example, an early version of the instructions 
asked participants to ensure that the flash on their camera was switched on. It 
was discovered during interviews that for some models of smartphone it was 
not possible to have a flash if using the front-facing camera, meaning that this 
instruction was not relevant for use with all devices. Another example was 
ambiguity over whether it was required to frame the whole wound in the 
photograph or whether it should be a close-up image with several taken if the 
wound was long. It was possible to overcome these issues with revisions to 
the instructions to improve clarity and precision. Revisions were then tested 






Participants provided suggestions to improve language and formatting for 
improved ease of use and comprehension. Specific examples included the use 
of the word “front-facing camera” and to streamline text to make the 
photography instructions as concise as possible.  
 
b) Feasibility / practical issues with photographing the wound 
It was possible for 13/16 (81.3%) participants to follow the photography 
instructions and take an image of their wound (Table 5-4). None of these 13 
participants needed any help to take the photograph. Reasons that three of the 
participants were not able to take a photograph included: i) having a dressing 
in place (n=1; a community nurse expected to be present to remove the 
dressing, timed with the study visit, was delayed); ii) not knowing how to 
reverse the camera on the mobile device and did not seek help (n=1), and; iii) 
needing time to work out how to use the camera on the phone and did not 
want to try during the study visit (n=1). The practical issue of a dressing 
being in place was a potential barrier for participants to take images of 







Table 5-4. Summary of participants able to take and transmit images during 
pre-testing 
 Number of participants (n=16) 





Unable to complete 
component; reasons 
n (%) 
1. Taking an image  13 (81.3%) 3 (18.8%) 
• Low competence using 
camera on device (n=2) 
• Dressing in place (n=1) 
2. Transmitting an 
image  
12 (75.0%) 4 (25.0%) 
• No facility on device to 
connect to the internet (n=1) 
• Security warning (n=1) 
• Administrative; online 
survey not finalised (n=1) 
• Participant ended interview 
early (n=1) 
  
c) Technical issues with using the device to take/transmit images 
It was possible for 12/16 (75.0%) participants to transmit an image of their 
wound, taken either during the interview or using an existing photograph 
taken prior to the interview (Table 5-4). Two participants needed help from 
the author of this thesis to navigate through the steps to upload their images 
using earlier versions of the online survey, which were subsequently 
improved in later revisions. Reasons that the four participants were not able 
to upload an image were: administrative (the online survey was not finalised 






finished early by the participant due to an expected appointment to attend 
hospital; n=1) and technical issues, including a security warning on a 
participant’s device while attempting to access the internet (n=1) and no 
facility to access the internet on the device (n=1). This participant reported 
that they would have been able to use a family member’s device to transmit 
their image if using the method in practice (that is, not a test setting). 
 
Participant views on acceptability of taking and transmitting wound 
images 
In general, the sample of participants that took part in the pre-testing phase of 
the study were supportive of providing images for remote wound 
assessment. There was no evidence to suggest any of the participants found 
the experience of seeing their wound upsetting, an issue considered as a 
potential barrier to the acceptability and, therefore, willingness to use the 
method in future. One participant described a family member and friend who 
had not wanted to look at their wound because they were squeamish. 
Conversely, there were many positive comments from participants about 
being able to take a photograph of their wound. One participant reported that 
they found viewing the image useful, because they could see their wound at 
closer proximity. Several participants reported that they had already taken 
images of their wounds prior to the invitation to take part in the current 
study. They reported that this was for their own interest, or so they could 
show others what the wound looked like. One participant had asked a nurse 
to take a photograph of their wound so they could see what the wound 
looked like immediately after surgery, before they were able to sit up and 






Suggestions for increasing acceptability of the method in future research and 
clinical practice emerged during pre-testing. Suggestions to use additional 
methods to remind people to take and transmit their images in order to 
improve responses were provided by some participants, such as text 
reminders. In particular, views about the study name (“Selfi”) were sought in 
some of the later interviews. Views on this topic were included following an 
earlier decline from one patient to take part in the study because of the study 
name. Findings on the acceptability of the study name were mixed. Some 
negative attitudes to the name were reported. One participant, for example, 
reported that they didn’t like the association with the popular term “selfie” 
(that is, a name used to describe an image that someone has taken of 
themselves, often for the purpose to share on social media), but that it may be 
more acceptable to younger people. Another participant, however, liked the 
name and thought it was sensible to have ‘Selfi’ in the title because “that is 
what it is” and “conveys what you want it to do”.  
 
Other topics explored with participants during pre-testing included asking 
others to help take the wound image. Many talked about asking family 
members, such as partners or children. Others, however, reported that they 
would prefer to take the image themselves as they would not want their 
partner to do it, for reasons related to dignity if the wound was in a personal 
location on their body. This was helpful to inform consideration for the 
feasibility and practicality of taking an image in future applications of use 







iii) Revisions to the photography instructions and 
process for transmitting images 
 
Photography instructions 
During the iterative process of pre-testing and refinement, four versions of the 
photography instructions were produced and pre-tested. A total of 43 edits 
were made (Figure 5-2). The majority of these were changes to the wording of 
the items in the instructions (n=22). Other edits were to streamline the 
instructions by reducing text (n=14) and to make improvements to formatting 
(n=7). 
 
Figure 5-2. Summary of changes made to the wound photography 













Process for transmitting images  
The process for transmitting images was modified four times during the pre-
testing phase of the study. Ten edits were made (Figure 5-3). The majority of 
these edits (n=8) were to the online survey design in order to make the steps 
for participants to upload images easier to follow. Examples included 
amending the software to enable participants to see small-sizes (that is, 
‘thumbnails’) of images that they had uploaded on the survey page before 
they submitted the data. This helped to prevent participants uploading the 
same image twice in error, when multiple images were intended to be 
transmitted. Other examples included streamlining text to ensure participants 
did not need to scroll down the device screen when completing the survey. 
This was found to be particularly important following observations that some 
participants did not know how to use the scroll bar on their devices, 
confirming the recommendations to avoid long survey pages in guidance for 
designing electronic systems for patients [125,145]. Other edits (n=2) were 
technical edits, required to make the online survey function as intended. 
These included the facility for participants to upload multiple images, if 
required, and an edit to the invitation email to reinstall the link to access the 
survey following a design error that unintentionally removed it. 
 
Figure 5-3. Summary of changes made to the process for transmitting images 




Design edits to improve 
usability (n=8) 
Technical edits to allow 






5.4. Phase 2 – Evaluation 
Phase 2 of the study focused on evaluation of the method for obtaining 
patient-generated wound images. This involved testing the method remotely 
with a large sample of patients who had recently undergone surgery. 
Evaluation included an examination of feasibility, usability, acceptability and 
image quality. The evaluation phase of the study, called “The Selfi wound 
study: self-taken images of surgical wounds (Phase B)”, ran between January 
and June 2019. 
 
5.4.1. Assessing feasibility: participant eligibility 
and recruitment  
Eligibility screening data varied in the level of detail provided by the three 
recruiting teams. Two teams (from centre number 2) did not record the 
number of patients screened for eligibility, only providing data on the 
number that were invited and consented (Table 5-5). 
 











recruited  (%)* 
1 General surgery 69 62 56 40 (71.4) 
2 General surgery Not recorded 50 46 41 (89.1) 
Vascular surgery Not recorded 17 14 10 (71.4) 
Total   129 116 91 (78.4) 






Data from the study screening logs showed that a total of 129 patients were 
invited for participation to test the method remotely. Some 10 (7.8%) were 
further found to be ineligible and 3 (2.3%) were missed for recruitment due to 
an administration error. Of the 116 eligible participants, 91 (78.4%) consented 
to take part (Figure 5-4). Reasons why participants were ineligible or declined 
the study are included in the flow diagram in Figure 5-4, where known.   
 
Two participants were excluded after recruitment. Of these, one participant 
did not provide contact details at the time of recruitment and attempts to 
obtain these were unsuccessful, while the other had an extended hospital stay 
that continued past data collection period of the study. This participant, 
therefore, was not able to test the method remotely after hospital discharge. 
Data from the remaining 89 participants were included in the analysis (Figure 









Figure 5-4. Recruitment flow diagram for the evaluation phase of the study 
 
  
Approached and invited to participate (n=129) 
Ineligible/excluded (n=13) 
• No access to camera/internet (n=10) 
• Administration error – missed (n=3) 
Consented (n=91) 
Excluded (n=2) 
• Did not provide contact details (n=1) 
• Extended hospital stay (n=1) 
Included in analysis (n=89) 
Eligible (n=116) 
Declined (n=25) 
• Too much on (n=6) 
• Not willing to photograph wound (n=2)  
• Not interested in participating (n=2) 
• Further health issues (n=1) 
• Dislike of using online systems (n=1) 
• Did not want to be followed up (n=1) 
• Not competent with technology (n=1) 
• Consent form issues (n=1) 






Table 5-6. Participant demographic and operative details (n=89) 
Characteristic   
Sex, n (%)   
Male 49 (55.1) 
Female 40 (44.9) 
Age category, years, n (%)    
18 to 35 26 (29.2) 
36 to 50 13 (14.6) 
51 to 70 33 (37.1) 
over 70 17 (19.1) 
Ethnicity, n (%)   
White/White British 87 (97.8) 
Asian/Asian British 1 (1.1) 
Mixed/multiple ethnic groups 1 (1.1) 
Type of surgery, n (%)   
General  81 (91.0) 
Vascular 8 (9.0) 
Location of wound(s), n (%)   
Abdomen 80 (89.9) 
Leg 4 (4.5) 
Armpit/Chest 2 (2.3) 
Back 1 (1.1) 
Groin 1 (1.1) 
Neck 1 (1.1) 
Number of wounds, median (range) 3 (1 to 6) 
Missing 1  
Urgency of surgery, n (%)   
Elective  58 (65.2) 
Unplanned 31 (34.8) 
Modality of surgery, n (%)   
Open  46 (51.7) 
Laparoscopic 39 (43.8) 
Mixed*  4 (4.5) 











a) Taking the wound images 
There was evidence to show that 52/89 (58.4%) participants completed step 
one and took an image of the wound (Figure 5-5). Of the 37 (41.6%) 
participants that did not take an image, it was possible to find out reasons 
from 16 (43.2%) participants, via reminders or follow-up telephone calls. The 
main reason for not taking a wound image was non-participation in the 
study, due to further health problems or life issues (n=11; 12.4%). A minority 
of reasons (n=4; 4.5%) related to usability of the method, with participants not 
being able to take an image due to technical/competency issues or practical 
issues relating to the wound. A breakdown of these reasons is provided in 
Figure 5-5. A more narrative description is provided under the subheading 
‘Assessing acceptability’ later in this chapter (section 5.4.3). One participant 
did not take an image as they decided to withdraw from the study. This 
participant reported that they no longer wanted to take part in the study in 
reply to a reminder email. They did not, however, provide a reason why they 
decided to withdraw. For the remaining 21 (23.6%) participants, it was not 
possible to ascertain whether attempts to take an image had been made as 
efforts to reach participants by telephone or email were unsuccessful 







b) Transmitting the wound images 
Of the 52 participants that took an image of their wound, 46 (88.5%) 
completed step two and successfully transmitted the image(s) via the online 
survey (Figure 5-5). It was possible to elicit reasons why six participants who 
took wound images but did not successfully transmit them using the online 
survey, via follow-up telephone calls. For three participants, reasons were due 
to a low level of competence with using technology; either reporting that they 
were not proficient in using their device to access the survey online (n=2) or 
had not been able to find the saved image within their device library when 
attempting to upload it to the online survey (n=1). These three participants 
instead sent their images to the author of this thesis, unprompted, by email. 
This was done as a reply to the automated invitation email to access the 
online survey, which came from the authors’ email address. One further 
participant was not able to transmit their image due to having no current 
access to email, and another participant had thought they had transmitted the 
image. Although other survey data was received from this participant (for 
example, responses to the debriefing question), no wound images were 
received. The final participant reported that they had not tried the online 
survey, without giving a further reason. This participant transmitted the 
image by email instead. In summary, of the six participants that did not 
transmit the images using the online survey, images were received by email 
from four participants (Figure 5-5). 
 
A comparison participant demographics and operative details for those who 
successfully completed the method and both took and transmitted an image 






(n=43/89;) is reported in Table 5-7. No apparent trend or statistical evidence 
to support a difference in age, surgery type or wound location between these 







Figure 5-5. Flow diagram of participants able to take and transmit images 
when testing the method remotely  
Number of participants 
included in analysis  
(n=89) 
Did not take an image (n=37) 
Reasons: 
Health/life issues (n=11) 
• Further health problems (n=7) 
• Intended to but kept forgetting (n=2) 
• No longer interested/too busy (n=2) 
Technical/competency issues (n=2) 
• Relying on family member to help; had 
not seen them (n=1) 
• No current access to email (n=1) 
Practical issues with the wound (n=2) 
• Dressing still in place (n=1) 
• Swelling made it too difficult to take 
image (n=1) 
Withdrew from study (n=1) 
Unknown (uncontactable; n=21) 
Step 1: Number of participants 
that took an image  
(n=52) 
Step 2: Number participants 
that transmitted image using 
online survey  
(n=46) 
Did not transmit image using online survey 
(n=6) 
Reasons: 
• not competent with technology (n=3)* 
• no current access to email (n=1) 
• no image uploaded (missing from online 
survey) (n=1) 
• no reason provided (n=1)*  
*sent image to study team by email 
Total number of images received by study team 






Table 5-7. Demographics and surgical details for participants who completed, 








Sex, n (%)                                           Male 27 (58.7) 22 (51.2) 
Female 19 (41.3) 21 (48.8) 
Age category, years, n (%)    
18 to 35 13 (28.3) 13 (30.2) 
36 to 50 7 (15.2) 6 (14.0) 
51 to 70 19 (41.3) 14 (32.6) 
over 70 7 (15.2) 10 (23.3) 
Ethnicity, n   
White/White British 45 (97.8) 42 (97.7) 
Asian/Asian British 0  1 (2.3) 
Mixed/multiple ethnic groups 1 (2.2) 0  
Type of surgery, n (%)   
General  43 (93.5) 38 (88.4) 
Vascular 3 (6.5) 5 (11.6) 
Location of wound(s), n (%)   
Abdomen 42 (91.3) 38 (88.4) 
Back 1 (2.2) 0 
Groin 0  1 (2.3) 
Leg 3 (6.5) 1 (2.3) 
Neck 0 1 (2.3) 
Armpit/Chest 0 2 (4.7) 
Number of wounds, median (IQR)** 3 (1 to 4) 3 (1 to 4) 
Urgency of surgery, n (%)   
Elective  29 (63.0) 29 (67.4) 
Unplanned 17 (37.0) 14 (32.6) 
Modality of surgery, n (%)   
Open  24 (52.2) 22 (51.2) 
Laparoscopic 19 (41.3) 20 (46.5) 
Mixed/Converted (e.g. lap to open) 3 (6.5) 1 (2.3) 
Living status after leaving hospital, n (%)**   
Living with others  7 (15.2) 5 (11.9) 
Living alone  39 (84.8) 37 (88.1) 
Time between surgery and first 
contact, days, median (IQR) 
22 (19 to 28) 22 (20 to 27) 
*n=37 did not complete step 1 (taking the photograph); n=6 did not complete step 2 
(transmitting the image using the online survey). p<0.05 for all comparison between 
completers vs non-completers. 








a) Time taken to obtain images from participants 
The median time to respond to the online survey and transmit images was 
four days after being sent the email invitation (range 0 to 24 days; inter-
quartile range one to 10 days). 
 
b) The need for reminders  
As described in the methods (Chapter 4), participants from whom no images 
had been received within approximately five days after being sent the 
invitation email were prompted with a reminder (via either an automated 
email and/or a telephone call). The exception were five participants for whom 
the study team already knew of a reason why they had not responded 
(further health issues (n=2), had an incorrect email address and previous 
attempts to contact by telephone were unsuccessful (n=1), had sent images by 
email as had attempted and not been successful in completing the online 
survey to transmit the image (n=2)).  
 
The number of participants that required a reminder was high. Of the 89 
participants that were sent an invitation email, only 28 (31.5%) took and 
transmitted a wound image without the need for a reminder. A total of 56 
(62.9%) participants, therefore, were contacted at least once with a reminder 
phone call or email. Reminders were effective for obtaining wound images 
from 19/56 (33.9%) participants, with these participants transmitting images 






(37.5%) participants, reminders were ineffective for obtaining an image from 
participants and it was not possible to ascertain a reason why no image had 
been received (Figure 5-6). Reminders made to the other 16 (28.6%) 
participants, however, were successful in receiving a response and provided 
an opportunity to elicit reasons why they had not taken and/or transmitted 








Participants included in analysis  
n=89 
Needed a reminder 
n=56 (62.9%) 
Not sent a reminder  
(reason for not 
taking/transmitting image 
already known) n=5 (5.6%) 
Took and transmitted images 
without a reminder n=28 (31.4%) 
Reminder effective for obtaining 
image from participants  
n=19 (33.9%) 
Reminder effective for obtaining 
reason why no image 
taken/transmitted 
n=16 (28.6%) 
Reminder ineffective for 







c) Time taken to take the wound image 
Of the 47 participants that completed the debriefing questions as part of the 
online survey, the majority (n=41; 87.2%) reported that the process of taking 
an image of the wound took less than five minutes (Table 5-8). Only one 
(2.1%) participant reported that it took more than 15 minutes to take the 
photograph(s). It was possible to find out more information during a follow-
up telephone call. The participant reported that the time was increased 
because their wounds were small in size and in a difficult location on their 
body (the neck) for them to photograph themselves. They asked their partner 
to help, however, the partner was not experienced with using the mobile 
device and it therefore took a long time to take a suitable image. 
 
d) Help from others to take/transmit images 
Debriefing questions within the online survey collected data on the 
requirement of help to take and transmit images (Table 5-8). Of the 47 
participants that completed the online survey, the majority (n=25; 53.2%) 
reported that someone else took the wound images. Reasons for why 
someone else took the images were not routinely collected as part of the 
study. The participant information leaflet and the photography instructions 
did state, however, that it was acceptable to ask someone else to take an 
image. Some 19/47 (40.4%) participants reported that they took the images 
themselves. The remaining three participants (6.4%) reported taking some 
photographs themselves while someone else took others (the participants had 







Few participants 8/47 (17.0%) reported that they needed help to transmit the 
image (Table 5-8). All of them asked a family member. Specific reasons that 
help was needed was not collected as part of the online survey. One 
participant who reported that they needed help with transmitting the images 
on the online survey took part in a follow-up telephone call. The reason they 
asked their partner to help was because they were more familiar with 
technology (which they described as “tech-minded”). This participant had not 
attempted to transmit the image themselves. 
 
Table 5-8. Participant burden to take and transmit images: time taken and 
requirement for help reported in the online survey 
Debriefing item n (%) 
Time taken to take the wound image, minutes   
Less than 5  41 (87.2) 
5 to 10  5 (10.6) 
10 to 15  0 0 
More than 15 1 (2.1) 
Help with taking the image   
Yes 25 (53.2) 
No (self-taken) 19 (40.4) 
Mixed (participant plus another person took 
images) 
3 (6.4) 
Help needed to transmit the image    
No 39 (83.0) 








5.4.3. Assessing acceptability: participant feedback 
and experiences  
 
Participant feedback and experiences with taking and transmitting images 
were collected in two ways. These were: i) free text space within the online 
survey (used by 8/47 (17.0%) participants), and ii) follow-up telephone calls 
to a sub-sample (n=13; 14.7%) of participants. A third, unanticipated source of 
feedback was obtained during reminder phone calls to participants who had 
not transmitted images within a week. During these reminder phone calls, 
participants provided feedback and reported where there had been problems 
with taking or transmitting the wound images. 
 
Feedback was categorised as either: i) positive or ii) describing problems 
encountered when taking and/or transmitting images. Problems were further 
categorised as: a) wound-related problems and b) technical/technical 
competency issues. A descriptive account of the feedback in relation to these 
different categories is provided below. 
 
i) Positive feedback 
Nine participants (five using free text space within the online survey and four 
participating in a follow-up call) described the process of taking and 
transmitting the images as easy and straightforward. Verbatim quotes are 







Box 10. Positive feedback reported by participants 
 
  
ii) Problems encountered when taking or transmitting images 
Participants’ reports of problems encountered or issues with taking or 
transmitting images are summarised in Table 5-9. Many of these reported 
problems, however, were overcome, with only four resulting in participants 
not being able to take or transmit an image at all. Where the problems had 
resulted in participants not being able to take an image, information was 
included in the study flow diagram above (Figure 5-5).  
 
Quotes reported in free text space in the online survey (n=5): 
• “Was not a difficult process at all.” [participant B020] 
• “Everything went smoothly.” [participant B030] 
• “It was a very easy process!” [participant B042] 
• “Easy to do, I think it's an excellent programme and should be 
introduced to all patients.” [participant B050] 
• “All pretty straightforward” [participant B034] 
Positive experiences described in follow-up calls (n=4).  
•  “Easy to do” 
• “Easy” 
• “Instructions were clear”  
• “Straightforward to follow” 









(number reporting a problem) 
Taking the 
image 
Wound-related • Difficult location of wound (n=3) 
 • Dressings in place for prolonged 
length of time (n=2) 
 • Swelling (n=1) 
 Technical 
competence 
• Did not have anyone technically 





• Problems transmitting image due 
to inexperience with technology 
(n=3) 
  • Problems finding the image on 
device (n=1) 
 Technical  • Problems with the online survey 
crashing (n=1) 




a) Wound-related problems 
 
Location of wound on the body 
Location of the wound was a particular problem for a small number of 
participants, as reported in free text within the online survey (Box 11). In a 
reminder phone call, one participant described how they had not taken a 
photograph as the location of their wound, and surrounding swelling, had 
made it difficult. They had not wanted to ask a family member to help 
because they wanted to protect their dignity.  
 
Box 11. Participant feedback in the free text space in the online survey about 
difficulties with wound location 
 
Dressing use 
During reminder phone calls, two participants reported that they had not yet 
been able to take images due to dressings still being in place. One 
participant’s wound was still covered with a dressing five weeks after surgery 
and they had not attempted to take a photograph because of this. For the 
other participant, dressings were still required after hospital discharge and 
• “Taking the selfi of my abdomen was quite difficult.” [participant B041] 
• “I got my partner to take the photos for me as I had difficulty seeing my phone 
camera screen on account of where the wounds were situated.” [participant 
B039] 







dressing changes were being undertaken by a district/practice nurse. This 
participant successfully took an image after the dressing had been removed, 
although this meant that the transmission of the image was delayed. 
b) Technical /technical competence issues 
Four participants sent their images by email rather than transmitting them 
using the online survey, as previously described. These participants were 
followed up with a telephone call to elicit reasons. Of these participants, two 
had attempted to transmit the images via the online survey but had been 
unsuccessful: one reported that they had not been directed to the filestore on 
their device when prompted to select and upload an image and the other 
reported that they had tried the online transmission but “couldn’t quite 
remember what had happened”, also reporting that they were “not very good 
with computers”. The remaining two participants had not attempted to 
transmit the images via the online survey. One had not noticed the hyperlink 
in the invitation email and the other did not provide any explanation.  
One further participant reported that they had had technical difficulties with 
transmitting an image (Box 12). A follow-up telephone call with this 
participant discovered they had found the whole process difficult. The wound 
was small and in a location that made it hard to see the device screen when 
taking the image themselves. They were not able to get help from their 
husband as he was not experienced with using the mobile device. They did, 
however, manage to take and transmit four images. The images were slightly 
blurry but were all rated sufficient for potentially assessing the wound for SSI 
in the analysis of image quality (described later in this chapter). This 







Box 12. Participant feedback of technical difficulties with transmitting images  
 
From the total number of participants testing the method remotely (n=89), 
one participant had completed the online survey and provided other data 
(such as the debriefing questions) but no wound image. Feedback via a 
follow-up call was sought to elicit further information and whether any 
problems had been encountered. The participant reported they had taken an 
image and had thought they had transmitted the image via the survey. To 
their knowledge, no problems had been encountered.  
  
“Couldn't upload from mobile; link kept crashing. I think if I hadn't agreed to 






5.4.4. Assessing image quality 
A total of 102 images were received from 50 participants. This was because 
the majority of participants (n=43; 48.3%) had more than one wound (Table 
5-6). All images were assessed for quality. Judgements on their suitability for 
potentially making a clinical assessment of the wound for SSI were made by 
three independent clinical assessors. 
 
Judgements of sufficient / insufficient images 
The majority of images (n=84 to 88; 82.4% to 86.3%, depending on the 
assessor) were considered sufficient to assess the wound for surgical site 
infection. An example of a wound image submitted by a participant and 
judged as sufficient by all three assessors is illustrated in Figure 5-7. The 
number of images judged as insufficient were between 14 (13.7%) and 18 


















n (%) Total 
1 88 (86.3%) 14 (13.7%) 102 
2 84 (82.4%) 18 (17.6%) 102 








Inter-rater agreement on judgements of image quality 
A comparison of assessors’ judgements of whether an image was sufficient 
quality for potentially assessing the wound for SSI demonstrated 85% overall 
agreement and a Krippendorff’s alpha co-efficient of 0.41, suggesting 
moderate agreement. Of the 102 images, 87 (85.3%) were considered to be 
sufficient quality by at least two of the three assessors and 75 (73.5%) were 
unanimously considered to be sufficient quality by all three assessors (Figure 
5-8). Only four (3.9%) images were considered insufficient by all three 
assessors. These images came from four different participants. 
 
Figure 5-8. Agreement between assessors for judgements of image quality 
 
 
Total number of images (n=102)
Images rated sufficient by at least one assessor: n=98 (96.1%)  
Images rated sufficient by at least two assessors: n=87 (85.3%)  






Assessors’ reasons for judging images as insufficient quality 
Assessors’ judgements of insufficient images were categorised as i) reasons 
that could be improved with modification to the photography instructions 
and ii) reasons that could not be improved with modification to the 
photography instructions (Table 5-11). Reasons that could be improved with 
modification to the photography instructions (applicable to 19/102 (18.6%) 
images) included: poor angle, poor focus, presence of shadow, too dark, over-
exposed, full wound not visible within the image, full extent of redness 
surrounding the wound not visible within the image. 
Reasons that could not be improved with modification to photography 
instructions (applicable to 8/102 (8.8%) images) related to where the wound 
was on the body. In all cases, these were images where wounds included the 
umbilicus cavity (belly button) and where part of the wound was hidden 
within this cavity. For these participants, it would only have been possible to 
photograph the full wound if the skin was pulled down and held taut, which 
would not have been suitable to include in the photography instructions for 
patients due to risk of introducing infection or potential damage to the 
wound. Full examination to adequately view and assess the wound in these 
cases would require manipulation of the skin by clinical staff rather than a 
patient and would be more appropriate for a face-to-face assessment. These 








Table 5-11. Reasons for assessors’ judgments of insufficient image quality 
(n=27)* 
Category Number 
of imagesꝉ  
Detailed reason  
(number of images) 
i) Reasons that could 




19 Poor focus (n=9) 
 Full wound not visible within image 
and no further image provided (n=8) 
 Shadow over the wound (n=4) 
 Poor angle (n=2) 
 Too dark (n=1) 
 Over exposed (n=1) 
 Extent of redness not visible as 
continued outside of image frame 
(n=1) 
ii) Reasons that could 




8 Part of wound not visible as inside 
belly button (n=8) 
* by any one of three assessors  
ꝉ Some images were judged as insufficient for more than one reason 
A sensitivity analysis to examine assessors’ agreement of image quality, 
excluding images that were judged as insufficient for reasons that could not 
be improved with modification to the photography instructions (n=8), 
indicated greater agreement between assessors (89% agreement; 








This chapter reports the findings from the development and evaluation of a 
method for patients to take and transmit images of their wound after leaving 
hospital for remote SSI assessment. Findings are reported in two study 
phases: first the development and pre-testing of the method, and second, its 
evaluation for intended use in future research or clinical practice.  
 
The first study phase included a content analysis of 11 existing documents 
relevant to taking standardised wound images photography (one guideline 
for medical illustrators, seven published papers and three study protocols 
using images for outcome assessment). Some 21 key features were identified 
and considered for the development of wound photography instructions for 
patients, ensuring they were relevant for patients to take standardised wound 
images after leaving hospital using their own mobile device. A process for 
patients to transmit images in the form of an online survey using existing IT 
software was developed, ensuring it was suitable for patients to access and 
upload images using their own device. Some 16 cognitive interviews with 
observation were conducted with patients to pre-test the photography 
instructions and process for transmitting images. Potential issues were 
identified and addressed with modifications and revisions to the 
photography instructions and transmission process.  
 
The second phase of the study undertook an evaluation of the method 
developed and pre-tested in Phase 1. Participants were recruited to test the 






acceptability and quality of the images. Obtaining images remotely was found 
to be feasible and acceptable to the majority of participants in the study, with 
91/116 (78.4%) approached and eligible patients consenting to take part. A 
number of participants did not complete the study for reasons such as further 
health problems or not having time/no longer being interested in taking part 
(n=11; 12.4%). A small number of problems were reported in taking or 
transmitting images, with a minority or participants (n=5) experiencing 
problems with technology or competency issues with using their devices to 
take or transmit images. For six participants, issues relating to the wound 
itself were problematic for taking an image, such as where the wound was 
located on the body or continued use of dressing for a prolonged period of 
time. Many of these problems, however, were overcome, with only four 
(4.45%) participants unable to take or transmit an image of their wound at all. 
Some 21 (23.6%) participants, however, did not complete the study and it was 
not possible to ascertain the reasons because attempts to contact participants 
were unsuccessful. Of the 102 images that were obtained from participants, 
image quality was high, with 87 (85.3%) images judged as sufficient to assess 
the wound for SSI by at least two of three clinical assessors.  
 
5.5.1. Strengths 
The development and evaluation of the method for patients to take and 
transmit wound images combined methodology from two approaches. This 
included established methods drawn from the field of PROM development 
and validation, to ensure the photography instructions for patients had 
relevant and appropriate content to produce a suitable image and were 






digital systems were also applied, to reflect the human-system interaction 
required for patients to perform the method of taking and transmitting 
images. Rigorous pre-testing using face-to-face cognitive interviews with 
observation was conducted to ensure the method was acceptable and fit for 
purpose before testing in a large sample of participants from the target 
population. Further strengths of the study include the purposive sampling, to 
include a diverse spread of participant ages, wound locations and types of 
surgery to maximise generalisability of the study findings. The photography 
instructions and process for patients to transmit images are reproducible, 
making them suitable for adoption in future research and clinical contexts.  
 
5.5.2. Limitations 
Analysis of feasibility 
Analysis of the feasibility of the method to take and transmit images was 
limited to some extent in the current study. Whilst there were attempts to 
collect data on the number of patients suitable for the study, screening data 
was found to differ across the recruiting centres. This meant that accurate 
data on the number of patients that were ineligible were unavailable. 
Problems with poorly reported screening data is common in research studies 
[146]. Although a high number of those approached consented to the study 
and had the appropriate device to take and transmit an image after leaving 
hospital, it is unknown whether this is reflective of the wider population. In 
future, however, it is likely that more of the population will have access to 
and be familiar with taking and transmitting images using digital devices. 






limited at present, although it is likely that the method will be even more 
feasible for future populations, because of the anticipated increase in the use 
and ownership of digital devices [72]. Efforts to collect accurate screening 
data warrants more attention in future studies to adequately assess the 
feasibility of the method in a wider context. 
Timing of outcome assessment and wound photography 
The evaluation of the method to obtain wound images is limited to a request 
for patients to take and transmit images on a single occasion, typically several 
weeks after the patient had left hospital following surgery. Findings 
demonstrated that taking images of wounds sooner after leaving hospital may 
incur more problems as it may be difficult for patients to take images if 
dressings were still in place. This may have implications for using this 
method to monitor wound healing in ‘real-time’ or on a regular basis 
immediately after leaving hospital. Findings are currently limited to 
evaluation of this method at a single timepoint two-to-three weeks after 
surgery and it is unknown whether use of the method for obtaining images 
sooner after leaving hospital is feasible. Further work to explore this is 
warranted. 
The next and final chapter will bring together the two studies conducted 
within this PhD work. It will discuss the work in the context of recent 
literature and its strengths and limitations. Applications of the new outcome 
measure and the method for obtaining wound images from patients for 
remote SSI assessment in research and routine practice are considered, 






CHAPTER 6.  DISCUSSION 
   
6.1. Introduction 
This thesis reports on research to improve SSI outcome assessment. It focuses 
on SSI data after the patient has left hospital. Two distinct but related studies 
were undertaken. The first study developed and validated a new outcome 
measure for SSI to be completed by the patient or healthcare professional. The 
second study explored a method for patients to take and transmit digital 
images of wounds for remote SSI assessment. The intention was that these 
methods would be complementary and reproducible for use in future 
applications. Whilst the concept of this work originated within the context of 
a research study, as the work developed it became evident that there was 
potential application in routine surgical follow-up, research and audit. This 
chapter will now discuss the work. First, the study findings will be 
summarised and considered in the context of recent literature. Next, the work 
will be critically evaluated, discussing the strengths and weaknesses. Finally, 
opportunities and recommendations for future work will be discussed, 
including plans for further research.  
 
Summary of the rationale for the research  
Surgical site infection continues to be a significant problem for healthcare 






surgical follow-up, research and audit. Data are needed to effectively evaluate 
interventions aimed to reduce SSI, and for benchmarking and priority setting 
in the healthcare service [20,21]. Accurate SSI assessment, however, is 
challenging because of the changing nature of care and the drive for shorter 
hospital stays, meaning that the timing of appearance of SSI is often when the 
patient has left hospital [18]. This has implications for research and routine 
surveillance. Follow-up visits with patients to assess symptoms and signs of 
SSI can be resource intensive, logistically difficult and costly to both patients 
and the health service [26].  
 
Before this research began, there was no outcome measure for SSI that had 
been developed and validated specifically for use after hospital discharge. 
Existing tools for assessing wounds included checklists of ‘SSI criteria’ based 
on SSI definitions and grading scales with either no or minimal validation 
[31]. These existing tools have limitations. They were designed for completion 
by healthcare professionals, primarily for use in-hospital and they are 
complex to complete [38]. In addition, they have been criticised as being too 
subjective, meaning SSI diagnoses are dependent largely on the views of the 
person assessing the wound. As a result, SSI diagnoses have been shown to be 
inconsistent and their data unreliable [36,54]. No patient-reported outcome 
measure has previously been developed. Use of the existing clinician-
completed tools relied primarily on a face-to-face assessment of the wound, 
which could be logistically challenging for patients travelling long distances 
or needing to take time off work, resource-intensive for healthcare staff and 
costly to both patients and the health services. Face-to-face assessments may 






timing of face-to-face assessments may be too late to recognise and treat early 
signs and symptoms of SSI, risking the severity of problems getting worse. 
Remote assessment of wounds using electronic transmission of patient-
generated digital images was an emerging area at the time of starting this 
research. Studies, however, had paid little attention to instructions for 
patients on how to photograph the wound to ensure that the image was fit for 
purpose.  
 
Summary of study aims 
The aims of this research were to address the limitations of existing methods 
and measures for SSI. Two aims were specified: 
1) Develop and validate an SSI outcome measure for patient or healthcare 
professional completion, suitable for use after the patient has left hospital 
2) Develop and evaluate a method for patients to take and transmit a 
standardised image of their wound after leaving hospital, for remote 
wound assessment  








6.2. Summary of the studies and key 
findings 
 
6.2.1. Study 1 
 Development and validation of a new SSI outcome measure  
The development and validation of a new SSI outcome measure is reported in 
Chapters 2 and 3 (methods and results, respectively). This work has been 
published in peer-reviewed journals [147,148] (Appendices 1 and 2). It has 
also been published as part of an NIHR HTA monograph reporting the wider 
Bluebelle feasibility study [1]. The development and validation work included 
a series of study phases to ensure that the new measure was reliable and valid 
for assessing wounds for SSI after patients had left hospital. The essential 
properties of an outcome measure were addressed, in accordance with 
established and widely-used methods for PROM development and validation 
[46,85,86]. Specifically, these properties included content, construct and 
criterion validity, reliability and acceptability. Key findings related to these 
measurement properties are summarised below. 
 
Content validity 
The final outcome measure comprised 18 items to assess a comprehensive set 
of domains relevant to assessing wounds for SSI. One of the domains, smell, 
was identified from interview data. This is not a criterion included in other 






infections, such as gram-negative and anaerobic bacteria, can create foul 
odours due to tissue breakdown [150]. Although it is recognised that not all 
infected wounds produce a smell and different types of bacteria produce 
odours of different types [151], smell was identified as an important domain 
in the assessment of wounds for SSI and relevant to include in the new 
measure. 
 
Novel methodology using lay language alongside medical terminology in 
items was employed in this work. This novel approach to questionnaire 
design was developed as part of this PhD. The use of medical terminology 
alongside plain language was found to influence the way an item was 
interpreted. It provided, therefore, a method for ensuring content validity; to 
make sure items accurately reflected the underlying domains intended to be 
measured. The discovered benefits for improving content validity have been 
published [152] (Appendix 3). The publication describes the new type of 
measure, applicable when the health issue of interest can be assessed by either 
the patient or an observer, calling it a ‘universal-reporter outcome measure’ 
(UROM). This type of measure is applicable for gathering information or 
opinions from patients and healthcare professionals on the same subject, such 
as Delphi surveys to prioritise outcomes for a core outcome set (COS) 
[153,154]. Where appropriate, the use of medical terminology alongside plain 
language as pioneered in the current study is now endorsed by the Core 
Outcome Measures in Effectiveness Trials (COMET) initiative and is included 








Language in the new outcome measure referred to ‘wound healing’ rather 
than ‘infection’. This was based on findings from the interviews that patients 
did not always refer to the word infection to describe their wound problems 
or experiences. This finding is supported in other published literature. A 
qualitative study exploring patients’ experiences of SSI, for example, found 
that patients were not always aware that they had had a wound infection 
when one had occurred [156]. The choice of words for items in an outcome 
measure is crucial to ensure that they are comprehensible to the target 
population and acceptable so that people are willing to complete it and data 
are reliable [45,46]. Indeed, if the word infection is included in the title, 
instructions or items of a measure and patients did not think it was relevant 
to them, it may result in the questionnaire being dismissed and not completed 
at all.  
 
A range of response categories allowed the severity or extent of a symptom to 
be reported in the new outcome measure, further strengthening its content 
validity. The importance of this is reflected in other studies that have explored 
the important factors for defining SSI. In a study by Sanger et al., for example, 
a prognostic model of SSI using daily wound assessments demonstrated that 
the amount of exudate was more strongly associated with SSI than the type of 










Construct validity was demonstrated by examining the underlying structure 
of the data, and whether responses to items clustered together to reflect a 
unidimensional (single scale) SSI construct or a more complex multi-
dimensional construct. Analyses supported the proposal that a single 
scale/factor model was the best fit for the data, suggesting that SSI could be 
measured as using a single scale that made clinical and practical sense. 
Internal consistency of the single SSI scale was good, with Cronbach’s alpha 




Criterion validity was examined by comparing participants’ self-assessment 
total score on the new outcome measure with a reference SSI assessment. The 
reference assessment of SSI or no SSI was determined from a face-to-face 
assessment with a healthcare professional using the CDC criteria and 
definition for SSI. The outcome measure demonstrated good criterion 
validation. A ROC curve analysis showed high sensitivity and specificity for 
SSI discrimination compared to the reference CDC diagnosis.  
 
Reliability 
Test-retest reliability was demonstrated to be good for the majority of items. 
Observed agreement between the test and re-test responses was more than 
86% for any of the items. Reliability of the measure as a patient self-reported 






observer-completed assessment. Agreement between self- and observer 
assessments was generally high. A trend for patients to report signs and 
symptoms a little more severely than healthcare professionals was observed, 
although the difference was small and not significant. The trend was seen in 
the lower end of the response categories, with a tendency for patients to 
report mild signs or symptoms whereas the healthcare professionals reported 
the sign or symptom as not being present. This observation is supported in 
previous studies, where a similar minor discrepancy in patient and healthcare 
professional reports of symptoms has been reported [158-161]. Some slight 
discrepancy in reports of whether wound care interventions had occurred 
were observed, although the number of occurrences of the intervention were 
too few in the sample to draw any inferences from this observation.  
 
Acceptability 
The measure was demonstrated to be acceptable to patients and healthcare 
professionals. Cognitive interviews confirmed that patients and healthcare 
professionals were willing and able to complete the measure and that the item 
language, questionnaire length, format and response categories were 
appropriate. Acceptability of the use of plain language alongside medical 
terminology was confirmed. In the field-testing study, levels of missing data 
to individual items were low. The exception were some sub-items, where 
responses were often missing when they were expected to have been 
completed. These responses were likely to be missing in error as a result of 
the formatting of the questionnaire. Formatting was improved to avoid this 
issue in a revised final version of the measure. Feedback from participants 






to complete with few problems. There were no complaints about the length or 
content of the questionnaire from patients or health professionals. 
 
6.2.2. Study 2 
Development and evaluation of a method for remote wound 
assessment using patient-generated digital images  
Study 2 developed and evaluated a method for patients to take a digital 
image of their wound and transmit it to a research/healthcare team for 
remote assessment after leaving hospital. The study was conduct in two 
phases: 1) development of the components of the method (that is, wound 
photography instructions and the process for transmitting images) and 2) 
evaluation of the feasibility, usability and acceptability of the method for SSI 
assessment in future applications of its use, including an evaluation of image 
quality.  
 
Content validity and acceptability 
Content validity of the photography instructions was addressed by 
undertaking an analysis of existing wound photography literature to identify 
the important features for photographing wounds. Some 21 key features for 
photographing wounds (for example, patient positioning, lighting) were 
identified. These were formulated into instructions for patients, suitable for 
use after leaving hospital using cameras on their own mobile device. Existing 
IT software was adapted to design an online survey with a facility to upload 






mobile device. An iterative process of pre-testing and subsequent 
modifications to the photography instructions and transmission process 
ensured that both components were comprehensive, comprehensible, and 
acceptable to patients. Participants generally supported the idea of taking and 
transmitting images after leaving hospital with few problems envisaged.  
 
Feasibility, usability, acceptability and image quality 
The second phase of the study focused on evaluation of the method for 
remote SSI assessment in future applications of its use. Patients undergoing 
surgery were invited to take part in a study to test the method remotely and 
take and transmit images of their wound after leaving hospital. Screening and 
recruitment data demonstrated the method was feasible, with 91/116 (78.4%) 
approached and eligible patients consenting to take part. The number of 
participants effectively taking and transmitting images was 52/89 (58.4%) and 
46/89 (51.7%), respectively. Where it was possible to ascertain reasons from 
participants for not taking or transmitting and images, reasons were primarily 
further health problems or low priority of the study compared to other 
demands in participants lives (n=11; 12.4%). Only a small minority (n=4; 
4.5%) of participants experienced practical problems with photographing the 
wound, or technical or competency issues with transmitting the image that 
made it impossible to take or transmit an image at all. Efficiency of the 
method was demonstrated with participants transmitting images a median of 
four days after being requested. Responses from participants answering 
debriefing questions found that the process was quick to do with few 
problems reported. Some problems with taking images when the wound was 






although many of these problems were overcome and it was possible to take 
an image with help from others. Quality of the images was generally very 
high. Some 87 (85.3%) images were judged to be adequate for potentially 








6.3. Findings in the context of recent 
literature 
 
A novel contribution to SSI assessment 
Recent literature demonstrates that accurate SSI outcome assessment 
continues to be a problem. The challenge of assessing wounds after the 
patient has left hospital means that data are unreliable and estimates of SSI 
rates are uncertain. Research to develop a reliable and valid measure for SSI 
suitable for patient self-report after leaving hospital was welcomed [44,57]. 
When the current PhD work describing the development of the new outcome 
measure was published in the Journal of Infection Prevention in 2017, for 
example, the journal editor wrote an accompanying editorial endorsing the 
work and methodology to include patients in the development and testing of 
the measure. The editor wrote that “finding robust methods of identifying 
infections after the patient has been discharged from hospital is critical to 
measuring the risk of SSI”. The editorial described how the development of 
the outcome measure addresses a key problem for SSI surveillance systems 
where reliable measure to identify SSI after the patient leaves hospital are 
needed [14].  
 
Further highlighting the ongoing problem in obtaining accurate SSI data after 
the patient has been discharged, a 2018 commentary in Lancet Infectious 
Diseases described the difficulties with achieving in-person wound reviews 






on to describe how novel methods using mobile devices to collect data, 
including images from patients, could make remote follow-up possible. More 
recently in October 2019, an entire special issue devoted to methods and 
technologies for assessing surgical site infection was published in Surgical 
Infections [163]. Papers emphasised the potential for using patient-generated 
data on symptoms and signs of SSI, including patient-provided images, 
discussing recent advances and future directions for SSI surveillance in 
research and clinical practice [62,75,78,120,164-169]. Of specific relevance to 
the current work, one of the papers in the series describes how patient-
generated data, including digital images, may improve the consistency and 
precision of SSI diagnosis, citing the work conducted in this PhD [120].  
 
The need for better measures and methods for SSI assessment after hospital 
discharge was further demonstrated at the 11th Healthcare Infection Society 
International conference in 2018. In a debate entitled “National surgical site 
infection surveillance – friend or foe?”, speakers on both sides of the 
argument described the limitations of the existing tools available to assess SSI 
and the particular difficulties in obtaining accurate data post-discharge, 
emphasising how this had implications for UK hospitals reporting SSI rates. 
Concerns remain that the true scale of SSI rates is unknown due to a lack of 
adequate and reliable data. All these examples demonstrate the timeliness 
and relevance of the work conducted in this PhD and the urgent need for 








Since commencing this PhD, the author of this thesis has become involved in 
networks and working groups of academic and clinical experts in this field. 
Specifically, these are the Wounds Research Network (WReN) and the NHS 
England National Wound Care Strategy Programme (NWCSP) [25,170]. More 
detail on the author’s involvement in these groups and how it has helped 
dissemination and uptake of this PhD work will be described later in this 
chapter (section 6.6). The WReN includes surgeons, wound infection control 
practitioners, tissue viability nurses and researchers involved in wound care 
across the UK and provides a platform for shared learning and support for all 
types of wound research [170].  The NWCSP includes clinical and academic 
experts in pressure ulcers, lower limb ulcers and surgical wounds. Empirical 
evidence found through involvement in these groups has confirmed that no 
new SSI measures have been developed, and the CDC diagnostic criteria and 
ASEPSIS grading scale remain to be the tools that are widely used. This 
includes use by the UK government agencies PHE and NICE [22,90]. This is 
supported with evidence from more recent Cochrane systematic reviews, 
which demonstrate that the CDC criteria are still the most widely used tool 
for defining SSI in clinical trials [20,117]. For example, The Getting it Right 
First Time (GIRFT) programme, an initiative funded by the Department of 
Health in 2016 to reduce infection rates in the NHS, collects data on SSI rates 
across hospitals in the UK and uses the CDC criteria to define SSI [23]. It has 
been criticised, however, because the methods to collect data within the 
programme are largely reliant on hospital data and use of sub-optimal tools 
based on the CDC criteria. There are concerns, therefore, that despite this 
recent initiative, SSI rates will continue to be an inaccurate reflection of the 






conferences throughout the course of this PhD. There have not been any other 
contributions presenting new SSI tools.  
 
In light of the recognised problems with existing methods and measures for 
SSI, this PhD work has produced two novel contributions to improve SSI 
outcome assessment. The new outcome measure, specifically designed for use 
after the patient has left hospital, is the first SSI outcome measure to be 
developed that can be completed by patients or a healthcare professional. It 
has been developed and validated with robust methodology, providing a 
much-needed tool for research and routine practice where existing tools are 
sub-optimal. Indeed, it is evident that clinicians and researchers are not 
satisfied with the existing tools available for assessing wounds for SSI. Since 
the findings from this study have been published and disseminated at 
conferences and via research networks, there has been a great deal of interest 
in using the new outcome measure, indicating its value to the field. As of 
March 2020, published papers and conference abstracts reporting the 
development and validation work of the new outcome measure have been 
cited a total of 13 times. Further evidence for the need for this work is 
demonstrated by the number of requests to use the new outcome measure. At 
the time of writing this thesis, the number of such requests has reached 30, 
including use in both research studies and routine follow-up. This has 
included international requests from Switzerland, the Netherlands, Australia, 
US, Turkey, Kosovo, Myanmar and Malaysia. In the UK, seven grant 
applications for studies that include the new measure to collect outcome data 
have been funded. New studies using the measure include RCTs exploring 






RfPB-funded SUNRRISE trial; PB-PG-0416-20045), multiple interventions to 
reduce SSI in general abdominal surgery (the NIHR HTA-funded ROSSINI 2 
trial; 16/31/123), negative pressure wound therapy for wounds healing with 
secondary intention (the NIHR HTA funded SWHSI 2; 17/42/94) and a trial 
of fibrin sealants in head and neck cancer surgery (part of an NIHR-funded 
doctoral research fellowship: the DEFeND trial). More details of these studies 
are described later in this chapter. Recruitment to these studies has started 
and data collection using the new outcome measure is ongoing. 
 
Recent literature has been published reporting other peoples’ work on wound 
photography that is relevant to this PhD research. As described in Chapter 1, 
existing studies exploring the use of patient-generated wound images lack 
detail on how the photography instructions for patients, if any, were 
developed or provided. Since starting the current research one study has 
subsequently been published that includes instructions for patients to take a 
wound image [71]. No detail, however, is included on how the instructions 
were developed and how their content was informed. The current study has 
paid attention to this issue, to ensure the images of the wound are suitable 
and of sufficient quality to be clinically usable to assess the wound for SSI.  
 
Work looking at patient-generated wound images continues. In the US, for 
example, a Health Technology Assessment of the current use of mobile health 
(mHealth) for SSI care, called the Assessing Surgical Site Infection 
Surveillance Technologies (ASSIST) project, was undertaken and published in 
2019 [75,76]. In contrast to the current study, many of the studies identified by 






Recent published literature and ongoing research in the US further 
demonstrates work surrounding the collection of patient-generated SSI using 
a mobile phone app [164,165]. The method for obtaining patient-generated 
images in the current study, however, intentionally did not involve the 
development of an app. Instead it utilised existing IT software and the 
cameras on patients’ own devices, making the method reproducible for future 
applications of its use. This utilisation of patients own devices was also 
intentional, with many recognised advantages for future use in trials and 
routine practice, as reported in current literature [163,119]. It reduces costs, for 
example, as the supply of devices to patients is not required. It also reduces 
learning burden, as patients can use a device they are already familiar with. 
The resources associated with app development, training in use of the app 
and the need for ongoing management of the app are also avoided. These 
benefits make the method more feasible for use in studies with large sample 
sizes or in routine practice where resources are limited. Indeed, the ‘Bring 
your own device’ (BYOD) approach has been a practical model for collecting 
data in clinical trials [119]. This PhD work has produced generic, reproducible 
instructions for patients to take standardised wound images that are not 
specific to a mobile phone app or a particular device, which can now be used 
in future applications of the method with required modifications if needed 
(for example, to accommodate any specific requirements for photographing 
wounds in different locations on the body).  
  
There have been several recent advances in methods for collecting electronic 
patient-generated data for aiding SSI diagnosis over the past 12 months. An 






smartphone-delivered tool can facilitate the assessment of SSI and result in 
earlier treatment [171]. The study aims to recruit 500 patients undergoing 
emergency abdominal surgery. The wound assessment tool is based on the 
CDC diagnostic criteria and ASEPSIS grading scale, being the most 
commonly used at the time of designing the study. Items for patients to 
complete were written based on the criteria from these existing scales. Unlike 
the current study, however, the items were not developed using robust 
methodology and have not been validated. Patients are also required to 
submit a wound image via the tool, which utilises the same IT software 
(REDCap) used in this PhD work. Instructions for patients on how to take a 
standardised image of their wound, however, are lacking.  
 
Technology and the use of wound images for aiding SSI diagnosis continues 
to advance. There are now, for example, cameras available that can detect 
temperature using infrared, making it possible to obtain thermographic 
profiles of wounds to contribute to SSI diagnosis [172,173]. There are types of 
thermal imaging cameras also now available on the market for use with 
smartphones. Whilst these techniques undoubtably contribute and are useful 
for diagnosing SSI where temperature of the wound is a sign of infection, it 
will be some time before this technology is readily available on patients’ own 








6.4. Strengths and limitations 
Reflections on study methodology and the specific strengths and limitations 
of the individual studies have been described previously, in the Discussion 
section at the end of each results chapter (Chapters 3 and 5). This is to 
facilitate coherence of the work for the reader of this thesis. Strengths and 
limitations relevant to the work as a whole are now described below. 
 
6.4.1. Strengths 
Sample size, study design and multidisciplinary 
collaboration  
Important strengths of the studies undertaken in this PhD research include 
the large number of patients, multiple centres and wide range of different 
types of surgery (including elective and unplanned) within the specialty 
under study that were involved. This supports the validation and 
generalisability of the work, increasing its relevance to the wider population. 
Undoubtably, a further strength of this PhD work has been the involvement 
of a collaborative multidisciplinary team. The studies have been designed and 
conducted with input from patients, nurses, surgeons, microbiologists, health 
service researchers, health economists, statisticians and medical illustrators to 
inform the design, conduct and analysis. The involvement of the 
multidisciplinary team has ensured that both the new outcome measure and 
the method for obtaining patient-generated wound images are relevant to a 
wide range of stakeholders in wound care and SSI measurement. Great 






the work has meaning and relevance to those that will benefit from it. 
Likewise, the involvement of surgical trainees who are the next generation of 
healthcare providers that will be using the research outputs also add strength 
to this work. For example, several requests to use the new outcome measure 
have come from surgical trainees planning studies and writing funding 
applications for research fellowships that will contribute to the impact and 
future research beyond this PhD.  
 
Having the engagement, support and opportunity to work with a 
multidisciplinary team to do the research has been extremely valuable and 
powerful for dissemination and implementation of the work. It has, for 
example, provided opportunities for wider dissemination of the work via 
research networks and in social media than may have otherwise been 
possible. This has promoted implementation of the new outcome measure 
and method for patients to take and transmit images in other studies and 
increased the impact of the work. Specific RCTs already using the new 
outcome measure include:  
1) the NIHR HTA funded ROSSINI 2 trial: Reduction of Surgical Site 
Infection Using Several Novel Interventions; a multicentre, multi-
arm, multi-stage (MAMS) trial with 6610 participants (grant 
number 16/31/123).  
2) the NIHR RfPB funded SUNRRISE trial: Single Use Negative 
pRessure dressing for Reduction In Surgical site infection following 







3) the NIHR HTA funded SWHSI-2 trial: Surgical Wounds Healing by 
Secondary Intention; an RCT with 696 participants. This study has 
also recently incorporated patient-generated images of wounds for 
remote assessment (grant number 17/42/94). 
4) the NIHR DRF programme funded DEFeND trial: Determining the 
Effectiveness of Fibrin Sealants in Reducing Complications in 
Patients Undergoing Lateral Neck Dissection: A randomised 




Although the large number of patients involved in the two studies described 
in this thesis is a considerable strength of this work, it is important to 
acknowledge limitations. The work was undertaken within the two surgical 
specialties of abdominal and vascular surgery. These surgical specialities have 
a higher risk of SSI [27], making them particularly relevant for developing 
and evaluating new methods to improve SSI outcome assessment. Whilst it 
was considered justified to focus the research within specific surgical 
specialties for practical, clinical and logistical reasons, it is acknowledged that 
generalisation of the findings to other wound specialities may be limited as a 
result. The suitability of the measure for measuring SSI in other specialities 
such as, for example, orthopaedics, is unknown. Similarly, the suitability of 
the photography method for patients undergoing other types of surgery 
where, for example, wounds are in different locations on the body, is 






undergoing different types of surgery are underway and are described in 
more detail later in this chapter (section 6.7).  
 
There are other limitations of this work in relation to the study population. It 
is important to acknowledge that the findings from these studies are 
potentially subject to participation or volunteer bias. This type of bias refers to 
potential underlying differences between patients that volunteer to 
participate in research and those that do not [174]. People that did not accept 
the invitation to participate in the current studies may have had, for example, 
different demographics or clinical profiles. This can have implications for 
interpretation of the study findings and ultimately their generalisability to the 
wider population [175]. Similarly, generalisability is also limited by the 
population demographic and socio-economic characteristics of those that did 
participate in the studies. There is, for example, very little ethnic variation  in 
the study populations. It is also acknowledged that data on participants’ 
socio-demographics for the complete sample is lacking, including information 
on education, and this is a limitation for understanding the generalisability of 
the findings to a broader population. 
 
Interpretation of the study findings are further limited by potential 
underlying differences between the participants that responded in the studies 
and those that did not. This type of bias is known as non-response bias [176]. 
With relevance to the current studies, this has implications, for example, in 
the analysis of criterion validity of the new outcome measure. The ability of 
the SSI measure to discriminate between SSI and no SSI in the current dataset 






data from those participants that completed and returned the self-reported 
SSI measure and attended a face-to-face follow-up for a reference SSI 
assessment. It is unknown whether the sensitivity and specificity of the 
measure to discriminate between SSI and no SSI would be different if data 
from all participants were available for analysis. Those that did not respond 
may have, for example, fewer or more wound healing problems. It was 
known that a higher number of participants who did not complete the SSI 
measure in the validation study had unplanned surgery. Based on evidence 
that SSI rates are higher in patients undergoing unplanned surgery [17], it 
could be suggested, therefore, that participants that responded to the study 
may have had more wound problems and higher rates of SSI than those that 
did respond. Certainly, this is an area that warrants further investigation.  
 
The potential for bias in the study population is also relevant to the 
development and evaluation of the method for taking and transmitting 
wound images. It is recognised that findings of patients’ acceptability of the 
method to take and transmit images of the wound after leaving hospital, for 
example, may be biased in the sample of participants accepting the invitation 
to participate in the study. It is unknown whether acceptability of the method 
would be similar for participants that declined the invitation to take part in 
the study. Patients who may have found the experience of seeing their wound 
upsetting and therefore not willing to photograph it, for example, may have 
declined the invitation to take part. Similarly, the interpretation of the 
findings from the photography study is also subject to non-response bias. For 
example, usability and acceptability of the method in participants that were 






unable to be contacted to elicit reasons, is unknown. Further testing to explore 
this is warranted. 
 
Literature searches  
An updated systematic search of the literature to identify SSI assessment tools 
was not undertaken as part of this thesis. As described in the discussion 
section of this study at the end of Chapter 3, the likely impact of this for 
identification of new SSI tools was regarded to be minimal because the tools 
identified in the previous systematic review conducted by Bruce et al. 2001 
[31] were found to still be the most commonly used tools in current practice. 
A content analysis of these tools, combined with data from the interviews, 
allowed for a comprehensive set of domains to be identified to inform the 
content of the new outcome measure.  
 
An informal scoping search was conducted to identify relevant documents to 
inform the development of instructions for patients to take wound images. 
The lack of a formal search for guidance on taking wound photography 
instructions is a potential weakness of this study as it may have identified 
existing literature on this topic that was missed in the scoping search. As 
previously described in the methods chapter for this study (Chapter 4) the 
impact of not conducting a formal search was, however, considered minimal. 
This is because guidelines for professional medical illustrators on how to take 
wound images were used as a key source document for informing the patient 
instructions. It was considered that this document was comprehensive to 






the wound and as such, along with the other included source documents, was 
sufficient to serve as a basis for developing the instructions for patients. This 
was then subsequently iterated and improved with input from patients 
during cognitive interviews in the next phase of the study. 
 
Response rates 
It is important to acknowledge the response rates in the two studies and how 
these impact on the interpretation of the findings. The response rate for the 
participant-completed outcome measure achieved through postal 
administration was 561/792 (70.8%) (Study 1). The response rate for obtaining 
wound images from patients achieved through electronic transmission was 
46/89 (51.7%) (Study 2). Whilst these response rates are acceptable and in line 
with published literature from other similar studies using postal 
questionnaires or electronic patient-reported data capture (for example, a 
systematic review of strategies to improve response rates in healthcare studies 
reported an average response rate to postal questionnaires of 65% and studies 
that have used ePRO systems to capture electronic data from patients have 
reported completion rates of 47% to 51% [177-179]), they are, however, a 
limitation to the generalisability and interpretation of the study findings. It is 
recognised that efforts to improve response rates would need to be 
considered for applications of the method in future research and routine 
practice to achieve more complete data to ensure they are accurate and 
reliable. Response rates would need to be improved if the methods were 
being used, for example, to measure a primary outcome in a trial. Ideas to 
address this are returned to later in this chapter under the sub-heading 






6.5. Applicability of the work to research and 
routine practice in wider contexts 
Whilst the outcome measure and method for obtaining patient-generated 
images were developed and evaluated in the context of a research study, a 
strength of this work is its relevance to both research and clinical practice in a 
wider context. Many of the findings are transferrable to other settings, 
emphasising the relevance and importance to examine the applicability of the 
methods in further work. 
 
6.5.1. Applications in routine surgical follow-up, 
SSI surveillance and audit 
Applications of the work in contexts other than research include monitoring 
of wounds in routine practice. For example, use of the outcome measure and 
images could be used in routine patient care as tools to inform further 
treatment or intervention. The role of patient-reported data integrated into 
routine care as a screening tool or to provide tailored advice to patients has 
many potential benefits for patients and healthcare providers, as 
demonstrated in the field of oncology [180]. An example of how the outcome 
measure is already being considered in this context is to monitor patients after 
routine surgical follow-up. A research group based at the Medical University 
of South Carolina, US, are developing a mobile phone app intended for use by 
patients for routine SSI follow-up after surgery [181]. The group have 






within the app to collect data and monitor the wound for signs of infection. 
The study aims to recruit the first cohort of patients in Spring 2020. 
 
The outcome measure and patient-provided images also have applications for 
use in SSI surveillance and audit. There is potential for the methods to 
provide more accurate and reliable data on the number of SSIs that have 
occurred after the patient has left hospital. The founder and lead for the 
GIRFT programme (described previously in section 6.3), for example, 
recognises the limitations of their SSI audit. In a published commentary 
shortly after the publication of the development work from this PhD research, 
the programme lead supported the use of the outcome measure to improve 
the methodology for identifying SSI, writing that “methods to improve SSI 
identification, such as those proposed by Macefield et al. (2017) are very much 
welcomed.”[24]. The PHE SSISS team are also aware that this new outcome 
measure has been developed and validated following an invited talk given by 
the author of this thesis at the Healthcare Infection Society 2018 conference 
and subsequent networking with members of the PHE team. Incorporation of 
the new outcome measure could add significant value to existing PHE 
surveillance methodology which currently uses an unvalidated questionnaire 
[34]. Opportunities to collaborate with the PHE team will be explored as part 
of the author’s plans beyond this PhD work. 
 
It is recognised that several aspects of the outcome measure and method for 
patients to take and transmit images would need modifications for use in 
routine surgical follow-up, surveillance and audit. Transmission of images, 






so that linkage with patients’ electronic health records are possible. 
Integration of patient-reported data with electronic health records, for 
example, requires careful planning, with consideration of ethical and legal 
issues [182]. Further work is warranted to explore potential barriers and how 
they may be overcome in the pathway to uptake and implementation of the 
methods in these settings. 
 
6.5.2. Applications in other surgical specialties 
The development and evaluation of the new outcome measure and method 
for obtaining patient-generated wound images was performed within the 
context of abdominal and vascular surgery. SSIs can, however, occur after any 
type of surgery making these new methods applicable to SSI outcome 
assessment in other surgical specialties outside those in which they have been 
developed. Examples of studies in other specialties that are already using the 
outcome measure include head and neck cancer, ulcerated skin cancer and 
cardiothoracic surgery. The new measure and photography method also have 
applications to wounds healing with secondary intention, that is, wounds that 
have not been closed after an operation and are instead left ‘open’ to heal 
from the bottom up. An example of how this is already being explored is in 
the SWHSI-2 trial [183,184]. The research team have included the outcome 
measure in the currently recruiting RCT and validation of the measure in this 
context will be examined. The author of this thesis is a member of the study 
management group for this trial. Although the new outcome measure and 
photography method have applications for use in these other surgical 
specialties and other types of wounds, it is recognised that modifications and 






these different procedures. More detail on further validation in other 
populations is discussed below (section 6.7 ‘Future research’). 
 
It is recognised that applications of the photography method in other surgical 
specialties would need to consider the feasibility of the method in relation to 
the location of the wound. In the current study, a few participants reported 
problems with taking images because of the location of the wound on the 
body made it difficult to see the camera screen to check that the wound was 
correctly framed in the image. Similar problems have been reported in the 
literature. For example, a study with nine patients following vascular and 
general surgery explored the usability of an app that allowed patients take 
images of their wound [83]. Problems with photographing groin wounds 
were reported because it was difficult to achieve the optimal angle to take the 
photograph. In the current study, the issue of dignity was raised if the wound 
was in a personal location on the body and how participants may not want 
others to help take an image. Further issues with wound location emerged 
from findings in the current study. Some of the reasons that assessors judged 
the wound images as insufficient related to the where the wound was on the 
body. There was a need to manipulate the skin in order to see the wound in 
full, for example, wounds inside the belly button. Whilst the current study 
identified that there are some wounds that may still require a face-to-face 
assessment so the healthcare professional can manipulate the skin to get a full 
view of the wound, it is likely the methods developed in this thesis are 
applicable for assessing most types of wounds. Further work and validation, 






to be considered in future applications of the method outside of general and 
vascular surgery. 
 
6.5.3. Applications in wound care outside of 
surgery 
The outcome measure and method for patient to take and transmit images 
have applications for use in other fields of wound care outside of surgery. In 
other types of wounds such as pressure ulcers, leg ulcers and diabetic foot 
ulcers, for example, wound healing and infection are important outcomes 
[185-187]. It is recognised that applications of the methods may require some 
modifications for use with these other types of wounds. Some items in the 
outcome measure, such as the item asking about dressing use, for example, 
may need adapting to make it applicable to chronic wounds that require 
dressings for longer periods of time. It may also be necessary to modify the 
photography instructions for use to assess other types of wounds. For 
example, it may be necessary to ask patients to photograph their wounds 
from different angles if perception of wound depth is important. Any 
modifications to the outcome measure and photography instructions would 







6.5.4. Applications in low- and middle-income 
countries (LMICs) 
A major strength of this work is its potential application worldwide. Whilst 
the work to develop and validated the SSI measure and the collection of 
images was performed within the UK, the methods have great potential for 
use in low- and middle-income countries (LMICs) where SSI rates are higher 
and access to hospitals is often limited due to distance or financial constraints 
[188]. Methods for remote wound assessment, therefore, have potential 
benefits to the patient and the health services in LMICs. Work to evaluate the 
feasibility and validity of the outcome measure in low resource settings has 
recently been funded as a sub-study within the NIHR-funded FALCON trial: 
Pragmatic multicentre FActorial randomised controlled triaL testing measures 
to reduCe surgical site infection in lOw and middle income couNtries (grant 
number 16/136/79). An NIHR doctoral fellowship (awarded to James 
Glasbey at the NIHR Unit on Global Surgery at the University of 
Birmingham) embedded within the NIHR HTA-funded FALCON study will 
explore the feasibility and diagnostic accuracy of the measure administrated 
by telephone for assessment of SSI following abdominal surgery in low and 
middle-income countries. Validity of the tool for use as a telephone-based 
assessment will be examine compared to an in-person face-to-face assessment. 
The author of this thesis will work closely with this group and has been 
invited to be a member of the study steering group. It is recognised that use of 
the methods in LMICs would require linguistic and cultural translations and 
this is planned as part of the fellowship. International validation of the 







6.5.5. Considerations for future applications of the 
work 
In addition to any modifications and further validation required for 
application of this work to other contexts described above, there are other 
considerations for future applications of this work.  
 
Ideas to maximise response rates have been considered. An electronic version 
of the outcome measure, for example, could be developed and participants 
could be asked for their preference on whether they would prefer a postal or 
electronic version of the questionnaire. This is often done in research studies 
to maximise response [189]. Validation of the outcome measure for electronic 
patient self-report would first be needed to assess its suitability and this is 
discussed later in this chapter (section 6.7). Other ideas to improve response 
rates could consider alternative ways to remind participants to respond. In 
the current studies, reminders were typically made by telephone calls. Some 
difficulties in reaching participants by telephone, however, were often found 
with many participants not answering calls. The study researchers were 
telephoning from hospital or university landlines where the number was 
often ‘protected’ and the caller ID is not displayed on the receiving mobile 
phone. The issue of no caller ID is recognised in the literature as a problem for 
trying to contact participants [190]. It was considered as a potential 
contributor to not being able to reach participants in the current studies. 
Alternative methods to remind participants in future studies could consider 






emails or calling from landlines with recognised numbers with an aim to 
maximise response rates. 
 
Further considerations for future applications of the method to obtain patient-
generated digital images include the use of patients’ own devices to take and 
transmit images. Whilst the use of patients’ own devices is an emerging field 
in SSI research and routine practice with many potential benefits for the 
patient and health services (as described in Chapter 1), some disadvantages, 
however, are also recognised. Not all patients have access to an appropriate 
device, for example. This may be problematic if the method were being used 
to collect outcome data in trials, as it introduces selection bias because the 
sample is not representative of the population [175]. It may be problematic in 
routine care, as it disadvantages patients without access to the appropriate 
device. Other problems include potential costs incurred to patients when 
there is a need to have internet access to transmit images. Privacy and security 
issues with using patients own devices may also be an issue and are 







6.6. Dissemination of the work 
The previous paragraphs describe the applicability of the work to research 
and routine practice in wider contexts. In order for uptake and 
implementation of the new outcome measure and method for obtaining 
patient-generated images in these settings, effective and efficient 
dissemination of the work is key. Informing the surgical field and other 
healthcare professionals involved in wound assessment that this research has 
been done has been an important part of this PhD work. Work has already 
been disseminated in several ways. In summary, this has included: 
i) Four peer-reviewed publications. Papers report: 1) the development 
work and 2) the validation work for the new outcome measure; 3) 
the novel approach to outcome measure design and the 
development of a measure for completion by patients and/or 
professionals and 4) the published NIHR HTA monograph as part 
of the wider Bluebelle feasibility study [147,148,50,1]. 
Details of these publications are provided at the beginning of this 
thesis. A fifth paper reporting the development and evaluation of 
the method for obtaining patient-generated wound images is 
planned.  
ii) Four oral conference contributions at national and international 
conferences in the UK and US: the International Clinical Trials 
Methodology Conference (2015 and 2019), the Society for Clinical 







iii) Four conference poster presentations at national and international 
conferences in the UK and US: International Clinical Trials 
Methodology Conference (2017), Patient Reported Outcome 
Measures conference (2018 and 2019) and the Society for Clinical 
Trials Conference (2019). 
iv) Five invited talks at conferences: the Wound Research Network 
Scientific meeting (2016, 2017 and 2019), the Healthcare Infection 
Society International Conference (2018) and the European Wound 
Management Association Wound Care conference (2020). 
 
During the course of this PhD, the author has become involved in several 
wound-related research networks and working groups as mentioned earlier 
in this chapter. These include WReN and the NHS England NWCSP [170,25]. 
The author was invited to join the NWCSP as a committee member of the 
surgical wounds workstream. The NWCSP was set up in 2018 with the 
purpose to develop a national strategy that focuses on improving wound care 
relating to pressure ulcers, lower limb ulcers and surgical wounds. The 
surgical wounds workstream are developing a set of recommendations to 
improve care for patients with surgical wounds. This includes 
recommendations to improve accurate diagnosis of SSI and the use of images 
for post-operative monitoring, to which the methods developed in this PhD 
are key. Involvement in these groups, therefore, has provided an ideal 
platform for dissemination of the research to those who may use them in 
practice. Continued involvement in the groups will allow for further 








Public engagement has also been conducted as part of this PhD work. The 
author of this thesis successfully applied to take part in the University of 
Bristol Research without Borders Festival, May 2018. This was a one-day 
public engagement event at the Colston Hall, open to the public, industry and 
other professionals and academics. A stand displayed the Selfi wound study 
and the opportunity for people to try taking self-taken images of ‘fake 
wounds’ (temporary tattoos) with their own mobile device. Discussions with 
people who visited the stand, feedback and observation of attempts to take 
photographs provided valuable input prior to the testing-phase of the study. 
 
Summary for participants 
The work has also been disseminated to study participants. A visual abstract, 
for example, to summarise the findings from the Selfi wound study was 
designed and sent to all study participants via email in December 2019. The 
initial draft of the visual abstract was reviewed by two members of a PPI 
panel working with the NIHR Bristol Biomedical Research Centre (BRC) for 
feedback and suggestions for improvements to ensure that it was appropriate 
and easy to understand for the general public.  
 
Webpage 
Further efforts to make the work available to the wider scientific community 
have included the development of a dedicated webpage for the new outcome 






webpages on the University of Bristol website [191]. A summary describing 
the new measure and how it was developed and validated is included, with 
links to the publications for readers to have access to full details. The 
webpage includes a purpose-designed request form for anyone wanting to 
use the measure, asking completers for to provide details on reasons for using 
the measure, including purpose (e.g. trial or other research study), details of 
intended use (e.g. setting, number of patients), requests for translations as 
well as contact details. The webpage also includes a licence for non-
commercial users to use the measure (with no fee for non-commercial use), 
which has been drawn up in collaboration with the University of Bristol 
Research and Enterprise Development team. The webpage hosts the licence 







6.7. Future research  
Areas for further work 
1) Further validation in different patient populations 
As discussed earlier in this chapter, further validation of the outcome 
measure and photography method is required to examine their application in 
different patient populations. Testing with patients, for example, with 
different demographics, different types of wounds and undergoing other 
types of surgery is required to determine how useful the methods are in 
patient populations other than that of the current study. Plans to work with 
others to further validate the new outcome measure are already underway. 
As described earlier (section 6.3), seven grant applications from other UK 
academics and clinicians have been funded for studies that include the new 
outcome measure. Recruitment and collection of data in four of these studies 
has started. These studies (four RCTs and three cohort studies) will allow for 
further examination of the performance of the new outcome measure in these 
different populations. Agreements to share data and work with these groups 
to further validate the outcome measure have been made. 
 
2) Determining a threshold score for SSI 
A key next step for further work is to establish an SSI ‘threshold’ score for the 
outcome measure. This would mean setting a cut-off threshold, for which 
scores over that particular value would be indicative that the patient had an 
SSI. Such as threshold score is important for future applications of the 






patient population to be reported. A threshold score may be useful, for 
example, in clinical practice as a screening tool to trigger further clinical 
investigation or treatment. Patient self-reported questionnaires with 
established threshold scores are used in other fields, for example, for 
detecting and guiding treatment decisions for depression [192].  
 
Choice of an appropriate threshold score is a clinical question and has to 
balance the risk (that is, the cost and consequences) of over or under 
estimating SSI. This may depend on the purpose of its use. For example, it 
may be preferable to have a lower threshold score for SSI if the measure was 
being used as a screening tool for inviting patients for a face-to-face follow-up 
to inform whether treatment is needed. It may be better to be more over-
cautious and have a higher rate of ‘false-positives’ than to risk missing some 
cases of SSI if the threshold score was too high. The ‘seriousness’ of an 
undetected SSI in clinical practice compared to an undetected SSI in trial 
outcome data may be more significant because it may have direct negative 
consequences if it results in a patient not being treated. 
 
Determination of a threshold score requires analysis of sensitivity and 
specificity of the outcome measure compared with a reference SSI diagnosis 
[112]. Data from the current study suggested a cut-off score around 6 to 8 
appeared to be a reasonable threshold for suggesting SSI / no SSI with 
relatively few misclassifications compared to a face-to-face diagnosis using 
the CDC criteria. More work with data from other studies is needed to 






There are plans after this PhD research to work with others to establish the 
SSI threshold score. The studies described above that are already collecting 
data using the new outcome measure are also designed to include a face-to-
face assessment of the wound and an SSI diagnosis using the CDC criteria. 
This is the same reference assessment to that used in the current study. These 
data will allow further exploration of the ability of the outcome measure to 
discriminate between SSI and no SSI in these different datasets and explore an 
SSI threshold. 
 
3) Combined use of the outcome measure and images 
An important area for further work is to combine the use of the outcome 
measure and patient-generated digital images. It is anticipated that combined 
use of the outcome measure and images will have added value for SSI 
assessment. Images may, for example, help to determine a diagnosis of SSI in 
a ‘grey area’ range of scores around a potential threshold for SSI. In the data 
in the current study a cut-off score of 6 to 8 appeared to be a reasonable 
threshold for suggesting SSI / no SSI compared to the reference face-to-face 
SSI diagnosis. Further work could explore the use of images for assessing 
wounds in this group where assessment of SSI using the new outcome 
measure alone is uncertain. A study that collects data using the new outcome 
measure, with or without a patient-generated wound image would be 
valuable to examine accuracy of SSI diagnosis using these new methods. 
Possible study designs include an RCT randomising patients to complete the 
new outcome measure after leaving hospital and return it with or without 
transmitting a supplementary digital image of their wound. Surgeons’ 






4) Full evaluation of the method for remote wound assessment 
using patient-generated digital images  
This PhD work performed an evaluation of the method for obtaining patient-
generated wound images, for potential use for SSI assessment in a research or 
clinical context. This next step for this work is conduct a full evaluation of the 
method. A pilot study, using the method to collect images from patients after 
having surgery and using the images to assess the wound for SSI in a research 
study or in routine follow-up is warranted. Evaluation of the clinical benefits 
of the method could then be examined, including measures of 
patient/healthcare professional satisfaction to see if the methods meet the 
user’s needs and expectations. Satisfaction is a  recommended outcome to 
assess in full evaluations of methods that involve electronic data collection 
and human-system interaction [130].  
 
5) Electronic use of the SSI measure for digital delivery 
Another area for further work that would add value to the outcome measure 
is it’s reproduction for electronic data capture, known as ‘eMigration’ or 
development as an electronic patient-reported outcome measure (ePROM) 
[125,119]. The outcome measure was developed and validated for use as a 
paper questionnaire. As mentioned earlier in this chapter, administration of 
electronic outcome measures has many benefits over paper-based methods, 
including convenience and cheaper and faster data collection with fewer data 
entry errors [193,194]. Migration to an ePROM would need to be done using 
robust methodology [145]. Consistent formatting, font size, ease of navigation 






need to be considered. Tests of usability to ensure that respondents are able to 
complete the ePROM correctly would also need to be conducted. 
 
6) International validation: cross-cultural and linguistic 
translation  
An important area for future work is international validation of the new 
outcome measure. All the participants contributing to this work were 
recruited in the UK. The validation of the outcome measure involved a multi-
centre study that recruited participants from different regions including 
Bristol, Birmingham and Worcester with the aim of having diversity in the 
population. Recruitment aimed to include a broad sample of demographics as 
possible. Despite this, there was very little ethnic diversity in the study 
population and the majority of the participants in the studies were white.  
 
The involvement of participants from outside the UK would have added 
cultural and ethnic diversity to the study population that may have 
potentially influenced the findings. For example, it may have influenced the 
language used in items in the new outcome measure. An international study, 
however, would have added administrative complexity and language and 
cost implications outside the resources possible for this PhD. As a result of its 
UK focus, there are cultural limitations to this work. It is currently unknown 
how the outcome measure would perform in a more diverse population, for 
example, whether the wording and plain language descriptions are 
appropriate. The language used to describe symptoms, for example, may be 
less understood in different cultures. Similarly, the suitability of the 






Cross-cultural translations and further testing in populations from different 
cultures and different ethnic groups is therefore warranted.  
 
The SSI outcome measure could be translated for populations in different 
cultures and countries to allow international implementation and use of the 
outcome measure with non-English speakers. Guidance and established 
methodology for translating outcome measures exist to ensure this process is 
done robustly [48]. This involves a two-stage process including forward and 
backward translations to ensure the translation is accurate and appropriate. 
As described earlier, specific interest is the application of the methods 
developed in this PhD work to low- and middle-income countries where rates 
of SSI are higher than the UK. There are plans to work with others to explore 
this. The recently funded NIHR DRF described earlier (applicant James 
Glasbey) plans to undertake work to examine cross-cultural translation of the 
measure in an English-speaking South African population as part of the wider 
NIHR-HTA funded FALCON study (grant number 16/136/79).  
 
7) Real-time monitoring of wound healing 
A further area of work is to investigate the applicability of the methods 
developed in this PhD for real-time monitoring of wound healing. The 
timeframe for collecting data in the current studies was approximately 30 
days after surgery, a widely accepted timeframe for SSI to have occurred [32]. 
Real-time monitoring of wounds using the methods at more immediate 
timepoints sooner after surgery may have advantages for identifying signs 
and symptoms of SSI earlier. It may mean, for example, treatment can be 






methods to get a clinical opinion when patients have concerns about their 
wound healing may help to reduce patient anxiety.  
Future management, licensing and marketing of the 
outcome measure 
In collaboration with the University of Bristol Research and Enterprise 
Development team, a recent agreement with an external company to manage 
licensing and future requests to use the new outcome measure has been set up 
to encourage the adoption and recognition of the new outcome measure. This 
decision has been a result of the high number of requests to use the new 
outcome measure over the last 12 months, including commercial interest (for 
example, from a company developing a new bacteriostatic dressing interested 
in using the outcome measure in an early-phase observational study). Oxford 
University Innovation (www.innovation.ox.ac.uk) have a Clinical Outcomes 
team that provide academic and consultancy services to support the 
management, licensing and marketing of clinical and patient-reported 
outcome measures. Their existing portfolio includes 30 outcome measures 
developed within Oxford University and other institutions. They will manage 
administration and future requests for use of the SSI outcome measure, with 
the official name as the Bluebelle Wound Healing Questionnaire (WHQ), 
including licensing responsibilities and fees for commercial requests and will 
develop the marketing and support structure. The company will advertise the 
measure using its own marketing channels, for example, their website, 
newsletter and Oxford University press releases. The potential impact 
through marketing through this professional company is a very exciting 
prospect for the future of the SSI outcome measure and the work conduct 







Accurate and reliable SSI outcome assessment is critical for routine surgical 
practice, research and audit. Challenges in SSI assessment, especially after the 
patient has left hospital, have been problematic for researchers and clinicians. 
This means SSI data are unreliable and true rates of SSI are unknown. This 
work has addressed a gap in the field of SSI assessment. Before the research 
for this thesis, no outcome measure for SSI existed. A new outcome measure, 
for patient or healthcare professional completion, has now been developed for 
use in hospital or after the patient been discharged. The measure has been 
developed with input from key stakeholders. Patients and healthcare 
professionals participated in qualitative interviews to inform the development 
of the measure, ensuring that the content was comprehensive and included 
issues that were important to patients and well as healthcare professionals for 
SSI assessment. A novel approach in formulating items for the questionnaire 
was applied by using plain language alongside medical terminology. This 
was found to maximise content validity of the measure and ensure that items 
were interpreted as intended. The measure was pre-tested with both patients 
and healthcare professionals to ensure it was acceptable and fit for purpose. 
The new outcome measure has been shown to be comprehensive and easy to 
complete. Findings from the validation study demonstrated the measure to be 
reliable and valid for assessing SSI in closed primary surgical wounds.  
 
This PhD work has made a second contribution to the field of SSI assessment, 
utilising the advances in technology and move towards using digital images 
for remote assessment. A reproducible method for obtaining patient-






been developed and evaluated for its potential use in future research and 
clinical practice. The method utilises patients own mobile devices and has 
shown to be feasible, acceptable to patients and capable of providing images 
of sufficient quality for remote wound assessment. This innovative patient-
centred method, incorporating digital images and data transmission, 
combined with the new outcome measure, has considerable potential for 
improving SSI assessment after hospital discharge.  
 
Plans for future work are now directed towards further evaluation and 
implementation of these new methods in research studies and routine practice 
to improve SSI outcome assessment in future. Several areas for further work 
have already commenced, involving multidisciplinary research teams across 
the UK. The high level of interest in using the new outcome measure is very 
encouraging. The potential for the new methods to have significant impact 
presents an exciting prospect for the use of these methods in future. The 
methods developed in this PhD work provide novel contributions to the field 
of surgery and SSI outcome assessment, and ultimately provide value for 
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Appendix 6. A schematic overview of the Bluebelle feasibility study 
The development and validation of the SSI measure were embedded within 
the wider study (highlighted in bold font) 
  
Bluebelle Phase A aims:  
1. Understand practice & views in relation to 
dressings and glue-as-a-dressing 
2. Survey current practice of wound dressing 
use & indication 
3. Define & categorise dressings  
4. Develop patient and observer completed 
questionnaire for SSI assessment and 
experience of wound dressings 
5. Develop and validate observer completed 
questionnaire of practical wound 
management 
6. Update evidence for wound dressings 
including glue-as-a-dressing 
7. Develop a metric to assess quality of 
wound closure 
8. Perform a value of information analysis to 
inform the main RCT design and worth 
9. Bring together study management group 
to design external pilot 
Bluebelle Phase B aims (pilot RCT): 
1. Identify numbers of patients 
eligible for RCT & randomise 370 
2. Identify, investigate & tackle 
barriers to recruitment 
3. Establish rates & reasons for non-
compliance to treatment allocation 
4. Assess the acceptability of the trial 
interventions and processes to 
participants and clinical staff 
5. Validate SSI measure, wound 
management & patient experience 
questionnaires & assess quality & 
completeness of secondary outcomes 
6. Explore & pilot methods for patient 
wound photography 
7. Design main trial 
Meetings with nurses, surgeons and 
methodologists to design the 
external pilot RCT  
In abdominal & obstetric surgery & 
contrast with the practice of ‘no 
dressings’ in paediatric surgery 
Collate information 
(properties, costs, 
evidence & use) 












Design main RCT 
Two types of surgery in five 
hospitals in Bristol, 





No dressings  
Standard clinical review & SSI measure assessment at day 30       
Secondary outcomes: patient experience, practical wound 







Appendix 7. Participant information leaflet for interviews to identify content 






































Appendix 8. Topic guide for interviews with patients to identify content domains for 
the SSI measure (Study 1; Phase 1) 
 
Opening  
Interviewer will re-iterate study information and purpose of interview, answer any 
questions, and take written consent.  
Background, interviewee detail and ice breaker 
Interviewee background and details of procedure that the interviewee has had, how 
long in hospital, when discharged.  
Patients experience of wound infection 
Discuss the patient’s experience of wound infection following planned surgery, 
including signs and symptoms and health care use. Note to the patient that they may 
or may not have experienced some of the signs/symptoms and health care use that 
are mentioned; we are talking to people with different experiences and asking a 
range of questions to capture these experiences.   
 
Signs/symptoms 
Experience of wound healing  
• Can you tell me about the healing of your wound after your operation? 
(Probe: where is your wound, have you looked at your wound, are you able 
to see your wound: what does/did it look like (discharge, redness, swelling, 
opening) what does it feel like (pain, heat), have you noticed any smell from 
you wound?) 
• Have you noticed/did you notice any problems with the healing? (Probe: 
what are/were the problems, when did you notice problems, has an infection 
been identified, how is your wound now, has it healed and if yes when did it 
heal e.g. 5/10 days after surgery?) 
• Have the problems with your wound healing affected your life in general? 
(Probe: How -sleep, functioning, relationships, work, for how long, and how 
has this made you feel? Did the wound healing affect others in your life?)   
Discharge [if not covered in above] 
• Have you noticed/did you notice any discharge from your wound? (Probe: 






identified problems and/or wound infection, how long did it last/do you still 
have discharge?) 
Redness [if not covered in above] 
• Have you noticed/ did you notice any redness of your wound? (Probe: 
where/what does/did it look like, when did this occur – before/after/during 
identified problems and/or wound infection, how long did it last/is it still 
red?) 
Swelling [if not covered in above] 
• Have you noticed/did you notice any swelling of your wound? (Probe: 
where, when did it occur – before/after/during identified problems and/or 
wound infection, how long did it last/is it still swollen?) 
Pain [if not covered in above] 
• Have you experienced any pain or soreness with your wound? (Probe: 
where/how painful, when did this occur – before/after/during identified 
problems and/or wound infection, were painkillers taken – what and how 
often, how long did this last/is it still painful?) 
Heat [if not covered in above] 
• How does/how did your wound feel to touch? (Probe: cool/warm, where, 
when did any heat occur – before/after/during identified problems and/or 
wound infection?) 
Opening [if not covered in above] 
• Have you noticed/did you notice your wound breaking open? (Probe: where, 
when did this happen – before/after/during identified problems and/or 
wound infection?) 
Smell [if not covered in above] 
• Have you noticed/did you notice any smell from your wound? (Probe: when 
did it occur – before/after/during identified problems and/or wound 
infection, how long did it last/does it still smell?) 
Other signs/symptoms  
• You’ve talked about various things you noticed about your wound (reiterate 
what) are there any other things you, or other people, have noticed/noticed 
about your wound healing? 






• How long did the infection/ problems with your wound last? (Probe: in 
hospital/post discharge) 
• Were there any things that helped with the healing of your wound? (Probe: 
what, when and how?) 
• Were there any things that did not help the healing of your wound? (Probe: 
what, when and how?) 
 
Health care use: interventions and investigations 
[Cover below topics if not already covered in relation to signs/symptoms above] 
• Have you talked to/seen any health professionals about your wound 
problems/infection? (Probe: who, when, why, about what, what happened 
(e.g. dressings, drainage, x-ray, biopsy, another operation), how often?) 
[Focus discussion as relevant: in hospital stay/post discharge and who made 
contact: patient or health professional] 
• Have you had your dressing changed? (Probe: how often, by whom, can/did 
you see your wound when the dressing was changed?) 
• Increased observation [if not covered in above] 
• Did a health professional look at your wound while in hospital? (probe: how 
often, what did they look at/do/ask?)  
• Did a health professional look at your wound after returning home? (probe: 
how often, when, where, what did they look at/do/ask?)  
• Investigations [if not covered in above] 
• Has a health professional ever taken a sample from you wound? (Probe: 
when, how did your wound look/feel at the time, what happened?) 
• Interventions [if not covered in above] 
• How long were you in hospital after your operation? (Probe: where, when 
discharged) 
• Have you been given/were you given any medications for your wound 
infection/problems? (Probe: what (e.g. antibiotics), when (in hospital/post 







• Did you need to go back to hospital for problems with your wound/wound 
infection? (Probe: why, where, when, what happened (e.g. dressings, 
drainage, x-ray, biopsy, another operation))? 
 
Current measures 
I have two questionnaires here that are currently used to assess problems with a 
patient’s wound after they have been discharged from hospital. 
We would value your feedback on how easy or difficult these questionnaires are to 
complete and if you think they ask useful questions. Would you mind completing 
these questionnaires?  If you have any thoughts as you are completing the 
questionnaire, or don’t understand what the question is asking or how to answer a 
question please let me know.  I will also ask you some questions after you have 
completed the questionnaire. [Make a note of any issues talked about during the 
process to probe on these in more depth once the questionnaire is complete] 
ASEPSIS-based PDQ 
• How did you find completing this questionnaire? (Probe: easy/difficult – 
which questions and why? Did the questions make sense? Were they relevant 
to your experience – not at all, a little, quite a bit, very much? Do the response 
categories [explain this] make sense? Are you able to answer the questions 
using a yes/no answer – relate back to patients experience?) 
Question specific 
• I noticed/you mentioned that question X may have been/was confusing? 
(Probe: what does this question mean to you? Was it easy to answer – 
why/why not?) 
• What does question [4/5/6] mean to you? What do you understand by the 
term [discharge/clear yellow fluid/pus/broken open]? 
• Was it easy to answer question [2/7/8/9/10]? (Probe why/why not? How 
could these questions be improved? Response categories?) 
• Do you have any other suggestions on how the questionnaire could be 
improved?  (Probe: alternative wording, additional questions, response 
categories, layout/presentation, length of questionnaire?)  
CDC-based PDQ (PHE SSISS) 
• How did you find completing this questionnaire? (Probe: easy/difficult – 
which questions and why? Did the questions make sense? Were they relevant 






categories [explain this] make sense? Are you able to answer the questions 
using the response categories provided – relate back to patients experience? 
Why/why not?) 
Question specific 
• I noticed/you mentioned that question X may have been/was confusing? 
(Probe: what does this question mean to you? Was it easy to answer – 
why/why not?) 
• What does question [2] mean to you? What do you understand by the term 
[discharge/leakage/ clear or blood stained/yellow green pus]? 
• Was it easy to answer question [1/2/3/4/5/6/7/8]? (Probe why/why not? 
How could these questions be improved? Response categories?) 
• Do you have any other suggestions on how the questionnaire could be 
improved?  (Probe: alternative wording, additional questions, response 
categories, layout/presentation, length of questionnaire?)  
General 
• When after your discharge from hospital do you think would be the best time 
to complete a questionnaire? (Probe: Why? Methods of receiving and 
returning questionnaire -person, post, (SAE for return) email?) 
 
Closing 
Interviewer checks understanding of any outstanding points, answers further 









Appendix 9. Topic guide for interviews with healthcare professionals to identify 
content domains for the SSI measure (Study 1; Phase 1) 
Opening  
Interviewer will re-iterate study information and purpose of interview, answer any 
questions, and take written consent.   
Background, interviewee detail and ice breaker 
Details of interviewee role and working history in role.  
 
Experience of SSI – lead in 
1) I understand in your role as ________________ you come into contact with patients 
experiencing wound infections after surgery.   
OR 
2) I understand in your role as ________________ you have experience of detecting wound 
infections in patients that develop after surgery.  
 
 
Surgeons, ward nurses, tissue viability nurses and other staff who come into contact 
with patients and may be involved in identifying and treating wound infections. 
 
Signs/symptoms 
Q. As you know wound infections are common. Can you tell me what would 
prompt you to treat a wound as infected? (Probe: why, what signs/symptoms or other 
information tell you it is infected? Does presence of pus require any treatment? How long 
after surgery do you see infections - in hospital/post discharge? Who is involved in the 
treatment of infections and why? How is the infection treated?) 
 
Health care use: interventions and investigations.  
Q. If a patient has a wound infection what follow-up is required? (Probe: 
observation - when, where, how often, and by whom; swabs; biopsy; xray; surgery; drainage; 
other? Why, how long after surgery, how often, does this vary by severity of infection, 
differences between in hospital/post discharge, who is involved at what stage, would anything 
else happen?) 
Q. Do you routinely swab wounds? (Focus on participant on them taking/asking for the 







Microbiologists, methodologists and others who may be involved in detecting SSI but not 
necessarily involved in treating infections. 
Q. Can you tell me about your experience of identifying wound infections in patients 
who have had surgery? (Probe: what information is used to identify infection, how long 
after surgery is this information obtained, how is this information obtained, who is  
involved in identifying infection, how is the information used, who is contacted, do 
you have any contact with patients and if so why?) 
 
Current measures of SSI 
In the Bluebelle trial we would like to find an effective way of measuring wound 
infection. Measures currently used widely include the Centre for Disease Control 
and Prevention (CDC) criteria and the ASEPSIS grading scale.  
Q. Are you familiar with either of these measures? (Probe: which measure, have you 
used them? If yes when, why, how often?) 
We are interested in finding out how easy or difficult these current measures are 
to use and would value your feedback.  
I have some pictures of a wound infection, with brief patient background, and a 
copy of the current clinician measures.  
Provide patient background scenario and picture (mild to moderate wound 
infection) and ask participant to run through patient reported questions.  
Using these criteria/this grading scale how would you classify this wound? If you 
have any comments or questions about the measures while you are doing this please 
do let me know. 







Q. How did you find using these criteria to classify wound infection? (Probe: 
Easy/difficult, why, which criteria?) 
Q. Do you think the criteria used are relevant? (Probe: Why/why not? Are any more 
relevant than others – why/why not and when?) 
Q. Do you think the distinctions between superficial, deep, and organ/space 
infections are useful? (Probe: why/why not? If yes who are they useful for – the 
hospital/patient and how are they useful?) 
Q. Do you have any suggestions on how these criteria could be improved? (Probe: 
How, why, are there any other criteria which could be included?) 
 
ASEPSIS 
Q. How did you find using the grading scale? (Probe: Easy/difficult, why, which 
parts?) 
Q. Do you think the criteria used to identify wound infection are relevant? (Probe: 
Why/why not?) 
Q. Do you think it is useful to grade wound characteristics over five days? (Probe: 
Why/why not?) 
Q. Do you think it is useful to assess the proportion of the wound affected? (Probe: 
Why/why not?) 
Q. Do you have any suggestions on how this grading scale could be improved? 
(Probe: How, why, what other items could be included?)  
 
General 
Q. Do you have any other suggestions about things to consider when measuring 
wound infection? (Probe: why, when?) 
Q. Discharge of patients after surgery is happening earlier than previously. We are 
thinking about the times at which we should measure presence of infection. If 
measuring it within 30 days, when during this timeframe do you think it is useful 
to try and measure this? (Probe: how often? Does this vary depending on the type of 
surgery? Appropriate person to complete?) 
Q. Patient reported measures have been developed to identify wound infection 30 






a wound infection? (Probe: why/why not, if yes what questions do you think is it relevant 
to ask patients, and why? Is 30 days after surgery a good timeframe?) 
I have the patient measures here. Do you have any comments on these? 
 
Closing 
Interviewer checks understanding of any outstanding points, answers further 









Appendix 10. Topic guide for cognitive interviews to pre-test the SSI measure (Study 
1; Phase 3)  
Opening  
• Ensure participant understands about the study and purpose of this interview (the 
Bluebelle study is looking at the use of wound dressings after surgery. As part of this 
study we are designing a questionnaire for patients to complete after they have been 
discharged from hospital, to monitor the healing of the wound and look for signs of 
wound infection. We would like to get feedback on the questionnaire so far) 
• Answer any questions 
• Ask if participant is happy for the interview to be audio-recorded, explain the recording 
will be kept confidential, will be anonymised (names, addresses etc will be removed) 
and all data will be stored securely 
• Obtain written consent (version 1.0) – check all sections have been initialled, signed and 
dated  
Explain to the participant that the interview will be in 3 parts: 
1) Answering some general questions about their surgery and experience 
2) Completing a questionnaire and “thinking out loud” – verbalising their thoughts while 
answering the questions. Remind them that we are interested in their feedback – how 
easy/difficult they find the questions and whether it covers what happened to them 
3) Discussing their views after finishing the questionnaire - asking further comments on 
their understanding of the questions and any suggestions for improvements 
 
Background of surgery and wound healing experience 
• Ask brief details of the surgical procedure that the participant has had. Include type of 
surgery and whether it was lap or open. 
• Determine how long it has been since their operation and how many days they initially 
spent in hospital  
• Ask for brief information about any problems with wound healing – (Probe: what were the 
first signs, when did you noticed any problems, what did you do, what advice did you seek, who 
did you see, what treatment was given?  
 
Completion of the SSI measure 
Explain the questionnaire the participant will now be asked to complete is one that 
we are designing for a research study. It is a questionnaire for patients who have had 
surgery so that we can monitor wound healing and look for any signs of wound 






feedback so that we can make improvements. Explain the information they provide 
is not going to be fed back to the clinical team.  
• Ask the participant to complete the questionnaire to the best of their ability and based on 
their own experience. There are no right or wrong answers. 
• Ask them to complete the questions based on what has happened in the last two weeks. 
• Ask the participant to ‘think out loud’ as they complete the questionnaire, verbalising 
their thoughts and tell you what they are thinking and how they are choosing your 
answers. “Tell me what you are thinking and how are you coming up with your 
answers”. Remind them that we can go back to any questions and talk in more depth 
when they have finished the questionnaire 
• Ask them to let you know if they don’t understand the question or are struggling to 
answer it accurately (e.g. if they cannot tick any of the response options) 
Document on a paper copy of the questionnaire any reported issues or problems 
during the process to probe on these in more depth once the questionnaire is 
complete 
When the participant has completed the questionnaire 
For each or select items 
• Can you tell me in your own words what that question was asking? (Probe: What does 
the word XX mean to you? Are there any other ways you would describe it?  
• Was it easy to choose an answer? (Probe: What does “a bit” “moderate” “very much” mean 
to you with regards to XXX (e.g. pain, leaking fluid). Are you able to answer the question 
accurately? Relate back to the patients’ own experience) 
• Explore where participants have indicated confusion 
• Choose two items to explore where the patient has not indicated symptomatology or 
difficulty to check false negatives 
General 
• How did you find completing this questionnaire? (Probe: Were the questions relevant to 
your experience – are there any others that should be included? Do the response categories 
[explain this] make sense?)  
• What does the word “wound” mean to you? 
• Do you have any other suggestions on how the questionnaire could be improved?  
(Probe: alternative wording, additional questions, response categories, layout/presentation, length 
of questionnaire?) 
• Timeframe - You have given your answers based on the last two weeks. Would your 
answers differ if you were thinking about just the last week? Or since you were 
discharged from hospital? (Probe: Why? Relate back to the patients’ own experience. When do 
you think would be the best time to complete questionnaires like these?)  
• Explore views on methods for receiving and returning questionnaire – in person, by post, 







Other signs, symptoms, wound healing interventions 
• Can you tell me anything else you noticed about your wound that has not been 
covered in these questions? (Probe: we you able to look at your wound after the operation? 
what does/did it look like (discharge, redness, swelling, opening) what did/does it feel like (pain, 
heat), have you noticed any smell from you wound?) 




• Check understanding of any outstanding points 
• Answer further questions 
• If not previously completed, interviewer completes form A2 (1), and A2 (2) as relevant.  








Appendix 11. Participant information leaflet for the cohort study to validate the SSI 









































Appendix 12. Consent form for participants for the cohort study to validate the SSI 




















































Appendix 18. Graphical representation of distribution of responses for items 
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Appendix 19. Item-to-item correlation matrix for responses in participant self-assessments (cohort study data) 
Item Q1 Q2 Q3 Q3a Q3b Q3c Q4 Q4a Q4b Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 Q15 Q16 
Q1 1                     
Q2 0.53 1                    
Q3 0.34 0.26 1                   
Q3a 0.15 0.13 0.60 1                  
Q3b 0.33 0.26 0.81 0.33 1                 
Q3c 0.29 0.14 0.56 0.17 0.27 1                
Q4 0.28 0.22 0.53 0.25 0.47 0.49 1               
Q4a 0.28 0.21 0.53 0.29 0.49 0.49 0.94 1              
Q4b 0.19 0.13 0.39 0.23 0.43 0.22 0.66 0.73 1             
Q5 0.25 0.27 0.11 0.15 0.10 0.06 0.14 0.16 0.12 1            
Q6 0.19 0.16 0.31 0.21 0.27 0.30 0.23 0.24 0.23 0.09 1           
Q7 0.24 0.27 0.07 0.07 0.07 0.10 0.10 0.14 0.06 0.31 0.26 1          
Q8 0.16 0.24 0.21 0.20 0.23 0.08 0.25 0.27 0.27 0.13 0.27 0.08 1         
Q9 0.27 0.22 0.50 0.39 0.42 0.31 0.40 0.41 0.29 0.19 0.21 0.18 0.21 1        
Q10 0.16 0.12 0.41 0.31 0.33 0.25 0.23 0.24 0.17 0.01 0.08 -0.05 0.07 0.30 1       
Q11 0.27 0.04 0.42 0.15 0.35 0.31 0.32 0.33 0.36 0.15 0.11 0.00 0.27 0.36 0.17 1      
Q12 0.42 0.27 0.51 0.28 0.46 0.45 0.35 0.35 0.18 0.11 0.11 0.04 0.24 0.47 0.30 0.50 1     
Q13 0.16 0.12 0.26 0.18 0.28 0.14 0.22 0.23 0.39 0.09 0.17 0.07 0.15 0.17 0.15 0.23 0.21 1    
Q14 0.13 -0.05 0.12 0.09 0.15 0.07 0.04 0.04 0.04 0.01 -0.03 0.04 -0.04 0.18 0.11 0.21 0.15 0.15 1   
Q15 0.17 0.04 0.33 0.20 0.28 0.27 0.19 0.13 0.21 0.02 0.19 0.01 0.09 0.18 0.17 0.31 0.37 0.38 0.12 1  
Q16 0.06 0.00 0.04 0.20 0.08 -0.02 0.03 0.03 -0.02 0.19 -0.02 -0.03 -0.03 0.13 0.07 -0.02 -0.03 -0.02 -0.01 -0.01 1 





Appendix 20. Multi-trait scaling: item-scale correlations for a hypothesised set of multiple scales and single items (cohort study data, 
participant self-assessments) 
 Patient self-assessment n=284  
















Number of items in scale  4 5 7 2 1 1 
Cronbach alpha co-efficient 0.62 0.70 0.64 0.75 - - 
Item  Item-scale correlation 
1 Was there redness spreading 
away from the wound? 
(erythema/cellulitis) 
0.42* 0.32 0.40 0.31 0.17 0.14 
2 Was the area around the wound 
warmer than the surrounding 
skin? 
0.47* 0.24 0.22 0.23 0.13 0.24 
5 Has the area around the wound 
become swollen? 
0.35* 0.08 0.20 0.14 0.07 0.11 
7 Has the wound been painful to 
touch? 
0.35* -0.00 0.12 0.11 0.24 0.07 
3 Was any part of the wound 
leaking fluid? 
0.25 0.73* 0.65 0.56 0.31 0.21 
3a Was it clear fluid? (serous 
exudate) 
0.19 0.54* 0.41 0.29 0.22 0.20 
3b Was it blood-stained fluid? 
(haemoserous exudate) 
0.24 0.67* 0.56 0.52 0.26 0.24 
3c Was it thick and yellow/green 
fluid (pus/purulent exudate) 
0.19 0.50* 0.45 0.48 0.30 0.06 
10 Has anything been put on the 
skin to cover the wound? 
(dressing) 

















*Indicates item-scale correlation with hypothesised scale 
        
9 Have you sought advice 
because of a problem with your 
wound, other than at a routine 
planned follow-up 
appointment? 
0.33 0.51 0.44* 0.41 0.22 0.22 
11 Have you been back into 
hospital for treatment with a 
problem with your wound? 
0.14 0.37 0.51* 0.35 0.10 0.26 
12 Have you been given antibiotics 
for a problem with you wound? 
0.29 0.51 0.55* 0.34 0.11 0.23 
13 Have the edges of your wound 
been deliberately separated by a 
doctor or nurse? 
0.16 0.27 0.33* 0.31 0.17 0.16 
14 Has your wound been scraped 
or cut to remove any unwanted 
tissue? (debridement of wound) 
0.08 0.12 0.24* 0.06 -0.03 -0.04 
15 Has your wound been drained? 
(drainage of pus/abscess) 
0.09 0.28 0.39* 0.26 0.21 0.09 
16 Have you had an operation 
under general anaesthetic for 
treatment of a problem with 
your wound? 
0.08 0.09 0.05* 0.00 -0.02 -0.03 
4 Have the edges of any part of 
the wound separated/gaped 
open on their own accord? 
(spontaneous dehiscence) 
0.27 0.52 0.46 0.66* 0.22 0.25 
4b Did the deeper tissue separate? 0.16 0.40 0.39 0.66* 0.22 0.26 
6 Has the wound been smelly? 0.23 0.25 0.23 0.23 * 0.27 
8 Have you had, or felt like you 
have had, a raised temperature 
or fever? (fever >38oC) 




Appendix 21. Multi-trait scaling: item-scale correlations for a hypothesised set of multiple scales and single items (cohort study 
data, HCP observer assessments) 
 HCP observer assessment n=307  
















Number of items in scale  4 5 7 2 1 1 
Cronbach alpha co-efficient 0.72 0.70 0.66 0.79 - - 
Item  Item-scale correlation 
1 Was there redness spreading away from the 
wound? (erythema/cellulitis) 
0.63* 0.48 0.43. 0.37 0.24 0.26 
2 Was the area around the wound warmer 
than the surrounding skin? 
0.61* 0.40 0.38 0.38 0.23 0.35 
5 Has the area around the wound become 
swollen? 
0.46* 0.22 0.27 0.22 0.23 0.25 
7 Has the wound been painful to touch? 0.35* 0.25 0.18 0.24 0.16 0.11 
3 Was any part of the wound leaking fluid? 0.45 0.78* 0.59 0.55 0.30 0.25 
3a Was it clear fluid? (serous exudate) 0.18 0.35* 0.21 0.25 0.17 0.06 
3b Was it blood-stained fluid? (haemoserous 
exudate) 
0.40 0.54* 0.45 0.43 0.27 0.31 
3c Was it thick and yellow/green fluid 
(pus/purulent exudate) 
0.51 0.45* 0.47 0.45 0.33 0.24 
10 Has anything been put on the skin to cover 
the wound? (dressing) 
0.28 0.48* 0.44 0.30 0.23 0.21 
9 Have you sought advice because of a 
problem with your wound, other than at a 
routine planned follow-up appointment? 
0.38 0.51 0.52* 0.38 0.28 0.24 
11 Have you been back into hospital for 
treatment with a problem with your 
wound? 






12 Have you been given antibiotics for a 
problem with you wound? 
0.48 0.51 0.57* 0.39 0.21 0.34 
13 Have the edges of your wound been 
deliberately separated by a doctor or nurse? 
0.19 0.33 0.37* 0.38 0.22 0.31 
14 Has your wound been scraped or cut to 
remove any unwanted tissue? 
(debridement of wound) 
0.17 0.15 0.12* 0.27 0.15 0.30 
15 Has your wound been drained? (drainage 
of pus/abscess) 
0.13 0.21 0.41* 0.22 0.08 0.10 
16† Have you had an operation under general 
anaesthetic for treatment of a problem with 
your wound? 
- - - - - - 
4 Have the edges of any part of the wound 
separated/gaped open on their own 
accord? (spontaneous dehiscence) 
0.42 0.55 0.54 0.73* 0.33 0.34 
4b Did the deeper tissue separate? 0.26 0.36 0.36 0.73* 0.11 0.29 
6 Has the wound been smelly? 0.29 0.34 0.31 0.31 * 0.24 
8 Have you had, or felt like you have had, a 
raised temperature or fever? (fever >38oC) 
0.32 0.29 0.43 0.37 0.24 * 
*Indicates item-scale correlation with hypothesised scale 





Appendix 22. Factor loadings for a three-factor model, ml method of 
estimation, unrotated (cohort study data, participant self-assessments) 
 
 Participant self-assessment (n=201) 
  Factor 1 Factor 2 Factor 3 










1 Was there redness spreading away from the wound? 
(erythema/cellulitis) 
0.2896 0.4564 0.0724 
2 Was the area around the wound warmer than the surrounding skin? 0.1267 0.2983 0.2885 
3 Was any part of the wound leaking fluid? 1.0000 -0.0000 -0.0000 
3a Was it clear fluid? (serous exudate) 0.5465 -0.0046 0.1192 
3b Was it blood-stained fluid? (haemoserous exudate) 0.7366 0.1735 0.0138 
3c Was it thick and yellow/green fluid (pus/purulent exudate) 0.4877 -0.0211 -0.0024 
4 Have the edges of any part of the wound separated/gaped open on 
their own accord? (spontaneous dehiscence) 
0.4973 0.1807 0.2473 
4b Did the deeper tissue separate? 0.3748 0.3580 0.3553 
5 Has the area around the wound become swollen? 0.0651 0.3232 0.1771 
6 Has the wound been smelly? 0.3911 0.1349 0.2796 
7 Has the wound been painful to touch? 0.1542 0.3286 0.3021 
8 Have you had, or felt like you have had, a raised temperature or 
fever? (fever >38oC) 
0.1896 0.2455 0.1583 
9 Have you sought advice because of a problem with your wound, 
other than at a routine planned follow-up appointment? 
0.5082 0.2573 -0.0303 
10 Has anything been put on the skin to cover the wound? (dressing) 0.3780 0.1142 -0.0231 
11 Have you been back into hospital for treatment with a problem with 
your wound? 
0.4123 0.4572 -0.4323 
12 Have you been given antibiotics for a problem with you wound? 0.5387 0.4339 -0.2726 
13 Have the edges of your wound been deliberately separated by a 
doctor or nurse? 
0.2675 0.4832 0.2198 
14 Has your wound been scraped or cut to remove any unwanted 
tissue? (debridement of wound) 
0.1929 0.4096 -0.3493 
15 Has your wound been drained? (drainage of pus/abscess) 0.4123 0.3658 0.1087 
16† Have you had an operation under general anaesthetic for treatment 
of a problem with your wound? 
- - - 







Appendix 23. Factor loadings for a three-factor model, ml method of 
estimation, unrotated (cohort study data, HCP observer assessments) 
 
 HCP assessment (n=290)  
Factor 1 Factor 2 Factor 3 











1 Was there redness spreading away from the wound? 
(erythema/cellulitis) 
0.7953 0.5143 -0.4552 
2 Was the area around the wound warmer than the surrounding skin? 0.3657 0.6071 -0.3791 
3 Was any part of the wound leaking fluid? 1.0000 -0.0000 -0.0000 
3a Was it clear fluid? (serous exudate) 0.5664 -0.1378 0.0327 
3b Was it blood-stained fluid? (haemoserous exudate) 0.6646 0.0852 -0.0489 
3c Was it thick and yellow/green fluid (pus/purulent exudate) 0.5951 0.3056 -0.0995 
4 Have the edges of any part of the wound separated/gaped open on 
their own accord? (spontaneous dehiscence) 
0.5481 0.5348 0.4237 
4b Did the deeper tissue separate? 0.3683 0.4743 0.4818 
5 Has the area around the wound become swollen? 0.1792 0.3324 -0.2812 
6 Has the wound been smelly? 0.2689 0.1619 0.0061 
7 Has the wound been painful to touch? 0.2364 0.2194 -0.1311 
8 Have you had, or felt like you have had, a raised temperature or fever? 
(fever >38oC) 
0.2461 0.3673 0.1335 
9 Have you sought advice because of a problem with your wound, other 
than at a routine planned follow-up appointment? 
0.4418 0.3285 -0.0030 
10 Has anything been put on the skin to cover the wound? (dressing) 0.4716 0.1414 -0.0060 
11 Have you been back into hospital for treatment with a problem with 
your wound? 
0.2559 0.1930 0.2606 
12 Have you been given antibiotics for a problem with you wound? 0.4910 0.4223 -0.0412 
13 Have the edges of your wound been deliberately separated by a doctor 
or nurse? 
0.3593 0.1417 0.1633 
14 Has your wound been scraped or cut to remove any unwanted tissue? 
(debridement of wound) 
0.0058 0.0710 0.1618 
15 Has your wound been drained? (drainage of pus/abscess) 0.2232 0.2429 0.1423 
16† Have you had an operation under general anaesthetic for treatment of a 
problem with your wound? 
- - - 






Appendix 24. Factor loadings for a single factor model, ml method of 








  Factor 1 Factor 1 





3 Was any part of the wound leaking fluid? 0.8636 0.9299 
4 Have the edges of any part of the wound 
separated/gaped open on their own accord? 
(spontaneous dehiscence) 
0.8425 0.4112 
4b** Did the deeper tissue separate? 0.7517 - 
3c Was it thick and yellow/green fluid 
(pus/purulent exudate) 
0.7096 0.7118 
3b Was it blood-stained fluid? (haemoserous 
exudate) 
0.6816 0.3994 
12 Have you been given antibiotics for a problem 
with you wound? 
0.6696 0.6648 
3a Was it clear fluid? (serous exudate) 0.6070 0.5172 
9 Have you sought advice because of a problem 
with your wound, other than at a routine planned 
follow-up appointment? 
0.6060 0.5042 
6 Has the wound been smelly? 0.5662 0.5885 
8 Have you had, or felt like you have had, a raised 
temperature or fever? (fever >38oC) 
0.5566 0.3571 
5 Has the area around the wound become swollen? 0.5067 0.4525 
1 Was there redness spreading away from the 
wound? (erythema/cellulitis) 
0.4811 0.6664 
14 Has your wound been scraped or cut to remove 
any unwanted tissue? (debridement of wound) 
0.4578 -0.0036 
10 Has anything been put on the skin to cover the 
wound? (dressing) 
0.4545 0.5238 
7 Has the wound been painful to touch? 0.4448 0.4765 
13 Have the edges of your wound been deliberately 
separated by a doctor or nurse? 
0.4334 0.4798 
2 Was the area around the wound warmer than the 
surrounding skin? 
0.4117 0.5708 
11 Have you been back into hospital for treatment 
with a problem with your wound? 
0.4044 0.2865 
15 Has your wound been drained? (drainage of 
pus/abscess) 
0.0856 0.3835 
16† Have you had an operation under general 
anaesthetic for treatment of a problem with your 
wound? 
- - 
*Items are ordered in ascending values for participant self-assessment item-factor loading  
**Model dropped this item because of zero variance 




Appendix 25. Polychoric matrix of item-to-item correlations for responses in participant self-assessments (combined cohort and 
pilot RCT data) 
Item Q1 Q2 Q3 Q3a Q3b Q3c Q4 Q4a Q4b Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 Q15 Q16 
Q1 1                     
Q2 0.63 1                    
Q3 0.51 0.28 1                   
Q3a 0.40 0.21 0.84 1                  
Q3b 0.46 0.30 0.90 0.61 1                 
Q3c 0.45 0.28 0.83 0.62 0.57 1                
Q4 0.46 0.35 0.74 0.57 0.64 0.74 1               
Q4a 0.47 0.35 0.77 0.61 0.68 0.74 0.99 1              
Q4b 0.58 0.48 0.79 0.51 0.73 0.62 0.91 0.93 1             
Q5 0.41 0.48 0.28 0.29 0.35 0.27 0.41 0.40 0.52 1            
Q6 0.44 0.19 0.64 0.44 0.56 0.61 0.55 0.54 0.61 0.25 1           
Q7 0.42 0.49 0.35 0.38 0.34 0.35 0.34 0.35 0.58 0.56 0.46 1          
Q8 0.29 0.46 0.38 0.31 0.44 0.34 0.49 0.48 0.56 0.33 0.52 0.31 1         
Q9 0.46 0.35 0.77 0.74 0.69 0.63 0.61 0.65 0.58 0.32 0.55 0.50 0.42 1        
Q10 0.20 0.17 0.62 0.47 0.61 0.56 0.40 0.41 0.50 0.11 0.24 0.17 0.23 0.50 1       
Q11 0.42 0.18 0.65 0.35 0.65 0.42 0.49 0.48 0.66 0.31 0.36 0.20 0.47 0.65 0.52 1      
Q12 0.61 0.45 0.77 0.58 0.67 0.78 0.71 0.71 0.68 0.38 0.57 0.35 0.45 0.81 0.57 0.80 1     
Q13 0.57 0.49 0.63 0.40 0.72 0.10 0.49 0.58 0.77 0.43 0.55 0.36 0.42 0.54 0.64 0.58 0.58 1    
Q14 0.78 0.10 0.73 0.22 0.81 . 0.56 0.56 0.75 0.42 0.42 0.53 0.34 . . . . 0.82 1   
Q15 0.28 0.19 0.70 0.53 0.61 0.43 0.45 0.43 0.58 0.11 0.40 0.13 0.46 0.44 0.56 0.53 0.60 0.81 0.55 1  




Appendix 26. Polychoric matrix factor loadings for a single factor model, ml 







  Factor 1 Factor 1 





12 Have you been given antibiotics for a problem 
with you wound? 
0.9224 0.8901 
9† Have you sought advice because of a problem 
with your wound, other than at a routine planned 
follow-up appointment? 
0.8548 - 
3b Was it blood-stained fluid? (haemoserous 
exudate) 
0.7893 0.6344 
4 Have the edges of any part of the wound 
separated/gaped open on their own accord? 
(spontaneous dehiscence) 
0.7692 0.7390 
3c Was it thick and yellow/green fluid 
(pus/purulent exudate) 
0.7618 0.8093 
11† Have you been back into hospital for treatment 
with a problem with your wound? 
0.7382 - 
3a Was it clear fluid? (serous exudate) 0.7005 0.5037 
6 Has the wound been smelly? 0.6447 0.6288 
15 Has your wound been drained? (drainage of 
pus/abscess) 
0.6263 0.6802 
1 Was there redness spreading away from the 
wound? (erythema/cellulitis) 
0.6109 0.7871 
10 Has anything been put on the skin to cover the 
wound? (dressing) 
0.6020 0.7159 
8 Have you had, or felt like you have had, a raised 
temperature or fever? (fever >38oC) 
0.5365 0.5778 
7 Has the wound been painful to touch? 0.4576 0.4174 
2 Was the area around the wound warmer than the 
surrounding skin? 
0.4486 0.7188 
5 Has the area around the wound become swollen? 0.4237 0.5024 
3† Was any part of the wound leaking fluid? - - 
4b† Did the deeper tissue separate? - - 
13† Have the edges of your wound been deliberately 
separated by a doctor or nurse? 
- 0.6617 
14** Has your wound been scraped or cut to remove 
any unwanted tissue? (debridement of wound) 
- - 
16** Have you had an operation under general 
anaesthetic for treatment of a problem with your 
wound? 
- - 
*Items are ordered in ascending values for item-factor loading  
**Item excluded because too few observations for a polychoric matrix 











































Appendix 30. Prompt sheet to guide the Selfi wound study cognitive 
interviews (Study 2; Phase 1) 
 
Opening  
Interviewer will re-iterate study information, answer any questions, and take written 
consent. Permission to audio-record the interview will be sought. 
 
Background, interviewee details and ice breaker 
• Pre-defined, targeted questions 
• Participant’s background (age, education level, cohabitation and employment 
information) and details of surgical procedure they have had (type of 
procedure, planned or emergency, when, location and number of wounds, 
wound healing experience). 
• Participant’s experience and familiarity with technology (type of phone they 
use, tablet or other handheld device, details on the camera facility, whether 
they access the internet on their phone, tablet or other handheld device, use of 
camera facility on phone, tablet or other handheld device, frequency of use, 
confidence)  
e.g. “Do you ever use your phone to send or receive email?” “Do you ever use 
your phone to take pictures?” 
 
Wound photography and image upload 
• Interviewer will provide paper-copy instructions to the participant and ask 
them to read through and follow the instructions to take a photograph(s) of 
their wound. Interviewer will explain the ‘think aloud’ technique and ask 
them to verbalise their thoughts as they read and carry out the instructions. 
Protection of privacy and dignity will be re-iterated and 
participant/interviewer will move to another room if required. 
• Interviewer will observe participant using mobile phone / tablet etc to access 
email and follow the link to log in to the REDCap database. Participant will 
be asked to follow the instructions and continue to ‘think aloud’. 
• Interviewer will follow-up on any observed or raised issues to explore 
problems or confusion further 
e.g. “You paused for a while as you were reading [part of the instructions]. Can 
you tell me what you were thinking?” 
 
Debriefing 
Pre-defined, targeted questions: 
1. Were there any parts of the wound photography instructions that you found 
confusing / difficult / problematic? If yes, which one? Why? 
2. Were there any parts of the image upload process that you found confusing / 






3. Do you have any suggestions for how the instructions could be improved? 
4. Do you have a preference for receiving the link to access the study database 
and upload your photograph via email or text if used in future? 
5. How did you find the experience of seeing your wound? 
 
 
Completion of Bluebelle wound healing questionnaire (WHQ) 
Interviewer will provide a paper-copy of the WHQ and ask the participant to 
complete it on their own / with help from their carer. After completion, Interviewer 
will run through the responses 
• Explore responses to items, elicit more information or elaboration to 
confirm/amend the patient’s response 
 
Closing 
Researcher checks understanding of any outstanding points, answers further 
questions, and checks to see if participant would like to receive a summary of 









Appendix 31. Participant information leaflet for the Selfi wound study 





























Appendix 33. Debriefing questions included in the Selfi wound study online 
survey (Study 2; Phase 2) 
 
Approximately how long did it take to take the wound photograph(s)?  
1, less than 5 minutes  
2, 5 to 10 minutes  
3, 10 to 15 minutes  
4, more than 15 minutes 
Who took the photograph(s)?  
1, I took them myself  
2, Someone else took them  
3, I took some and someone else took others 
Who helped to take the photographs?  
1, family member  
2, nurse or other healthcare professional  
3, friend or neighbour  
9, other person 
Was any help needed from another person to upload the photograph? 
Yes/No 
Who helped to upload the photograph(s)?  
1, family member  
2, nurse or other healthcare professional  
3, friend or neighbour  
9, other person 
How would you rate your level of experience with using your mobile device? 
0, Not experienced 
1, Somewhat experienced 
2, Moderately experienced 
3, Very experienced 
4, Expert 
On average, how often do you send or receive emails using your phone or 
tablet? 
0, Never 
1, Yearly  
2, Monthly  
3, Weekly  
4, Every day 
On average, how often do you take photographs using your phone or tablet? 
0, Never  
1, Yearly  
2, Monthly  
3, Weekly  






Appendix 34. Prompt sheet for Selfi wound study participant follow-up calls 
(Study 2; Phase 2) 
 
1. How easy was it to follow the instructions to take a photograph of your 
wound? 
2. Did you need help any with taking the photograph(s)? If so, which 
part(s) did you need help with and why? 
3. Were there any parts of the instructions that you found confusing or 
difficult to follow? If so, which part(s) did you need help with and 
why? 
 
4. How long did it take to take the photograph(s)? 
 
5. How easy was it to access the study online database / webpage? 
 
6. How easy was it to upload you wound photograph? 
 
7. Did you need help with logging into the system and/or uploading the 
photograph(s)? 
 
8. How long did it take to upload the photograph(s) and fill out the 
questions online? 
 
9. Do you have any comments on the design of the study online system? 
 
10. Do you have any other comments or feedback you can give us about 
the overall process of taking and uploading your wound 
photograph(s)? 
 
 
 
